id	sid	tid	token	lemma	pos
dpc-5050	1	1	dermatology	dermatology	NOUN
dpc-5050	1	2	:	:	PUNCT
dpc-5050	1	3	practical	practical	ADJ
dpc-5050	1	4	and	and	CCONJ
dpc-5050	1	5	conceptual	conceptual	ADJ
dpc-5050	1	6	original	original	ADJ
dpc-5050	1	7	article	article	NOUN
dpc-5050	1	8	|	|	ADV
dpc-5050	1	9	dermatol	dermatol	ADJ
dpc-5050	1	10	pract	pract	NOUN
dpc-5050	1	11	concept	concept	NOUN
dpc-5050	1	12	.	.	PUNCT
dpc-5050	2	1	2025;15(2):5050	2025;15(2):5050	NUM
dpc-5050	2	2	1	1	NUM
dpc-5050	2	3	risk	risk	NOUN
dpc-5050	2	4	of	of	ADP
dpc-5050	2	5	osteoporosis	osteoporosis	NOUN
dpc-5050	2	6	associated	associate	VERB
dpc-5050	2	7	with	with	ADP
dpc-5050	2	8	glucocorticoid	glucocorticoid	ADJ
dpc-5050	2	9	use	use	NOUN
dpc-5050	2	10	in	in	ADP
dpc-5050	2	11	pemphigus	pemphigus	NOUN
dpc-5050	2	12	vulgaris	vulgaris	NOUN
dpc-5050	2	13	:	:	PUNCT
dpc-5050	2	14	insights	insight	NOUN
dpc-5050	2	15	from	from	ADP
dpc-5050	2	16	a	a	DET
dpc-5050	2	17	retrospective	retrospective	ADJ
dpc-5050	2	18	cohort	cohort	NOUN
dpc-5050	2	19	study	study	NOUN
dpc-5050	2	20	merve	merve	NOUN
dpc-5050	2	21	kaya1	kaya1	NOUN
dpc-5050	2	22	,	,	PUNCT
dpc-5050	2	23	gülhan	gülhan	VERB
dpc-5050	2	24	aksoy	aksoy	ADJ
dpc-5050	2	25	saraç1	saraç1	NOUN
dpc-5050	2	26	,	,	PUNCT
dpc-5050	2	27	onur	onur	PROPN
dpc-5050	2	28	acar2	acar2	PROPN
dpc-5050	2	29	,	,	PUNCT
dpc-5050	2	30	selma	selma	PROPN
dpc-5050	2	31	emre3	emre3	PROPN
dpc-5050	2	32	,	,	PUNCT
dpc-5050	2	33	akın	akın	PROPN
dpc-5050	2	34	aktaş3	aktaş3	NOUN
dpc-5050	2	35	1	1	NUM
dpc-5050	2	36	department	department	NOUN
dpc-5050	2	37	of	of	ADP
dpc-5050	2	38	dermatology	dermatology	NOUN
dpc-5050	2	39	,	,	PUNCT
dpc-5050	2	40	bilkent	bilkent	NOUN
dpc-5050	2	41	city	city	PROPN
dpc-5050	2	42	hospital	hospital	PROPN
dpc-5050	2	43	,	,	PUNCT
dpc-5050	2	44	ankara	ankara	PROPN
dpc-5050	2	45	,	,	PUNCT
dpc-5050	2	46	turkey	turkey	NOUN
dpc-5050	2	47	2	2	NUM
dpc-5050	2	48	orhangazi	orhangazi	NOUN
dpc-5050	2	49	district	district	NOUN
dpc-5050	2	50	health	health	NOUN
dpc-5050	2	51	directorate	directorate	NOUN
dpc-5050	2	52	,	,	PUNCT
dpc-5050	2	53	bursa	bursa	NOUN
dpc-5050	2	54	,	,	PUNCT
dpc-5050	2	55	turkey	turkey	PROPN
dpc-5050	2	56	3	3	NUM
dpc-5050	2	57	department	department	NOUN
dpc-5050	2	58	of	of	ADP
dpc-5050	2	59	dermatology	dermatology	NOUN
dpc-5050	2	60	,	,	PUNCT
dpc-5050	2	61	ankara	ankara	PROPN
dpc-5050	2	62	yıldırım	yıldırım	PROPN
dpc-5050	2	63	beyazıt	beyazıt	PROPN
dpc-5050	2	64	university	university	PROPN
dpc-5050	2	65	,	,	PUNCT
dpc-5050	2	66	medical	medical	ADJ
dpc-5050	2	67	school	school	NOUN
dpc-5050	2	68	,	,	PUNCT
dpc-5050	2	69	ankara	ankara	PROPN
dpc-5050	2	70	,	,	PUNCT
dpc-5050	2	71	turkey	turkey	PROPN
dpc-5050	2	72	key	key	ADJ
dpc-5050	2	73	words	word	NOUN
dpc-5050	2	74	:	:	PUNCT
dpc-5050	2	75	pemphigus	pemphigus	NOUN
dpc-5050	2	76	vulgaris	vulgaris	NOUN
dpc-5050	2	77	,	,	PUNCT
dpc-5050	2	78	glucocorticoids	glucocorticoid	NOUN
dpc-5050	2	79	,	,	PUNCT
dpc-5050	2	80	bone	bone	NOUN
dpc-5050	2	81	mineral	mineral	NOUN
dpc-5050	2	82	density	density	NOUN
dpc-5050	2	83	,	,	PUNCT
dpc-5050	2	84	osteoporosis	osteoporosis	NOUN
dpc-5050	2	85	,	,	PUNCT
dpc-5050	2	86	bone	bone	NOUN
dpc-5050	2	87	loss	loss	NOUN
dpc-5050	2	88	,	,	PUNCT
dpc-5050	2	89	corticosteroid	corticosteroid	NOUN
dpc-5050	2	90	-	-	PUNCT
dpc-5050	2	91	induced	induce	VERB
dpc-5050	2	92	osteoporosis	osteoporosis	NOUN
dpc-5050	2	93	,	,	PUNCT
dpc-5050	2	94	retrospective	retrospective	ADJ
dpc-5050	2	95	cohort	cohort	NOUN
dpc-5050	2	96	citation	citation	NOUN
dpc-5050	2	97	:	:	PUNCT
dpc-5050	2	98	kaya	kaya	PROPN
dpc-5050	2	99	m	m	PROPN
dpc-5050	2	100	,	,	PUNCT
dpc-5050	2	101	saraç	saraç	PROPN
dpc-5050	2	102	ga	ga	PROPN
dpc-5050	2	103	,	,	PUNCT
dpc-5050	2	104	acar	acar	VERB
dpc-5050	2	105	o	o	NOUN
dpc-5050	2	106	,	,	PUNCT
dpc-5050	2	107	emre	emre	PROPN
dpc-5050	2	108	s	s	PROPN
dpc-5050	2	109	,	,	PUNCT
dpc-5050	2	110	aktaş	aktaş	ADJ
dpc-5050	2	111	a.	a.	NOUN
dpc-5050	2	112	risk	risk	NOUN
dpc-5050	2	113	of	of	ADP
dpc-5050	2	114	osteoporosis	osteoporosis	NOUN
dpc-5050	2	115	associated	associate	VERB
dpc-5050	2	116	with	with	ADP
dpc-5050	2	117	glucocorticoid	glucocorticoid	ADJ
dpc-5050	2	118	use	use	NOUN
dpc-5050	2	119	in	in	ADP
dpc-5050	2	120	pemphigus	pemphigus	NOUN
dpc-5050	2	121	vulgaris	vulgaris	NOUN
dpc-5050	2	122	:	:	PUNCT
dpc-5050	2	123	insights	insight	NOUN
dpc-5050	2	124	from	from	ADP
dpc-5050	2	125	a	a	DET
dpc-5050	2	126	retrospective	retrospective	ADJ
dpc-5050	2	127	cohort	cohort	NOUN
dpc-5050	2	128	study	study	NOUN
dpc-5050	2	129	.	.	PUNCT
dpc-5050	3	1	dermatol	dermatol	NOUN
dpc-5050	3	2	pract	pract	PROPN
dpc-5050	3	3	concept	concept	NOUN
dpc-5050	3	4	.	.	PUNCT
dpc-5050	4	1	2025;15(2):5050	2025;15(2):5050	NUM
dpc-5050	4	2	.	.	PUNCT
dpc-5050	5	1	doi	doi	NOUN
dpc-5050	5	2	:	:	PUNCT
dpc-5050	5	3	https://doi.org/10.5826/dpc.1502a5050	https://doi.org/10.5826/dpc.1502a5050	PROPN
dpc-5050	5	4	accepted	accept	VERB
dpc-5050	5	5	:	:	PUNCT
dpc-5050	5	6	january	january	PROPN
dpc-5050	5	7	2	2	NUM
dpc-5050	5	8	,	,	PUNCT
dpc-5050	5	9	2025	2025	NUM
dpc-5050	5	10	;	;	PUNCT
dpc-5050	5	11	published	publish	VERB
dpc-5050	5	12	:	:	PUNCT
dpc-5050	6	1	april	april	PROPN
dpc-5050	6	2	2025	2025	NUM
dpc-5050	6	3	copyright	copyright	NOUN
dpc-5050	6	4	:	:	PUNCT
dpc-5050	7	1	©	©	PROPN
dpc-5050	7	2	2025	2025	NUM
dpc-5050	7	3	kaya	kaya	PROPN
dpc-5050	7	4	et	et	PROPN
dpc-5050	7	5	al	al	PROPN
dpc-5050	7	6	.	.	PUNCT
dpc-5050	8	1	this	this	PRON
dpc-5050	8	2	is	be	AUX
dpc-5050	8	3	an	an	DET
dpc-5050	8	4	open	open	ADJ
dpc-5050	8	5	-	-	PUNCT
dpc-5050	8	6	access	access	NOUN
dpc-5050	8	7	article	article	NOUN
dpc-5050	8	8	distributed	distribute	VERB
dpc-5050	8	9	under	under	ADP
dpc-5050	8	10	the	the	DET
dpc-5050	8	11	terms	term	NOUN
dpc-5050	8	12	of	of	ADP
dpc-5050	8	13	the	the	DET
dpc-5050	8	14	creative	creative	ADJ
dpc-5050	8	15	commons	common	NOUN
dpc-5050	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5050	8	17	license	license	NOUN
dpc-5050	8	18	(	(	PUNCT
dpc-5050	8	19	by	by	ADP
dpc-5050	8	20	-	-	PUNCT
dpc-5050	8	21	nc-4.0	nc-4.0	NOUN
dpc-5050	8	22	)	)	PUNCT
dpc-5050	8	23	,	,	PUNCT
dpc-5050	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5050	8	25	,	,	PUNCT
dpc-5050	8	26	which	which	PRON
dpc-5050	8	27	permits	permit	VERB
dpc-5050	8	28	unrestricted	unrestricted	ADJ
dpc-5050	8	29	noncommercial	noncommercial	ADJ
dpc-5050	8	30	use	use	NOUN
dpc-5050	8	31	,	,	PUNCT
dpc-5050	8	32	distribution	distribution	NOUN
dpc-5050	8	33	,	,	PUNCT
dpc-5050	8	34	and	and	CCONJ
dpc-5050	8	35	reproduction	reproduction	NOUN
dpc-5050	8	36	in	in	ADP
dpc-5050	8	37	any	any	DET
dpc-5050	8	38	medium	medium	NOUN
dpc-5050	8	39	,	,	PUNCT
dpc-5050	8	40	provided	provide	VERB
dpc-5050	8	41	the	the	DET
dpc-5050	8	42	original	original	ADJ
dpc-5050	8	43	authors	author	NOUN
dpc-5050	8	44	and	and	CCONJ
dpc-5050	8	45	source	source	NOUN
dpc-5050	8	46	are	be	AUX
dpc-5050	8	47	credited	credit	VERB
dpc-5050	8	48	.	.	PUNCT
dpc-5050	9	1	funding	funding	NOUN
dpc-5050	9	2	:	:	PUNCT
dpc-5050	9	3	none	none	NOUN
dpc-5050	9	4	.	.	PUNCT
dpc-5050	10	1	competing	compete	VERB
dpc-5050	10	2	interests	interest	NOUN
dpc-5050	10	3	:	:	PUNCT
dpc-5050	10	4	none	none	NOUN
dpc-5050	10	5	.	.	PUNCT
dpc-5050	11	1	authorship	authorship	NOUN
dpc-5050	11	2	:	:	PUNCT
dpc-5050	11	3	all	all	DET
dpc-5050	11	4	authors	author	NOUN
dpc-5050	11	5	have	have	AUX
dpc-5050	11	6	contributed	contribute	VERB
dpc-5050	11	7	significantly	significantly	ADV
dpc-5050	11	8	to	to	ADP
dpc-5050	11	9	this	this	DET
dpc-5050	11	10	publication	publication	NOUN
dpc-5050	11	11	.	.	PUNCT
dpc-5050	12	1	corresponding	correspond	VERB
dpc-5050	12	2	author	author	NOUN
dpc-5050	12	3	:	:	PUNCT
dpc-5050	12	4	merve	merve	PROPN
dpc-5050	12	5	kaya	kaya	PROPN
dpc-5050	12	6	,	,	PUNCT
dpc-5050	12	7	department	department	NOUN
dpc-5050	12	8	of	of	ADP
dpc-5050	12	9	dermatology	dermatology	NOUN
dpc-5050	12	10	,	,	PUNCT
dpc-5050	12	11	bilkent	bilkent	NOUN
dpc-5050	12	12	city	city	PROPN
dpc-5050	12	13	hospital	hospital	NOUN
dpc-5050	12	14	,	,	PUNCT
dpc-5050	12	15	06800	06800	NUM
dpc-5050	12	16	,	,	PUNCT
dpc-5050	12	17	ankara	ankara	PROPN
dpc-5050	12	18	,	,	PUNCT
dpc-5050	12	19	turkey	turkey	PROPN
dpc-5050	12	20	.	.	PUNCT
dpc-5050	13	1	orcid	orcid	NOUN
dpc-5050	14	1	i	i	PRON
dpc-5050	14	2	d	d	NOUN
dpc-5050	14	3	:	:	PUNCT
dpc-5050	14	4	0000	0000	NUM
dpc-5050	14	5	-	-	SYM
dpc-5050	14	6	00025188	00025188	NUM
dpc-5050	14	7	-	-	SYM
dpc-5050	14	8	1245	1245	NUM
dpc-5050	14	9	.	.	PUNCT
dpc-5050	15	1	e	e	X
dpc-5050	15	2	-	-	NOUN
dpc-5050	15	3	mail	mail	NOUN
dpc-5050	15	4	:	:	PUNCT
dpc-5050	15	5	mervekaya203@gmail.com	mervekaya203@gmail.com	X
dpc-5050	16	1	introduction	introduction	NOUN
dpc-5050	16	2	:	:	PUNCT
dpc-5050	16	3	pemphigus	pemphigus	NOUN
dpc-5050	16	4	vulgaris	vulgaris	NOUN
dpc-5050	16	5	(	(	PUNCT
dpc-5050	16	6	pv	pv	NOUN
dpc-5050	16	7	)	)	PUNCT
dpc-5050	16	8	is	be	AUX
dpc-5050	16	9	an	an	DET
dpc-5050	16	10	autoimmune	autoimmune	ADJ
dpc-5050	16	11	bullous	bullous	ADJ
dpc-5050	16	12	disease	disease	NOUN
dpc-5050	16	13	affecting	affect	VERB
dpc-5050	16	14	the	the	DET
dpc-5050	16	15	skin	skin	NOUN
dpc-5050	16	16	and	and	CCONJ
dpc-5050	16	17	mucous	mucous	ADJ
dpc-5050	16	18	membranes	membrane	NOUN
dpc-5050	16	19	.	.	PUNCT
dpc-5050	17	1	osteoporosis	osteoporosis	NOUN
dpc-5050	17	2	,	,	PUNCT
dpc-5050	17	3	a	a	DET
dpc-5050	17	4	significant	significant	ADJ
dpc-5050	17	5	side	side	ADJ
dpc-5050	17	6	effect	effect	NOUN
dpc-5050	17	7	of	of	ADP
dpc-5050	17	8	commonly	commonly	ADV
dpc-5050	17	9	used	use	VERB
dpc-5050	17	10	glucocorticoids	glucocorticoid	NOUN
dpc-5050	17	11	in	in	ADP
dpc-5050	17	12	treatment	treatment	NOUN
dpc-5050	17	13	,	,	PUNCT
dpc-5050	17	14	can	can	AUX
dpc-5050	17	15	adversely	adversely	ADV
dpc-5050	17	16	contribute	contribute	VERB
dpc-5050	17	17	to	to	ADP
dpc-5050	17	18	the	the	DET
dpc-5050	17	19	existing	exist	VERB
dpc-5050	17	20	morbidity	morbidity	NOUN
dpc-5050	17	21	.	.	PUNCT
dpc-5050	18	1	objectives	objective	NOUN
dpc-5050	18	2	:	:	PUNCT
dpc-5050	19	1	this	this	DET
dpc-5050	19	2	study	study	NOUN
dpc-5050	19	3	aimed	aim	VERB
dpc-5050	19	4	to	to	PART
dpc-5050	19	5	assess	assess	VERB
dpc-5050	19	6	the	the	DET
dpc-5050	19	7	impact	impact	NOUN
dpc-5050	19	8	of	of	ADP
dpc-5050	19	9	glucocorticoid	glucocorticoid	ADJ
dpc-5050	19	10	therapy	therapy	NOUN
dpc-5050	19	11	on	on	ADP
dpc-5050	19	12	bone	bone	NOUN
dpc-5050	19	13	mineral	mineral	NOUN
dpc-5050	19	14	density	density	NOUN
dpc-5050	19	15	in	in	ADP
dpc-5050	19	16	patients	patient	NOUN
dpc-5050	19	17	with	with	ADP
dpc-5050	19	18	pv	pv	NOUN
dpc-5050	19	19	.	.	PUNCT
dpc-5050	19	20	methods	method	NOUN
dpc-5050	19	21	:	:	PUNCT
dpc-5050	19	22	patients	patient	NOUN
dpc-5050	19	23	newly	newly	ADV
dpc-5050	19	24	diagnosed	diagnose	VERB
dpc-5050	19	25	with	with	ADP
dpc-5050	19	26	pv	pv	PROPN
dpc-5050	19	27	were	be	AUX
dpc-5050	19	28	included	include	VERB
dpc-5050	19	29	in	in	ADP
dpc-5050	19	30	this	this	DET
dpc-5050	19	31	study	study	NOUN
dpc-5050	19	32	.	.	PUNCT
dpc-5050	20	1	femur	femur	NOUN
dpc-5050	20	2	and	and	CCONJ
dpc-5050	20	3	lumbar	lumbar	NOUN
dpc-5050	20	4	t	t	PROPN
dpc-5050	20	5	-	-	PUNCT
dpc-5050	20	6	scores	score	NOUN
dpc-5050	20	7	,	,	PUNCT
dpc-5050	20	8	serum	serum	NOUN
dpc-5050	20	9	calcium	calcium	NOUN
dpc-5050	20	10	,	,	PUNCT
dpc-5050	20	11	vitamin	vitamin	NOUN
dpc-5050	20	12	d	d	NOUN
dpc-5050	20	13	,	,	PUNCT
dpc-5050	20	14	alkaline	alkaline	ADJ
dpc-5050	20	15	phosphatase	phosphatase	NOUN
dpc-5050	20	16	(	(	PUNCT
dpc-5050	20	17	alp	alp	PROPN
dpc-5050	20	18	)	)	PUNCT
dpc-5050	20	19	,	,	PUNCT
dpc-5050	20	20	and	and	CCONJ
dpc-5050	20	21	lactate	lactate	NOUN
dpc-5050	20	22	dehydrogenase	dehydrogenase	NOUN
dpc-5050	20	23	(	(	PUNCT
dpc-5050	20	24	ldh	ldh	PROPN
dpc-5050	20	25	)	)	PUNCT
dpc-5050	20	26	levels	level	NOUN
dpc-5050	20	27	were	be	AUX
dpc-5050	20	28	analyzed	analyze	VERB
dpc-5050	20	29	before	before	ADV
dpc-5050	20	30	and	and	CCONJ
dpc-5050	20	31	one	one	NUM
dpc-5050	20	32	year	year	NOUN
dpc-5050	20	33	after	after	ADP
dpc-5050	20	34	therapy	therapy	NOUN
dpc-5050	20	35	.	.	PUNCT
dpc-5050	21	1	results	result	NOUN
dpc-5050	21	2	:	:	PUNCT
dpc-5050	21	3	among	among	ADP
dpc-5050	21	4	66	66	NUM
dpc-5050	21	5	patients	patient	NOUN
dpc-5050	21	6	,	,	PUNCT
dpc-5050	21	7	the	the	DET
dpc-5050	21	8	average	average	ADJ
dpc-5050	21	9	time	time	NOUN
dpc-5050	21	10	to	to	ADP
dpc-5050	21	11	diagnosis	diagnosis	NOUN
dpc-5050	21	12	was	be	AUX
dpc-5050	21	13	10.14	10.14	NUM
dpc-5050	21	14	months	month	NOUN
dpc-5050	21	15	,	,	PUNCT
dpc-5050	21	16	and	and	CCONJ
dpc-5050	21	17	the	the	DET
dpc-5050	21	18	average	average	ADJ
dpc-5050	21	19	daily	daily	NOUN
dpc-5050	21	20	dose	dose	NOUN
dpc-5050	21	21	of	of	ADP
dpc-5050	21	22	prednisone	prednisone	PROPN
dpc-5050	21	23	was	be	AUX
dpc-5050	21	24	16.95	16.95	NUM
dpc-5050	21	25	mg	mg	PROPN
dpc-5050	21	26	,	,	PUNCT
dpc-5050	21	27	with	with	ADP
dpc-5050	21	28	63.6	63.6	NUM
dpc-5050	21	29	%	%	NOUN
dpc-5050	21	30	of	of	ADP
dpc-5050	21	31	patients	patient	NOUN
dpc-5050	21	32	receiving	receive	VERB
dpc-5050	21	33	medium	medium	ADJ
dpc-5050	21	34	doses	dose	NOUN
dpc-5050	21	35	.	.	PUNCT
dpc-5050	22	1	our	our	PRON
dpc-5050	22	2	data	datum	NOUN
dpc-5050	22	3	showed	show	VERB
dpc-5050	22	4	no	no	DET
dpc-5050	22	5	significant	significant	ADJ
dpc-5050	22	6	change	change	NOUN
dpc-5050	22	7	in	in	ADP
dpc-5050	22	8	lumbar	lumbar	PROPN
dpc-5050	22	9	t	t	PROPN
dpc-5050	22	10	-	-	PUNCT
dpc-5050	22	11	scores	score	NOUN
dpc-5050	22	12	after	after	ADP
dpc-5050	22	13	one	one	NUM
dpc-5050	22	14	year	year	NOUN
dpc-5050	22	15	of	of	ADP
dpc-5050	22	16	glucocorticoid	glucocorticoid	ADJ
dpc-5050	22	17	treatment	treatment	NOUN
dpc-5050	22	18	,	,	PUNCT
dpc-5050	22	19	but	but	CCONJ
dpc-5050	22	20	a	a	DET
dpc-5050	22	21	significant	significant	ADJ
dpc-5050	22	22	decrease	decrease	NOUN
dpc-5050	22	23	in	in	ADP
dpc-5050	22	24	femur	femur	ADJ
dpc-5050	22	25	density	density	NOUN
dpc-5050	22	26	was	be	AUX
dpc-5050	22	27	observed	observe	VERB
dpc-5050	22	28	.	.	PUNCT
dpc-5050	23	1	the	the	DET
dpc-5050	23	2	decrease	decrease	NOUN
dpc-5050	23	3	in	in	ADP
dpc-5050	23	4	femur	femur	ADJ
dpc-5050	23	5	t	t	PROPN
dpc-5050	23	6	-	-	PUNCT
dpc-5050	23	7	scores	score	NOUN
dpc-5050	23	8	was	be	AUX
dpc-5050	23	9	significant	significant	ADJ
dpc-5050	23	10	in	in	ADP
dpc-5050	23	11	the	the	DET
dpc-5050	23	12	medium	medium	ADJ
dpc-5050	23	13	-	-	PUNCT
dpc-5050	23	14	dose	dose	NOUN
dpc-5050	23	15	group	group	NOUN
dpc-5050	23	16	,	,	PUNCT
dpc-5050	23	17	while	while	SCONJ
dpc-5050	23	18	the	the	DET
dpc-5050	23	19	lumbar	lumbar	NOUN
dpc-5050	23	20	t	t	PROPN
dpc-5050	23	21	-	-	PUNCT
dpc-5050	23	22	scores	score	NOUN
dpc-5050	23	23	decreased	decrease	VERB
dpc-5050	23	24	significantly	significantly	ADV
dpc-5050	23	25	in	in	ADP
dpc-5050	23	26	the	the	DET
dpc-5050	23	27	high	high	ADJ
dpc-5050	23	28	-	-	PUNCT
dpc-5050	23	29	dose	dose	NOUN
dpc-5050	23	30	group	group	NOUN
dpc-5050	23	31	.	.	PUNCT
dpc-5050	24	1	there	there	PRON
dpc-5050	24	2	was	be	VERB
dpc-5050	24	3	no	no	DET
dpc-5050	24	4	significant	significant	ADJ
dpc-5050	24	5	correlation	correlation	NOUN
dpc-5050	24	6	between	between	ADP
dpc-5050	24	7	t	t	PROPN
dpc-5050	24	8	-	-	PUNCT
dpc-5050	24	9	scores	score	NOUN
dpc-5050	24	10	and	and	CCONJ
dpc-5050	24	11	sex	sex	NOUN
dpc-5050	24	12	,	,	PUNCT
dpc-5050	24	13	menopausal	menopausal	ADJ
dpc-5050	24	14	state	state	NOUN
dpc-5050	24	15	,	,	PUNCT
dpc-5050	24	16	diagnosis	diagnosis	NOUN
dpc-5050	24	17	time	time	NOUN
dpc-5050	24	18	,	,	PUNCT
dpc-5050	24	19	or	or	CCONJ
dpc-5050	24	20	obesity	obesity	NOUN
dpc-5050	24	21	.	.	PUNCT
dpc-5050	25	1	additionally	additionally	ADV
dpc-5050	25	2	,	,	PUNCT
dpc-5050	25	3	vitamin	vitamin	NOUN
dpc-5050	25	4	d	d	NOUN
dpc-5050	25	5	and	and	CCONJ
dpc-5050	25	6	ldh	ldh	PROPN
dpc-5050	25	7	levels	level	NOUN
dpc-5050	25	8	significantly	significantly	ADV
dpc-5050	25	9	increased	increase	VERB
dpc-5050	25	10	after	after	ADP
dpc-5050	25	11	treatment	treatment	NOUN
dpc-5050	25	12	,	,	PUNCT
dpc-5050	25	13	while	while	SCONJ
dpc-5050	25	14	changes	change	NOUN
dpc-5050	25	15	in	in	ADP
dpc-5050	25	16	serum	serum	NOUN
dpc-5050	25	17	calcium	calcium	NOUN
dpc-5050	25	18	and	and	CCONJ
dpc-5050	25	19	alp	alp	NOUN
dpc-5050	25	20	levels	level	NOUN
dpc-5050	25	21	were	be	AUX
dpc-5050	25	22	not	not	PART
dpc-5050	25	23	significant	significant	ADJ
dpc-5050	25	24	.	.	PUNCT
dpc-5050	26	1	conclusion	conclusion	NOUN
dpc-5050	26	2	:	:	PUNCT
dpc-5050	26	3	given	give	VERB
dpc-5050	26	4	the	the	DET
dpc-5050	26	5	multiple	multiple	ADJ
dpc-5050	26	6	factors	factor	NOUN
dpc-5050	26	7	that	that	PRON
dpc-5050	26	8	reduce	reduce	VERB
dpc-5050	26	9	bone	bone	NOUN
dpc-5050	26	10	mineral	mineral	NOUN
dpc-5050	26	11	density	density	NOUN
dpc-5050	26	12	in	in	ADP
dpc-5050	26	13	pv	pv	NOUN
dpc-5050	26	14	patients	patient	NOUN
dpc-5050	26	15	,	,	PUNCT
dpc-5050	26	16	the	the	DET
dpc-5050	26	17	current	current	ADJ
dpc-5050	26	18	strategies	strategy	NOUN
dpc-5050	26	19	for	for	ADP
dpc-5050	26	20	glucocorticoid	glucocorticoid	NOUN
dpc-5050	26	21	-	-	PUNCT
dpc-5050	26	22	induced	induce	VERB
dpc-5050	26	23	osteoporosis	osteoporosis	NOUN
dpc-5050	26	24	prophylaxis	prophylaxis	NOUN
dpc-5050	26	25	in	in	ADP
dpc-5050	26	26	this	this	DET
dpc-5050	26	27	group	group	NOUN
dpc-5050	26	28	may	may	AUX
dpc-5050	26	29	need	need	VERB
dpc-5050	26	30	re	re	NOUN
dpc-5050	26	31	-	-	NOUN
dpc-5050	26	32	evaluation	evaluation	NOUN
dpc-5050	26	33	,	,	PUNCT
dpc-5050	26	34	with	with	ADP
dpc-5050	26	35	potential	potential	NOUN
dpc-5050	26	36	for	for	ADP
dpc-5050	26	37	additional	additional	ADJ
dpc-5050	26	38	recommendations	recommendation	NOUN
dpc-5050	26	39	to	to	PART
dpc-5050	26	40	be	be	AUX
dpc-5050	26	41	included	include	VERB
dpc-5050	26	42	in	in	ADP
dpc-5050	26	43	pemphigus	pemphigus	NOUN
dpc-5050	26	44	guidelines	guideline	NOUN
dpc-5050	26	45	.	.	PUNCT
dpc-5050	27	1	abstract	abstract	ADJ
dpc-5050	27	2	2	2	NUM
dpc-5050	27	3	original	original	ADJ
dpc-5050	27	4	article	article	NOUN
dpc-5050	27	5	|	|	ADV
dpc-5050	27	6	dermatol	dermatol	ADJ
dpc-5050	27	7	pract	pract	NOUN
dpc-5050	27	8	concept	concept	NOUN
dpc-5050	27	9	.	.	PUNCT
dpc-5050	28	1	2025;15(2):5050	2025;15(2):5050	NUM
dpc-5050	28	2	introduction	introduction	NOUN
dpc-5050	28	3	pemphigus	pemphigus	NOUN
dpc-5050	28	4	vulgaris	vulgaris	NOUN
dpc-5050	28	5	(	(	PUNCT
dpc-5050	28	6	pv	pv	NOUN
dpc-5050	28	7	)	)	PUNCT
dpc-5050	28	8	is	be	AUX
dpc-5050	28	9	an	an	DET
dpc-5050	28	10	autoimmune	autoimmune	ADJ
dpc-5050	28	11	bullous	bullous	ADJ
dpc-5050	28	12	disease	disease	NOUN
dpc-5050	28	13	affecting	affect	VERB
dpc-5050	28	14	the	the	DET
dpc-5050	28	15	skin	skin	NOUN
dpc-5050	28	16	and	and	CCONJ
dpc-5050	28	17	mucous	mucous	ADJ
dpc-5050	28	18	membranes	membrane	NOUN
dpc-5050	28	19	.	.	PUNCT
dpc-5050	29	1	it	it	PRON
dpc-5050	29	2	is	be	AUX
dpc-5050	29	3	characterized	characterize	VERB
dpc-5050	29	4	by	by	ADP
dpc-5050	29	5	acantholysis	acantholysis	NOUN
dpc-5050	29	6	resulting	result	VERB
dpc-5050	29	7	from	from	ADP
dpc-5050	29	8	antibodies	antibody	NOUN
dpc-5050	29	9	against	against	ADP
dpc-5050	29	10	desmoglein	desmoglein	NOUN
dpc-5050	29	11	1	1	NUM
dpc-5050	29	12	and	and	CCONJ
dpc-5050	29	13	desmoglein	desmoglein	NOUN
dpc-5050	29	14	3	3	NUM
dpc-5050	30	1	[	[	X
dpc-5050	30	2	1,2	1,2	NUM
dpc-5050	30	3	]	]	PUNCT
dpc-5050	30	4	.	.	PUNCT
dpc-5050	31	1	clinically	clinically	ADV
dpc-5050	31	2	,	,	PUNCT
dpc-5050	31	3	this	this	PRON
dpc-5050	31	4	typically	typically	ADV
dpc-5050	31	5	presents	present	VERB
dpc-5050	31	6	as	as	ADP
dpc-5050	31	7	flaccid	flaccid	ADJ
dpc-5050	31	8	vesicles	vesicle	NOUN
dpc-5050	31	9	,	,	PUNCT
dpc-5050	31	10	bullae	bullae	NOUN
dpc-5050	31	11	,	,	PUNCT
dpc-5050	31	12	or	or	CCONJ
dpc-5050	31	13	erosions	erosion	NOUN
dpc-5050	31	14	on	on	ADP
dpc-5050	31	15	the	the	DET
dpc-5050	31	16	skin	skin	NOUN
dpc-5050	31	17	and	and	CCONJ
dpc-5050	31	18	mucous	mucous	ADJ
dpc-5050	31	19	membranes	membrane	NOUN
dpc-5050	31	20	,	,	PUNCT
dpc-5050	31	21	with	with	ADP
dpc-5050	31	22	the	the	DET
dpc-5050	31	23	oral	oral	ADJ
dpc-5050	31	24	mucosa	mucosa	NOUN
dpc-5050	31	25	being	be	AUX
dpc-5050	31	26	the	the	DET
dpc-5050	31	27	primary	primary	ADJ
dpc-5050	31	28	site	site	NOUN
dpc-5050	31	29	of	of	ADP
dpc-5050	31	30	onset	onset	NOUN
dpc-5050	31	31	[	[	X
dpc-5050	31	32	3	3	NUM
dpc-5050	31	33	]	]	PUNCT
dpc-5050	31	34	.	.	PUNCT
dpc-5050	32	1	although	although	SCONJ
dpc-5050	32	2	its	its	PRON
dpc-5050	32	3	incidence	incidence	NOUN
dpc-5050	32	4	worldwide	worldwide	ADV
dpc-5050	32	5	is	be	AUX
dpc-5050	32	6	2.83	2.83	NUM
dpc-5050	32	7	per	per	ADP
dpc-5050	32	8	million	million	NUM
dpc-5050	32	9	person	person	NOUN
dpc-5050	32	10	-	-	PUNCT
dpc-5050	32	11	years	year	NOUN
dpc-5050	32	12	,	,	PUNCT
dpc-5050	32	13	it	it	PRON
dpc-5050	32	14	is	be	AUX
dpc-5050	32	15	a	a	DET
dpc-5050	32	16	life	life	NOUN
dpc-5050	32	17	-	-	PUNCT
dpc-5050	32	18	threatening	threaten	VERB
dpc-5050	32	19	disease	disease	NOUN
dpc-5050	32	20	[	[	X
dpc-5050	32	21	4	4	NUM
dpc-5050	32	22	]	]	PUNCT
dpc-5050	32	23	.	.	PUNCT
dpc-5050	33	1	while	while	SCONJ
dpc-5050	33	2	corticosteroids	corticosteroid	NOUN
dpc-5050	33	3	have	have	AUX
dpc-5050	33	4	been	be	AUX
dpc-5050	33	5	the	the	DET
dpc-5050	33	6	first	first	ADJ
dpc-5050	33	7	choice	choice	NOUN
dpc-5050	33	8	of	of	ADP
dpc-5050	33	9	treatment	treatment	NOUN
dpc-5050	33	10	for	for	ADP
dpc-5050	33	11	many	many	ADJ
dpc-5050	33	12	years	year	NOUN
dpc-5050	33	13	,	,	PUNCT
dpc-5050	33	14	they	they	PRON
dpc-5050	33	15	have	have	AUX
dpc-5050	33	16	been	be	AUX
dpc-5050	33	17	ranked	rank	VERB
dpc-5050	33	18	alongside	alongside	ADP
dpc-5050	33	19	rituximab	rituximab	NOUN
dpc-5050	33	20	in	in	ADP
dpc-5050	33	21	new	new	ADJ
dpc-5050	33	22	guidelines	guideline	NOUN
dpc-5050	33	23	due	due	ADP
dpc-5050	33	24	to	to	ADP
dpc-5050	33	25	the	the	DET
dpc-5050	33	26	risk	risk	NOUN
dpc-5050	33	27	of	of	ADP
dpc-5050	33	28	morbidity	morbidity	NOUN
dpc-5050	33	29	and	and	CCONJ
dpc-5050	33	30	mortality	mortality	NOUN
dpc-5050	33	31	[	[	X
dpc-5050	33	32	5,6	5,6	NUM
dpc-5050	33	33	]	]	PUNCT
dpc-5050	33	34	.	.	PUNCT
dpc-5050	34	1	osteoporosis	osteoporosis	NOUN
dpc-5050	34	2	,	,	PUNCT
dpc-5050	34	3	a	a	DET
dpc-5050	34	4	known	know	VERB
dpc-5050	34	5	side	side	NOUN
dpc-5050	34	6	effect	effect	NOUN
dpc-5050	34	7	of	of	ADP
dpc-5050	34	8	corticosteroids	corticosteroid	NOUN
dpc-5050	34	9	,	,	PUNCT
dpc-5050	34	10	can	can	AUX
dpc-5050	34	11	occur	occur	VERB
dpc-5050	34	12	due	due	ADP
dpc-5050	34	13	to	to	ADP
dpc-5050	34	14	senility	senility	NOUN
dpc-5050	34	15	,	,	PUNCT
dpc-5050	34	16	reduced	reduce	VERB
dpc-5050	34	17	mechanical	mechanical	ADJ
dpc-5050	34	18	stimulation/	stimulation/	NUM
dpc-5050	34	19	immobilization	immobilization	NOUN
dpc-5050	34	20	,	,	PUNCT
dpc-5050	34	21	bone	bone	NOUN
dpc-5050	34	22	and	and	CCONJ
dpc-5050	34	23	hormone	hormone	NOUN
dpc-5050	34	24	metabolism	metabolism	NOUN
dpc-5050	34	25	disorders	disorder	NOUN
dpc-5050	34	26	,	,	PUNCT
dpc-5050	34	27	inflammatory	inflammatory	ADJ
dpc-5050	34	28	diseases	disease	NOUN
dpc-5050	34	29	,	,	PUNCT
dpc-5050	34	30	and	and	CCONJ
dpc-5050	34	31	malnutrition	malnutrition	NOUN
dpc-5050	35	1	[	[	X
dpc-5050	35	2	7	7	NUM
dpc-5050	35	3	]	]	PUNCT
dpc-5050	35	4	.	.	PUNCT
dpc-5050	36	1	various	various	ADJ
dpc-5050	36	2	guidelines	guideline	NOUN
dpc-5050	36	3	are	be	AUX
dpc-5050	36	4	being	be	AUX
dpc-5050	36	5	developed	develop	VERB
dpc-5050	36	6	for	for	ADP
dpc-5050	36	7	the	the	DET
dpc-5050	36	8	prophylaxis	prophylaxis	NOUN
dpc-5050	36	9	and	and	CCONJ
dpc-5050	36	10	treatment	treatment	NOUN
dpc-5050	36	11	of	of	ADP
dpc-5050	36	12	corticosteroid	corticosteroid	NOUN
dpc-5050	36	13	-	-	PUNCT
dpc-5050	36	14	induced	induce	VERB
dpc-5050	36	15	osteoporosis	osteoporosis	NOUN
dpc-5050	36	16	[	[	X
dpc-5050	36	17	8,9	8,9	NUM
dpc-5050	36	18	]	]	PUNCT
dpc-5050	36	19	.	.	PUNCT
dpc-5050	37	1	however	however	ADV
dpc-5050	37	2	,	,	PUNCT
dpc-5050	37	3	these	these	DET
dpc-5050	37	4	guidelines	guideline	NOUN
dpc-5050	37	5	are	be	AUX
dpc-5050	37	6	not	not	PART
dpc-5050	37	7	disease	disease	NOUN
dpc-5050	37	8	-	-	PUNCT
dpc-5050	37	9	specific	specific	ADJ
dpc-5050	37	10	.	.	PUNCT
dpc-5050	38	1	current	current	ADJ
dpc-5050	38	2	pv	pv	NOUN
dpc-5050	38	3	guidelines	guideline	NOUN
dpc-5050	38	4	include	include	VERB
dpc-5050	38	5	recommendations	recommendation	NOUN
dpc-5050	38	6	for	for	ADP
dpc-5050	38	7	calcium	calcium	NOUN
dpc-5050	38	8	and	and	CCONJ
dpc-5050	38	9	vitamin	vitamin	NOUN
dpc-5050	38	10	d	d	NOUN
dpc-5050	38	11	supplementation	supplementation	NOUN
dpc-5050	38	12	,	,	PUNCT
dpc-5050	38	13	screening	screen	VERB
dpc-5050	38	14	for	for	ADP
dpc-5050	38	15	osteoporosis	osteoporosis	NOUN
dpc-5050	38	16	,	,	PUNCT
dpc-5050	38	17	and	and	CCONJ
dpc-5050	38	18	bisphosphonates	bisphosphonate	NOUN
dpc-5050	38	19	in	in	ADP
dpc-5050	38	20	patients	patient	NOUN
dpc-5050	38	21	at	at	ADP
dpc-5050	38	22	risk	risk	NOUN
dpc-5050	38	23	[	[	X
dpc-5050	38	24	5	5	NUM
dpc-5050	38	25	]	]	PUNCT
dpc-5050	38	26	.	.	PUNCT
dpc-5050	39	1	the	the	DET
dpc-5050	39	2	clinical	clinical	ADJ
dpc-5050	39	3	impact	impact	NOUN
dpc-5050	39	4	of	of	ADP
dpc-5050	39	5	adhering	adhere	VERB
dpc-5050	39	6	to	to	ADP
dpc-5050	39	7	pv	pv	VERB
dpc-5050	39	8	guidelines	guideline	NOUN
dpc-5050	39	9	on	on	ADP
dpc-5050	39	10	bone	bone	NOUN
dpc-5050	39	11	mineral	mineral	NOUN
dpc-5050	39	12	density	density	NOUN
dpc-5050	39	13	needs	need	VERB
dpc-5050	39	14	to	to	PART
dpc-5050	39	15	be	be	AUX
dpc-5050	39	16	investigated	investigate	VERB
dpc-5050	39	17	since	since	SCONJ
dpc-5050	39	18	there	there	PRON
dpc-5050	39	19	is	be	VERB
dpc-5050	39	20	a	a	DET
dpc-5050	39	21	lack	lack	NOUN
dpc-5050	39	22	of	of	ADP
dpc-5050	39	23	studies	study	NOUN
dpc-5050	39	24	on	on	ADP
dpc-5050	39	25	this	this	DET
dpc-5050	39	26	topic	topic	NOUN
dpc-5050	39	27	.	.	PUNCT
dpc-5050	40	1	objectives	objective	VERB
dpc-5050	40	2	our	our	PRON
dpc-5050	40	3	study	study	NOUN
dpc-5050	40	4	aimed	aim	VERB
dpc-5050	40	5	to	to	PART
dpc-5050	40	6	retrospectively	retrospectively	ADV
dpc-5050	40	7	evaluate	evaluate	VERB
dpc-5050	40	8	the	the	DET
dpc-5050	40	9	bone	bone	NOUN
dpc-5050	40	10	mineral	mineral	NOUN
dpc-5050	40	11	density	density	NOUN
dpc-5050	40	12	changes	change	NOUN
dpc-5050	40	13	in	in	ADP
dpc-5050	40	14	patients	patient	NOUN
dpc-5050	40	15	diagnosed	diagnose	VERB
dpc-5050	40	16	with	with	ADP
dpc-5050	40	17	pv	pv	INTJ
dpc-5050	40	18	who	who	PRON
dpc-5050	40	19	were	be	AUX
dpc-5050	40	20	taking	take	VERB
dpc-5050	40	21	corticosteroids	corticosteroid	NOUN
dpc-5050	40	22	,	,	PUNCT
dpc-5050	40	23	receiving	receive	VERB
dpc-5050	40	24	treatment	treatment	NOUN
dpc-5050	40	25	and	and	CCONJ
dpc-5050	40	26	lifestyle	lifestyle	NOUN
dpc-5050	40	27	modifications	modification	NOUN
dpc-5050	40	28	according	accord	VERB
dpc-5050	40	29	to	to	ADP
dpc-5050	40	30	osteoporosis	osteoporosis	NOUN
dpc-5050	40	31	prevention	prevention	NOUN
dpc-5050	40	32	measures	measure	NOUN
dpc-5050	40	33	within	within	ADP
dpc-5050	40	34	the	the	DET
dpc-5050	40	35	first	first	ADJ
dpc-5050	40	36	year	year	NOUN
dpc-5050	40	37	.	.	PUNCT
dpc-5050	41	1	methods	method	NOUN
dpc-5050	41	2	study	study	NOUN
dpc-5050	41	3	design	design	VERB
dpc-5050	41	4	this	this	DET
dpc-5050	41	5	retrospective	retrospective	ADJ
dpc-5050	41	6	study	study	NOUN
dpc-5050	41	7	was	be	AUX
dpc-5050	41	8	conducted	conduct	VERB
dpc-5050	41	9	in	in	ADP
dpc-5050	41	10	dermatology	dermatology	NOUN
dpc-5050	41	11	inpatient	inpatient	NOUN
dpc-5050	41	12	and	and	CCONJ
dpc-5050	41	13	outpatient	outpatient	NOUN
dpc-5050	41	14	clinics	clinic	NOUN
dpc-5050	41	15	between	between	ADP
dpc-5050	41	16	june	june	PROPN
dpc-5050	41	17	2019	2019	NUM
dpc-5050	41	18	and	and	CCONJ
dpc-5050	41	19	may	may	AUX
dpc-5050	41	20	2024	2024	NUM
dpc-5050	41	21	in	in	ADP
dpc-5050	41	22	a	a	DET
dpc-5050	41	23	training	training	NOUN
dpc-5050	41	24	and	and	CCONJ
dpc-5050	41	25	research	research	NOUN
dpc-5050	41	26	hospital	hospital	NOUN
dpc-5050	41	27	in	in	ADP
dpc-5050	41	28	ankara	ankara	PROPN
dpc-5050	41	29	,	,	PUNCT
dpc-5050	41	30	turkey	turkey	PROPN
dpc-5050	41	31	.	.	PUNCT
dpc-5050	42	1	the	the	DET
dpc-5050	42	2	study	study	NOUN
dpc-5050	42	3	was	be	AUX
dpc-5050	42	4	approved	approve	VERB
dpc-5050	42	5	by	by	ADP
dpc-5050	42	6	the	the	DET
dpc-5050	42	7	hospital	hospital	NOUN
dpc-5050	42	8	’s	’s	PART
dpc-5050	42	9	ethics	ethic	NOUN
dpc-5050	42	10	and	and	CCONJ
dpc-5050	42	11	scientific	scientific	ADJ
dpc-5050	42	12	committee	committee	NOUN
dpc-5050	42	13	(	(	PUNCT
dpc-5050	42	14	approval	approval	NOUN
dpc-5050	42	15	date	date	NOUN
dpc-5050	42	16	:	:	PUNCT
dpc-5050	42	17	29.05.2024	29.05.2024	NUM
dpc-5050	42	18	,	,	PUNCT
dpc-5050	42	19	decision	decision	NOUN
dpc-5050	42	20	number	number	NOUN
dpc-5050	42	21	:	:	PUNCT
dpc-5050	42	22	2	2	NUM
dpc-5050	42	23	-	-	SYM
dpc-5050	42	24	24	24	NUM
dpc-5050	42	25	-	-	PUNCT
dpc-5050	42	26	206	206	NUM
dpc-5050	42	27	)	)	PUNCT
dpc-5050	42	28	.	.	PUNCT
dpc-5050	43	1	study	study	NOUN
dpc-5050	43	2	population	population	NOUN
dpc-5050	43	3	newly	newly	ADV
dpc-5050	43	4	diagnosed	diagnose	VERB
dpc-5050	43	5	pemphigus	pemphigus	NOUN
dpc-5050	43	6	vulgaris	vulgaris	NOUN
dpc-5050	43	7	patients	patient	NOUN
dpc-5050	43	8	who	who	PRON
dpc-5050	43	9	were	be	AUX
dpc-5050	43	10	glucocorticoid	glucocorticoid	ADJ
dpc-5050	43	11	-	-	PUNCT
dpc-5050	43	12	naive	naive	ADJ
dpc-5050	43	13	and	and	CCONJ
dpc-5050	43	14	whose	whose	DET
dpc-5050	43	15	diagnosis	diagnosis	NOUN
dpc-5050	43	16	was	be	AUX
dpc-5050	43	17	confirmed	confirm	VERB
dpc-5050	43	18	by	by	ADP
dpc-5050	43	19	biopsy	biopsy	NOUN
dpc-5050	43	20	were	be	AUX
dpc-5050	43	21	included	include	VERB
dpc-5050	43	22	in	in	ADP
dpc-5050	43	23	our	our	PRON
dpc-5050	43	24	study	study	NOUN
dpc-5050	43	25	.	.	PUNCT
dpc-5050	44	1	patients	patient	NOUN
dpc-5050	44	2	with	with	ADP
dpc-5050	44	3	endocrinological	endocrinological	ADJ
dpc-5050	44	4	,	,	PUNCT
dpc-5050	44	5	rheumatological	rheumatological	ADJ
dpc-5050	44	6	,	,	PUNCT
dpc-5050	44	7	and	and	CCONJ
dpc-5050	44	8	inflammatory	inflammatory	ADJ
dpc-5050	44	9	diseases	disease	NOUN
dpc-5050	44	10	,	,	PUNCT
dpc-5050	44	11	malignancies	malignancy	NOUN
dpc-5050	44	12	,	,	PUNCT
dpc-5050	44	13	having	have	VERB
dpc-5050	44	14	a	a	DET
dpc-5050	44	15	history	history	NOUN
dpc-5050	44	16	of	of	ADP
dpc-5050	44	17	antiepileptic	antiepileptic	ADJ
dpc-5050	44	18	or	or	CCONJ
dpc-5050	44	19	benzodiazepine	benzodiazepine	NOUN
dpc-5050	44	20	usage	usage	NOUN
dpc-5050	44	21	,	,	PUNCT
dpc-5050	44	22	having	have	VERB
dpc-5050	44	23	diseases	disease	NOUN
dpc-5050	44	24	causing	cause	VERB
dpc-5050	44	25	malnutrition	malnutrition	NOUN
dpc-5050	44	26	,	,	PUNCT
dpc-5050	44	27	or	or	CCONJ
dpc-5050	44	28	with	with	SCONJ
dpc-5050	44	29	a	a	DET
dpc-5050	44	30	history	history	NOUN
dpc-5050	44	31	of	of	ADP
dpc-5050	44	32	gastrointestinal	gastrointestinal	ADJ
dpc-5050	44	33	surgery	surgery	NOUN
dpc-5050	44	34	were	be	AUX
dpc-5050	44	35	excluded	exclude	VERB
dpc-5050	44	36	.	.	PUNCT
dpc-5050	45	1	patients	patient	NOUN
dpc-5050	45	2	who	who	PRON
dpc-5050	45	3	were	be	AUX
dpc-5050	45	4	not	not	PART
dpc-5050	45	5	documented	document	VERB
dpc-5050	45	6	to	to	PART
dpc-5050	45	7	have	have	AUX
dpc-5050	45	8	regularly	regularly	ADV
dpc-5050	45	9	taken	take	VERB
dpc-5050	45	10	daily	daily	ADJ
dpc-5050	45	11	calcium	calcium	NOUN
dpc-5050	45	12	and	and	CCONJ
dpc-5050	45	13	vitamin	vitamin	NOUN
dpc-5050	45	14	d	d	NOUN
dpc-5050	45	15	supplements	supplement	NOUN
dpc-5050	45	16	or	or	CCONJ
dpc-5050	45	17	to	to	PART
dpc-5050	45	18	adhere	adhere	VERB
dpc-5050	45	19	to	to	ADP
dpc-5050	45	20	daily	daily	ADJ
dpc-5050	45	21	lifestyle	lifestyle	NOUN
dpc-5050	45	22	and	and	CCONJ
dpc-5050	45	23	diet	diet	NOUN
dpc-5050	45	24	recommendations	recommendation	NOUN
dpc-5050	45	25	or	or	CCONJ
dpc-5050	45	26	patients	patient	NOUN
dpc-5050	45	27	with	with	ADP
dpc-5050	45	28	incomplete	incomplete	ADJ
dpc-5050	45	29	documents	document	NOUN
dpc-5050	45	30	were	be	AUX
dpc-5050	45	31	also	also	ADV
dpc-5050	45	32	excluded	exclude	VERB
dpc-5050	45	33	from	from	ADP
dpc-5050	45	34	the	the	DET
dpc-5050	45	35	study	study	NOUN
dpc-5050	45	36	.	.	PUNCT
dpc-5050	46	1	all	all	DET
dpc-5050	46	2	patients	patient	NOUN
dpc-5050	46	3	were	be	AUX
dpc-5050	46	4	provided	provide	VERB
dpc-5050	46	5	with	with	ADP
dpc-5050	46	6	a	a	DET
dpc-5050	46	7	daily	daily	ADJ
dpc-5050	46	8	supplement	supplement	NOUN
dpc-5050	46	9	of	of	ADP
dpc-5050	46	10	1200	1200	NUM
dpc-5050	46	11	mg	mg	NOUN
dpc-5050	46	12	of	of	ADP
dpc-5050	46	13	calcium	calcium	NOUN
dpc-5050	46	14	and	and	CCONJ
dpc-5050	46	15	800	800	NUM
dpc-5050	46	16	iu	iu	NOUN
dpc-5050	46	17	of	of	ADP
dpc-5050	46	18	vitamin	vitamin	NOUN
dpc-5050	46	19	d	d	NOUN
dpc-5050	46	20	in	in	ADP
dpc-5050	46	21	accordance	accordance	NOUN
dpc-5050	46	22	with	with	ADP
dpc-5050	46	23	current	current	ADJ
dpc-5050	46	24	guidelines	guideline	NOUN
dpc-5050	46	25	,	,	PUNCT
dpc-5050	46	26	along	along	ADP
dpc-5050	46	27	with	with	ADP
dpc-5050	46	28	dietary	dietary	ADJ
dpc-5050	46	29	and	and	CCONJ
dpc-5050	46	30	exercise	exercise	NOUN
dpc-5050	46	31	recommendations	recommendation	NOUN
dpc-5050	46	32	[	[	X
dpc-5050	46	33	8	8	NUM
dpc-5050	46	34	]	]	PUNCT
dpc-5050	46	35	.	.	PUNCT
dpc-5050	47	1	additionally	additionally	ADV
dpc-5050	47	2	,	,	PUNCT
dpc-5050	47	3	further	further	ADJ
dpc-5050	47	4	treatment	treatment	NOUN
dpc-5050	47	5	options	option	NOUN
dpc-5050	47	6	were	be	AUX
dpc-5050	47	7	discussed	discuss	VERB
dpc-5050	47	8	with	with	ADP
dpc-5050	47	9	the	the	DET
dpc-5050	47	10	physical	physical	ADJ
dpc-5050	47	11	therapy	therapy	NOUN
dpc-5050	47	12	and	and	CCONJ
dpc-5050	47	13	rehabilitation	rehabilitation	NOUN
dpc-5050	47	14	department	department	PROPN
dpc-5050	47	15	when	when	SCONJ
dpc-5050	47	16	necessary	necessary	ADJ
dpc-5050	47	17	.	.	PUNCT
dpc-5050	48	1	studied	study	VERB
dpc-5050	48	2	variables	variable	NOUN
dpc-5050	48	3	the	the	DET
dpc-5050	48	4	charts	chart	NOUN
dpc-5050	48	5	of	of	ADP
dpc-5050	48	6	pemphigus	pemphigus	NOUN
dpc-5050	48	7	vulgaris	vulgaris	NOUN
dpc-5050	48	8	patients	patient	NOUN
dpc-5050	48	9	were	be	AUX
dpc-5050	48	10	reviewed	review	VERB
dpc-5050	48	11	from	from	ADP
dpc-5050	48	12	the	the	DET
dpc-5050	48	13	medical	medical	ADJ
dpc-5050	48	14	records	record	NOUN
dpc-5050	48	15	.	.	PUNCT
dpc-5050	49	1	age	age	NOUN
dpc-5050	49	2	,	,	PUNCT
dpc-5050	49	3	sex	sex	NOUN
dpc-5050	49	4	,	,	PUNCT
dpc-5050	49	5	body	body	NOUN
dpc-5050	49	6	mass	mass	NOUN
dpc-5050	49	7	index	index	NOUN
dpc-5050	49	8	(	(	PUNCT
dpc-5050	49	9	bmi	bmi	PROPN
dpc-5050	49	10	)	)	PUNCT
dpc-5050	49	11	,	,	PUNCT
dpc-5050	49	12	menopausal	menopausal	ADJ
dpc-5050	49	13	status	status	NOUN
dpc-5050	49	14	of	of	ADP
dpc-5050	49	15	female	female	ADJ
dpc-5050	49	16	patients	patient	NOUN
dpc-5050	49	17	,	,	PUNCT
dpc-5050	49	18	lumbar	lumbar	NOUN
dpc-5050	49	19	and	and	CCONJ
dpc-5050	49	20	femur	femur	ADJ
dpc-5050	49	21	t	t	PROPN
dpc-5050	49	22	-	-	PUNCT
dpc-5050	49	23	scores	score	NOUN
dpc-5050	49	24	,	,	PUNCT
dpc-5050	49	25	serum	serum	NOUN
dpc-5050	49	26	25	25	NUM
dpc-5050	49	27	-	-	PUNCT
dpc-5050	49	28	hydroxyvitamin	hydroxyvitamin	NOUN
dpc-5050	49	29	d	d	NOUN
dpc-5050	49	30	(	(	PUNCT
dpc-5050	49	31	25(oh)d	25(oh)d	NOUN
dpc-5050	49	32	)	)	PUNCT
dpc-5050	49	33	,	,	PUNCT
dpc-5050	49	34	serum	serum	NOUN
dpc-5050	49	35	calcium	calcium	NOUN
dpc-5050	49	36	corrected	correct	VERB
dpc-5050	49	37	for	for	ADP
dpc-5050	49	38	serum	serum	NOUN
dpc-5050	49	39	albumin	albumin	NOUN
dpc-5050	49	40	(	(	PUNCT
dpc-5050	49	41	reference	reference	NOUN
dpc-5050	49	42	interval	interval	NOUN
dpc-5050	49	43	8.410.2	8.410.2	NUM
dpc-5050	49	44	mg	mg	PROPN
dpc-5050	49	45	/	/	SYM
dpc-5050	49	46	dl	dl	PROPN
dpc-5050	49	47	)	)	PUNCT
dpc-5050	49	48	,	,	PUNCT
dpc-5050	49	49	serum	serum	NOUN
dpc-5050	49	50	total	total	ADJ
dpc-5050	49	51	alkaline	alkaline	NOUN
dpc-5050	49	52	phosphatase	phosphatase	NOUN
dpc-5050	49	53	(	(	PUNCT
dpc-5050	49	54	alp	alp	PROPN
dpc-5050	49	55	)	)	PUNCT
dpc-5050	49	56	(	(	PUNCT
dpc-5050	49	57	reference	reference	NOUN
dpc-5050	49	58	interval	interval	NOUN
dpc-5050	49	59	53–128	53–128	PROPN
dpc-5050	49	60	ui	ui	PROPN
dpc-5050	49	61	/	/	SYM
dpc-5050	49	62	l	l	NOUN
dpc-5050	49	63	)	)	PUNCT
dpc-5050	49	64	,	,	PUNCT
dpc-5050	49	65	and	and	CCONJ
dpc-5050	49	66	serum	serum	NOUN
dpc-5050	49	67	lactate	lactate	PROPN
dpc-5050	49	68	dehydrogenase	dehydrogenase	NOUN
dpc-5050	49	69	(	(	PUNCT
dpc-5050	49	70	reference	reference	NOUN
dpc-5050	49	71	interval	interval	NOUN
dpc-5050	49	72	120	120	NUM
dpc-5050	49	73	-	-	SYM
dpc-5050	49	74	246	246	NUM
dpc-5050	49	75	u	u	NOUN
dpc-5050	49	76	/	/	SYM
dpc-5050	49	77	l	l	NOUN
dpc-5050	49	78	)	)	PUNCT
dpc-5050	49	79	levels	level	NOUN
dpc-5050	49	80	before	before	ADP
dpc-5050	49	81	and	and	CCONJ
dpc-5050	49	82	one	one	NUM
dpc-5050	49	83	year	year	NOUN
dpc-5050	49	84	after	after	ADP
dpc-5050	49	85	treatment	treatment	NOUN
dpc-5050	49	86	were	be	AUX
dpc-5050	49	87	obtained	obtain	VERB
dpc-5050	49	88	from	from	ADP
dpc-5050	49	89	the	the	DET
dpc-5050	49	90	data	datum	NOUN
dpc-5050	49	91	system	system	NOUN
dpc-5050	49	92	.	.	PUNCT
dpc-5050	50	1	additionally	additionally	ADV
dpc-5050	50	2	,	,	PUNCT
dpc-5050	50	3	the	the	DET
dpc-5050	50	4	cumulative	cumulative	ADJ
dpc-5050	50	5	and	and	CCONJ
dpc-5050	50	6	daily	daily	ADJ
dpc-5050	50	7	prednisone	prednisone	NOUN
dpc-5050	50	8	doses	dose	NOUN
dpc-5050	50	9	were	be	AUX
dpc-5050	50	10	also	also	ADV
dpc-5050	50	11	evaluated	evaluate	VERB
dpc-5050	50	12	.	.	PUNCT
dpc-5050	51	1	the	the	DET
dpc-5050	51	2	average	average	ADJ
dpc-5050	51	3	daily	daily	ADJ
dpc-5050	51	4	glucocorticoid	glucocorticoid	NOUN
dpc-5050	51	5	dose	dose	NOUN
dpc-5050	51	6	was	be	AUX
dpc-5050	51	7	classified	classify	VERB
dpc-5050	51	8	as	as	ADP
dpc-5050	51	9	low	low	ADJ
dpc-5050	51	10	(	(	PUNCT
dpc-5050	51	11	≤	≤	NUM
dpc-5050	51	12	7.5	7.5	NUM
dpc-5050	51	13	mg	mg	NUM
dpc-5050	51	14	/	/	SYM
dpc-5050	51	15	day	day	NOUN
dpc-5050	51	16	)	)	PUNCT
dpc-5050	51	17	,	,	PUNCT
dpc-5050	51	18	medium	medium	NOUN
dpc-5050	51	19	(	(	PUNCT
dpc-5050	51	20	>	>	X
dpc-5050	51	21	7.5	7.5	NUM
dpc-5050	51	22	mg	mg	NUM
dpc-5050	51	23	/	/	SYM
dpc-5050	51	24	day	day	NOUN
dpc-5050	51	25	but	but	CCONJ
dpc-5050	51	26	≤	≤	NUM
dpc-5050	52	1	30	30	NUM
dpc-5050	52	2	mg	mg	NUM
dpc-5050	52	3	/	/	SYM
dpc-5050	52	4	day	day	NOUN
dpc-5050	52	5	)	)	PUNCT
dpc-5050	52	6	,	,	PUNCT
dpc-5050	52	7	or	or	CCONJ
dpc-5050	52	8	high	high	ADJ
dpc-5050	52	9	(	(	PUNCT
dpc-5050	52	10	>	>	SYM
dpc-5050	52	11	30	30	NUM
dpc-5050	52	12	mg	mg	NUM
dpc-5050	52	13	/	/	SYM
dpc-5050	52	14	day	day	NOUN
dpc-5050	52	15	)	)	PUNCT
dpc-5050	53	1	[	[	X
dpc-5050	53	2	10	10	NUM
dpc-5050	53	3	]	]	PUNCT
dpc-5050	53	4	.	.	PUNCT
dpc-5050	54	1	bone	bone	NOUN
dpc-5050	54	2	mineral	mineral	NOUN
dpc-5050	54	3	density	density	NOUN
dpc-5050	54	4	(	(	PUNCT
dpc-5050	54	5	bmd	bmd	PROPN
dpc-5050	54	6	)	)	PUNCT
dpc-5050	54	7	was	be	AUX
dpc-5050	54	8	measured	measure	VERB
dpc-5050	54	9	by	by	ADP
dpc-5050	54	10	dual	dual	ADJ
dpc-5050	54	11	-	-	PUNCT
dpc-5050	54	12	energy	energy	NOUN
dpc-5050	54	13	x	x	NOUN
dpc-5050	54	14	-	-	NOUN
dpc-5050	54	15	ray	ray	NOUN
dpc-5050	54	16	absorptiometry	absorptiometry	NOUN
dpc-5050	54	17	(	(	PUNCT
dpc-5050	54	18	dxa	dxa	PROPN
dpc-5050	54	19	)	)	PUNCT
dpc-5050	54	20	(	(	PUNCT
dpc-5050	54	21	ge	ge	PROPN
dpc-5050	54	22	healthcare	healthcare	PROPN
dpc-5050	54	23	,	,	PUNCT
dpc-5050	54	24	madison	madison	PROPN
dpc-5050	54	25	wi	wi	PROPN
dpc-5050	54	26	,	,	PUNCT
dpc-5050	54	27	usa	usa	PROPN
dpc-5050	54	28	)	)	PUNCT
dpc-5050	54	29	at	at	ADP
dpc-5050	54	30	lumbar	lumbar	NOUN
dpc-5050	54	31	spine	spine	NOUN
dpc-5050	54	32	and	and	CCONJ
dpc-5050	54	33	femoral	femoral	ADJ
dpc-5050	54	34	neck	neck	NOUN
dpc-5050	54	35	and	and	CCONJ
dpc-5050	54	36	expressed	express	VERB
dpc-5050	54	37	as	as	ADP
dpc-5050	54	38	standard	standard	ADJ
dpc-5050	54	39	deviation	deviation	NOUN
dpc-5050	54	40	(	(	PUNCT
dpc-5050	54	41	sd	sd	NOUN
dpc-5050	54	42	)	)	PUNCT
dpc-5050	54	43	units	unit	NOUN
dpc-5050	54	44	in	in	ADP
dpc-5050	54	45	relation	relation	NOUN
dpc-5050	54	46	to	to	ADP
dpc-5050	54	47	the	the	DET
dpc-5050	54	48	reference	reference	NOUN
dpc-5050	54	49	healthy	healthy	ADJ
dpc-5050	54	50	population	population	NOUN
dpc-5050	54	51	of	of	ADP
dpc-5050	54	52	the	the	DET
dpc-5050	54	53	same	same	ADJ
dpc-5050	54	54	age	age	NOUN
dpc-5050	54	55	(	(	PUNCT
dpc-5050	54	56	z	z	NOUN
dpc-5050	54	57	-	-	PUNCT
dpc-5050	54	58	score	score	NOUN
dpc-5050	54	59	)	)	PUNCT
dpc-5050	54	60	and	and	CCONJ
dpc-5050	54	61	of	of	ADP
dpc-5050	54	62	the	the	DET
dpc-5050	54	63	young	young	ADJ
dpc-5050	54	64	adults	adult	NOUN
dpc-5050	54	65	(	(	PUNCT
dpc-5050	54	66	t	t	NOUN
dpc-5050	54	67	-	-	PUNCT
dpc-5050	54	68	score	score	NOUN
dpc-5050	54	69	)	)	PUNCT
dpc-5050	54	70	.	.	PUNCT
dpc-5050	55	1	osteopenia	osteopenia	NOUN
dpc-5050	55	2	was	be	AUX
dpc-5050	55	3	defined	define	VERB
dpc-5050	55	4	as	as	ADP
dpc-5050	55	5	a	a	DET
dpc-5050	55	6	t	t	NOUN
dpc-5050	55	7	-	-	PUNCT
dpc-5050	55	8	score	score	NOUN
dpc-5050	55	9	between	between	ADP
dpc-5050	55	10	-1.0	-1.0	PROPN
dpc-5050	55	11	and	and	CCONJ
dpc-5050	55	12	-2.5	-2.5	PROPN
dpc-5050	55	13	and	and	CCONJ
dpc-5050	55	14	osteoporosis	osteoporosis	NOUN
dpc-5050	55	15	as	as	ADP
dpc-5050	55	16	a	a	DET
dpc-5050	55	17	t	t	NOUN
dpc-5050	55	18	-	-	PUNCT
dpc-5050	55	19	score	score	NOUN
dpc-5050	55	20	of	of	ADP
dpc-5050	55	21	-2.5	-2.5	PUNCT
dpc-5050	55	22	and	and	CCONJ
dpc-5050	55	23	less	less	ADJ
dpc-5050	55	24	.	.	PUNCT
dpc-5050	56	1	serum	serum	NOUN
dpc-5050	56	2	25	25	NUM
dpc-5050	56	3	(	(	PUNCT
dpc-5050	56	4	oh)d	oh)d	PROPN
dpc-5050	56	5	levels	level	NOUN
dpc-5050	56	6	were	be	AUX
dpc-5050	56	7	measured	measure	VERB
dpc-5050	56	8	by	by	ADP
dpc-5050	56	9	competitive	competitive	ADJ
dpc-5050	56	10	immunoassay	immunoassay	NOUN
dpc-5050	56	11	(	(	PUNCT
dpc-5050	56	12	atellica	atellica	PROPN
dpc-5050	56	13	i	i	PRON
dpc-5050	56	14	m	m	PROPN
dpc-5050	56	15	,	,	PUNCT
dpc-5050	56	16	siemens	siemens	PROPN
dpc-5050	56	17	healthineers	healthineer	NOUN
dpc-5050	56	18	,	,	PUNCT
dpc-5050	56	19	forchheim	forchheim	PROPN
dpc-5050	56	20	,	,	PUNCT
dpc-5050	56	21	germany	germany	PROPN
dpc-5050	56	22	)	)	PUNCT
dpc-5050	56	23	(	(	PUNCT
dpc-5050	56	24	reference	reference	NOUN
dpc-5050	56	25	interval	interval	NOUN
dpc-5050	56	26	:	:	PUNCT
dpc-5050	56	27	30–100	30–100	NUM
dpc-5050	56	28	μg	μg	PROPN
dpc-5050	56	29	/	/	SYM
dpc-5050	56	30	l	l	NOUN
dpc-5050	56	31	)	)	PUNCT
dpc-5050	56	32	.	.	PUNCT
dpc-5050	57	1	statistical	statistical	ADJ
dpc-5050	57	2	analysis	analysis	NOUN
dpc-5050	57	3	the	the	DET
dpc-5050	57	4	data	datum	NOUN
dpc-5050	57	5	were	be	AUX
dpc-5050	57	6	analyzed	analyze	VERB
dpc-5050	57	7	using	use	VERB
dpc-5050	57	8	spss	spss	PROPN
dpc-5050	57	9	version	version	NOUN
dpc-5050	57	10	26.0	26.0	NUM
dpc-5050	57	11	for	for	ADP
dpc-5050	57	12	windows	window	NOUN
dpc-5050	57	13	(	(	PUNCT
dpc-5050	57	14	ibm	ibm	PROPN
dpc-5050	57	15	spss	spss	PROPN
dpc-5050	57	16	statistics	statistics	PROPN
dpc-5050	57	17	,	,	PUNCT
dpc-5050	57	18	armonk	armonk	PROPN
dpc-5050	57	19	,	,	PUNCT
dpc-5050	57	20	ny	ny	PROPN
dpc-5050	57	21	)	)	PUNCT
dpc-5050	57	22	.	.	PUNCT
dpc-5050	58	1	categorical	categorical	ADJ
dpc-5050	58	2	variables	variable	NOUN
dpc-5050	58	3	are	be	AUX
dpc-5050	58	4	expressed	express	VERB
dpc-5050	58	5	as	as	ADP
dpc-5050	58	6	numbers	number	NOUN
dpc-5050	58	7	and	and	CCONJ
dpc-5050	58	8	percentages	percentage	NOUN
dpc-5050	58	9	.	.	PUNCT
dpc-5050	59	1	continuous	continuous	ADJ
dpc-5050	59	2	variables	variable	NOUN
dpc-5050	59	3	are	be	AUX
dpc-5050	59	4	expressed	express	VERB
dpc-5050	59	5	as	as	ADP
dpc-5050	59	6	mean	mean	ADJ
dpc-5050	59	7	and	and	CCONJ
dpc-5050	59	8	standard	standard	ADJ
dpc-5050	59	9	deviation	deviation	NOUN
dpc-5050	59	10	.	.	PUNCT
dpc-5050	60	1	for	for	ADP
dpc-5050	60	2	normal	normal	ADJ
dpc-5050	60	3	distributions	distribution	NOUN
dpc-5050	60	4	,	,	PUNCT
dpc-5050	60	5	continuous	continuous	ADJ
dpc-5050	60	6	variables	variable	NOUN
dpc-5050	60	7	were	be	AUX
dpc-5050	60	8	compared	compare	VERB
dpc-5050	60	9	using	use	VERB
dpc-5050	60	10	independent	independent	ADJ
dpc-5050	60	11	samples	sample	NOUN
dpc-5050	60	12	t	t	NOUN
dpc-5050	60	13	-	-	PUNCT
dpc-5050	60	14	test	test	NOUN
dpc-5050	60	15	and	and	CCONJ
dpc-5050	60	16	paired	pair	VERB
dpc-5050	60	17	sample	sample	NOUN
dpc-5050	60	18	t	t	PROPN
dpc-5050	60	19	-	-	PUNCT
dpc-5050	60	20	test	test	NOUN
dpc-5050	60	21	.	.	PUNCT
dpc-5050	61	1	for	for	ADP
dpc-5050	61	2	non	non	ADJ
dpc-5050	61	3	-	-	ADJ
dpc-5050	61	4	parametric	parametric	ADJ
dpc-5050	61	5	distributions	distribution	NOUN
dpc-5050	61	6	,	,	PUNCT
dpc-5050	61	7	mann	mann	PROPN
dpc-5050	61	8	-	-	PUNCT
dpc-5050	61	9	whitney	whitney	PROPN
dpc-5050	61	10	u	u	PROPN
dpc-5050	61	11	test	test	NOUN
dpc-5050	61	12	was	be	AUX
dpc-5050	61	13	used	use	VERB
dpc-5050	61	14	.	.	PUNCT
dpc-5050	62	1	a	a	DET
dpc-5050	62	2	p	p	NOUN
dpc-5050	62	3	-	-	PUNCT
dpc-5050	62	4	value	value	NOUN
dpc-5050	62	5	of	of	ADP
dpc-5050	62	6	0.05	0.05	NUM
dpc-5050	62	7	was	be	AUX
dpc-5050	62	8	considered	consider	VERB
dpc-5050	62	9	the	the	DET
dpc-5050	62	10	threshold	threshold	NOUN
dpc-5050	62	11	for	for	ADP
dpc-5050	62	12	statistical	statistical	ADJ
dpc-5050	62	13	significance	significance	NOUN
dpc-5050	62	14	.	.	PUNCT
dpc-5050	63	1	results	result	VERB
dpc-5050	63	2	a	a	DET
dpc-5050	63	3	total	total	NOUN
dpc-5050	63	4	of	of	ADP
dpc-5050	63	5	73	73	NUM
dpc-5050	63	6	patients	patient	NOUN
dpc-5050	63	7	were	be	AUX
dpc-5050	63	8	included	include	VERB
dpc-5050	63	9	in	in	ADP
dpc-5050	63	10	this	this	DET
dpc-5050	63	11	study	study	NOUN
dpc-5050	63	12	,	,	PUNCT
dpc-5050	63	13	with	with	ADP
dpc-5050	63	14	66	66	NUM
dpc-5050	63	15	  	  	SPACE
dpc-5050	63	16	patients	patient	NOUN
dpc-5050	63	17	evaluated	evaluate	VERB
dpc-5050	63	18	due	due	ADP
dpc-5050	63	19	to	to	ADP
dpc-5050	63	20	exclusion	exclusion	NOUN
dpc-5050	63	21	criteria	criterion	NOUN
dpc-5050	63	22	.	.	PUNCT
dpc-5050	64	1	of	of	ADP
dpc-5050	64	2	the	the	DET
dpc-5050	64	3	66	66	NUM
dpc-5050	64	4	  	  	SPACE
dpc-5050	64	5	patients	patient	NOUN
dpc-5050	64	6	(	(	PUNCT
dpc-5050	64	7	39	39	NUM
dpc-5050	64	8	females	female	NOUN
dpc-5050	64	9	,	,	PUNCT
dpc-5050	64	10	27	27	NUM
dpc-5050	64	11	males	male	NOUN
dpc-5050	64	12	)	)	PUNCT
dpc-5050	64	13	,	,	PUNCT
dpc-5050	64	14	the	the	DET
dpc-5050	64	15	mean	mean	ADJ
dpc-5050	64	16	age	age	NOUN
dpc-5050	64	17	of	of	ADP
dpc-5050	64	18	females	female	NOUN
dpc-5050	64	19	original	original	ADJ
dpc-5050	64	20	article	article	NOUN
dpc-5050	64	21	|	|	ADV
dpc-5050	64	22	dermatol	dermatol	ADJ
dpc-5050	64	23	pract	pract	NOUN
dpc-5050	64	24	concept	concept	NOUN
dpc-5050	64	25	.	.	PUNCT
dpc-5050	65	1	2025;15(2):5050	2025;15(2):5050	NUM
dpc-5050	65	2	3	3	NUM
dpc-5050	65	3	was	be	AUX
dpc-5050	65	4	53.15	53.15	NUM
dpc-5050	65	5	±	±	NUM
dpc-5050	65	6	17.06	17.06	NUM
dpc-5050	65	7	and	and	CCONJ
dpc-5050	65	8	of	of	ADP
dpc-5050	65	9	males	male	NOUN
dpc-5050	65	10	was	be	AUX
dpc-5050	65	11	54.8	54.8	NUM
dpc-5050	65	12	±	±	NUM
dpc-5050	65	13	14.9	14.9	NUM
dpc-5050	65	14	years	year	NOUN
dpc-5050	65	15	.	.	PUNCT
dpc-5050	66	1	the	the	DET
dpc-5050	66	2	age	age	NOUN
dpc-5050	66	3	of	of	ADP
dpc-5050	66	4	these	these	DET
dpc-5050	66	5	patients	patient	NOUN
dpc-5050	66	6	ranged	range	VERB
dpc-5050	66	7	from	from	ADP
dpc-5050	66	8	18	18	NUM
dpc-5050	66	9	to	to	PART
dpc-5050	66	10	83	83	NUM
dpc-5050	66	11	years	year	NOUN
dpc-5050	66	12	,	,	PUNCT
dpc-5050	66	13	with	with	ADP
dpc-5050	66	14	a	a	DET
dpc-5050	66	15	mean	mean	NOUN
dpc-5050	66	16	of	of	ADP
dpc-5050	66	17	53.83	53.83	NUM
dpc-5050	66	18	±	±	NUM
dpc-5050	66	19	16.15	16.15	NUM
dpc-5050	66	20	years	year	NOUN
dpc-5050	66	21	.	.	PUNCT
dpc-5050	67	1	the	the	DET
dpc-5050	67	2	mean	mean	ADJ
dpc-5050	67	3	bmi	bmi	NOUN
dpc-5050	67	4	was	be	AUX
dpc-5050	67	5	27.61	27.61	NUM
dpc-5050	67	6	±	±	NUM
dpc-5050	67	7	5.06	5.06	NUM
dpc-5050	67	8	.	.	PUNCT
dpc-5050	68	1	according	accord	VERB
dpc-5050	68	2	to	to	ADP
dpc-5050	68	3	bmi	bmi	PROPN
dpc-5050	68	4	,	,	PUNCT
dpc-5050	68	5	66.7	66.7	NUM
dpc-5050	68	6	%	%	NOUN
dpc-5050	68	7	(	(	PUNCT
dpc-5050	68	8	n=44	n=44	NOUN
dpc-5050	68	9	)	)	PUNCT
dpc-5050	68	10	were	be	AUX
dpc-5050	68	11	overweight	overweight	ADJ
dpc-5050	68	12	and	and	CCONJ
dpc-5050	68	13	obese	obese	ADJ
dpc-5050	68	14	,	,	PUNCT
dpc-5050	68	15	while	while	SCONJ
dpc-5050	68	16	33.3	33.3	NUM
dpc-5050	68	17	%	%	NOUN
dpc-5050	68	18	(	(	PUNCT
dpc-5050	68	19	n=22	n=22	PROPN
dpc-5050	68	20	)	)	PUNCT
dpc-5050	68	21	were	be	AUX
dpc-5050	68	22	of	of	ADP
dpc-5050	68	23	normal	normal	ADJ
dpc-5050	68	24	weight	weight	NOUN
dpc-5050	68	25	.	.	PUNCT
dpc-5050	69	1	among	among	ADP
dpc-5050	69	2	the	the	DET
dpc-5050	69	3	female	female	ADJ
dpc-5050	69	4	patients	patient	NOUN
dpc-5050	69	5	,	,	PUNCT
dpc-5050	69	6	45.5	45.5	NUM
dpc-5050	69	7	%	%	NOUN
dpc-5050	69	8	(	(	PUNCT
dpc-5050	69	9	n=30	n=30	NOUN
dpc-5050	69	10	)	)	PUNCT
dpc-5050	69	11	were	be	AUX
dpc-5050	69	12	postmenopausal	postmenopausal	ADJ
dpc-5050	69	13	.	.	PUNCT
dpc-5050	70	1	the	the	DET
dpc-5050	70	2	average	average	ADJ
dpc-5050	70	3	time	time	NOUN
dpc-5050	70	4	to	to	ADP
dpc-5050	70	5	diagnosis	diagnosis	NOUN
dpc-5050	70	6	was	be	AUX
dpc-5050	70	7	10.14	10.14	NUM
dpc-5050	70	8	±	±	NUM
dpc-5050	70	9	13.89	13.89	NUM
dpc-5050	70	10	months	month	NOUN
dpc-5050	70	11	,	,	PUNCT
dpc-5050	70	12	and	and	CCONJ
dpc-5050	70	13	the	the	DET
dpc-5050	70	14	daily	daily	ADJ
dpc-5050	70	15	dose	dose	NOUN
dpc-5050	70	16	of	of	ADP
dpc-5050	70	17	prednisone	prednisone	PROPN
dpc-5050	70	18	was	be	AUX
dpc-5050	70	19	16.95	16.95	NUM
dpc-5050	70	20	±	±	NUM
dpc-5050	70	21	16.10	16.10	NUM
dpc-5050	70	22	mg	mg	NOUN
dpc-5050	70	23	.	.	PUNCT
dpc-5050	71	1	when	when	SCONJ
dpc-5050	71	2	categorized	categorize	VERB
dpc-5050	71	3	according	accord	VERB
dpc-5050	71	4	to	to	ADP
dpc-5050	71	5	daily	daily	ADJ
dpc-5050	71	6	prednisone	prednisone	PROPN
dpc-5050	71	7	doses	dose	NOUN
dpc-5050	71	8	,	,	PUNCT
dpc-5050	71	9	18.2	18.2	NUM
dpc-5050	71	10	%	%	NOUN
dpc-5050	71	11	(	(	PUNCT
dpc-5050	71	12	n=12	n=12	NOUN
dpc-5050	71	13	)	)	PUNCT
dpc-5050	71	14	were	be	AUX
dpc-5050	71	15	on	on	ADP
dpc-5050	71	16	low	low	ADJ
dpc-5050	71	17	,	,	PUNCT
dpc-5050	71	18	63.6	63.6	NUM
dpc-5050	71	19	%	%	NOUN
dpc-5050	71	20	(	(	PUNCT
dpc-5050	71	21	n=42	n=42	NOUN
dpc-5050	71	22	)	)	PUNCT
dpc-5050	71	23	were	be	AUX
dpc-5050	71	24	on	on	ADP
dpc-5050	71	25	medium	medium	ADJ
dpc-5050	71	26	,	,	PUNCT
dpc-5050	71	27	and	and	CCONJ
dpc-5050	71	28	18.2	18.2	NUM
dpc-5050	71	29	%	%	NOUN
dpc-5050	71	30	(	(	PUNCT
dpc-5050	71	31	n=12	n=12	NOUN
dpc-5050	71	32	)	)	PUNCT
dpc-5050	71	33	were	be	AUX
dpc-5050	71	34	on	on	ADP
dpc-5050	71	35	high	high	ADJ
dpc-5050	71	36	doses	dose	NOUN
dpc-5050	71	37	.	.	PUNCT
dpc-5050	72	1	the	the	DET
dpc-5050	72	2	mean	mean	ADJ
dpc-5050	72	3	cumulative	cumulative	ADJ
dpc-5050	72	4	prednisone	prednisone	PROPN
dpc-5050	72	5	dose	dose	NOUN
dpc-5050	72	6	was	be	AUX
dpc-5050	72	7	6190.08	6190.08	NUM
dpc-5050	72	8	±	±	NUM
dpc-5050	72	9	3598.4	3598.4	NUM
dpc-5050	72	10	mg	mg	NOUN
dpc-5050	72	11	(	(	PUNCT
dpc-5050	72	12	table	table	NOUN
dpc-5050	72	13	 	 	SPACE
dpc-5050	72	14	1	1	NUM
dpc-5050	72	15	)	)	PUNCT
dpc-5050	72	16	.	.	PUNCT
dpc-5050	73	1	our	our	PRON
dpc-5050	73	2	results	result	NOUN
dpc-5050	73	3	show	show	VERB
dpc-5050	73	4	that	that	SCONJ
dpc-5050	73	5	the	the	DET
dpc-5050	73	6	lumbar	lumbar	NOUN
dpc-5050	73	7	t	t	PROPN
dpc-5050	73	8	-	-	PUNCT
dpc-5050	73	9	scores	score	NOUN
dpc-5050	73	10	did	do	AUX
dpc-5050	73	11	not	not	PART
dpc-5050	73	12	differ	differ	VERB
dpc-5050	73	13	before	before	ADV
dpc-5050	73	14	and	and	CCONJ
dpc-5050	73	15	after	after	ADP
dpc-5050	73	16	one	one	NUM
dpc-5050	73	17	year	year	NOUN
dpc-5050	73	18	of	of	ADP
dpc-5050	73	19	glucocorticoid	glucocorticoid	ADJ
dpc-5050	73	20	treatment	treatment	NOUN
dpc-5050	73	21	(	(	PUNCT
dpc-5050	73	22	p=0.102	p=0.102	NOUN
dpc-5050	73	23	)	)	PUNCT
dpc-5050	73	24	.	.	PUNCT
dpc-5050	74	1	in	in	ADP
dpc-5050	74	2	contrast	contrast	NOUN
dpc-5050	74	3	,	,	PUNCT
dpc-5050	74	4	there	there	PRON
dpc-5050	74	5	was	be	VERB
dpc-5050	74	6	a	a	DET
dpc-5050	74	7	significant	significant	ADJ
dpc-5050	74	8	decrease	decrease	NOUN
dpc-5050	74	9	in	in	ADP
dpc-5050	74	10	femur	femur	ADJ
dpc-5050	74	11	density	density	NOUN
dpc-5050	74	12	(	(	PUNCT
dpc-5050	74	13	p=0.001	p=0.001	NUM
dpc-5050	74	14	)	)	PUNCT
dpc-5050	74	15	.	.	PUNCT
dpc-5050	75	1	after	after	ADP
dpc-5050	75	2	one	one	NUM
dpc-5050	75	3	year	year	NOUN
dpc-5050	75	4	of	of	ADP
dpc-5050	75	5	glucocorticoid	glucocorticoid	ADJ
dpc-5050	75	6	therapy	therapy	NOUN
dpc-5050	75	7	,	,	PUNCT
dpc-5050	75	8	the	the	DET
dpc-5050	75	9	changes	change	NOUN
dpc-5050	75	10	in	in	ADP
dpc-5050	75	11	mean	mean	PROPN
dpc-5050	75	12	serum	serum	NOUN
dpc-5050	75	13	calcium	calcium	NOUN
dpc-5050	75	14	and	and	CCONJ
dpc-5050	75	15	serum	serum	PROPN
dpc-5050	75	16	alp	alp	PROPN
dpc-5050	75	17	levels	level	NOUN
dpc-5050	75	18	were	be	AUX
dpc-5050	75	19	not	not	PART
dpc-5050	75	20	significant	significant	ADJ
dpc-5050	75	21	(	(	PUNCT
dpc-5050	75	22	p=0.819	p=0.819	NOUN
dpc-5050	75	23	,	,	PUNCT
dpc-5050	75	24	p=0.724	p=0.724	X
dpc-5050	75	25	,	,	PUNCT
dpc-5050	75	26	respectively	respectively	ADV
dpc-5050	75	27	)	)	PUNCT
dpc-5050	75	28	.	.	PUNCT
dpc-5050	76	1	a	a	DET
dpc-5050	76	2	significant	significant	ADJ
dpc-5050	76	3	increase	increase	NOUN
dpc-5050	76	4	in	in	ADP
dpc-5050	76	5	25	25	NUM
dpc-5050	76	6	(	(	PUNCT
dpc-5050	76	7	oh)d	oh)d	PROPN
dpc-5050	76	8	levels	level	NOUN
dpc-5050	76	9	(	(	PUNCT
dpc-5050	76	10	p=0.018	p=0.018	NOUN
dpc-5050	76	11	)	)	PUNCT
dpc-5050	76	12	and	and	CCONJ
dpc-5050	76	13	in	in	ADP
dpc-5050	76	14	ldh	ldh	PROPN
dpc-5050	76	15	levels	level	NOUN
dpc-5050	76	16	(	(	PUNCT
dpc-5050	76	17	p<0.001	p<0.001	PROPN
dpc-5050	76	18	)	)	PUNCT
dpc-5050	76	19	were	be	AUX
dpc-5050	76	20	observed	observe	VERB
dpc-5050	76	21	after	after	ADP
dpc-5050	76	22	treatment	treatment	NOUN
dpc-5050	76	23	compared	compare	VERB
dpc-5050	76	24	to	to	ADP
dpc-5050	76	25	pre	pre	ADJ
dpc-5050	76	26	-	-	ADJ
dpc-5050	76	27	treatment	treatment	ADJ
dpc-5050	76	28	levels	level	NOUN
dpc-5050	76	29	(	(	PUNCT
dpc-5050	76	30	table	table	NOUN
dpc-5050	76	31	2	2	NUM
dpc-5050	76	32	)	)	PUNCT
dpc-5050	76	33	.	.	PUNCT
dpc-5050	77	1	there	there	PRON
dpc-5050	77	2	was	be	VERB
dpc-5050	77	3	no	no	DET
dpc-5050	77	4	significant	significant	ADJ
dpc-5050	77	5	correlation	correlation	NOUN
dpc-5050	77	6	between	between	ADP
dpc-5050	77	7	t	t	PROPN
dpc-5050	77	8	-	-	PUNCT
dpc-5050	77	9	scores	score	NOUN
dpc-5050	77	10	and	and	CCONJ
dpc-5050	77	11	sex	sex	NOUN
dpc-5050	77	12	,	,	PUNCT
dpc-5050	77	13	diagnosis	diagnosis	NOUN
dpc-5050	77	14	time	time	NOUN
dpc-5050	77	15	,	,	PUNCT
dpc-5050	77	16	or	or	CCONJ
dpc-5050	77	17	obesity	obesity	NOUN
dpc-5050	77	18	(	(	PUNCT
dpc-5050	77	19	table	table	NOUN
dpc-5050	77	20	3	3	NUM
dpc-5050	77	21	)	)	PUNCT
dpc-5050	77	22	.	.	PUNCT
dpc-5050	78	1	although	although	SCONJ
dpc-5050	78	2	femur	femur	NOUN
dpc-5050	78	3	and	and	CCONJ
dpc-5050	78	4	lumbar	lumbar	PROPN
dpc-5050	78	5	t	t	PROPN
dpc-5050	78	6	-	-	PUNCT
dpc-5050	78	7	scores	score	NOUN
dpc-5050	78	8	were	be	AUX
dpc-5050	78	9	low	low	ADJ
dpc-5050	78	10	both	both	CCONJ
dpc-5050	78	11	before	before	ADV
dpc-5050	78	12	and	and	CCONJ
dpc-5050	78	13	after	after	ADP
dpc-5050	78	14	treatment	treatment	NOUN
dpc-5050	78	15	in	in	ADP
dpc-5050	78	16	the	the	DET
dpc-5050	78	17	menopausal	menopausal	ADJ
dpc-5050	78	18	group	group	NOUN
dpc-5050	78	19	,	,	PUNCT
dpc-5050	78	20	the	the	DET
dpc-5050	78	21	difference	difference	NOUN
dpc-5050	78	22	was	be	AUX
dpc-5050	78	23	not	not	PART
dpc-5050	78	24	significant	significant	ADJ
dpc-5050	78	25	(	(	PUNCT
dpc-5050	78	26	table	table	NOUN
dpc-5050	78	27	4	4	NUM
dpc-5050	78	28	)	)	PUNCT
dpc-5050	78	29	.	.	PUNCT
dpc-5050	79	1	vitamin	vitamin	NOUN
dpc-5050	79	2	d	d	NOUN
dpc-5050	79	3	values	value	NOUN
dpc-5050	79	4	of	of	ADP
dpc-5050	79	5	non	non	ADJ
dpc-5050	79	6	-	-	ADJ
dpc-5050	79	7	menopausal	menopausal	ADJ
dpc-5050	79	8	patients	patient	NOUN
dpc-5050	79	9	increased	increase	VERB
dpc-5050	79	10	significantly	significantly	ADV
dpc-5050	79	11	compared	compare	VERB
dpc-5050	79	12	to	to	ADP
dpc-5050	79	13	menopausal	menopausal	ADJ
dpc-5050	79	14	patients	patient	NOUN
dpc-5050	79	15	(	(	PUNCT
dpc-5050	79	16	p=0.044	p=0.044	NOUN
dpc-5050	79	17	)	)	PUNCT
dpc-5050	79	18	.	.	PUNCT
dpc-5050	80	1	when	when	SCONJ
dpc-5050	80	2	analyzing	analyze	VERB
dpc-5050	80	3	glucocorticoid	glucocorticoid	ADJ
dpc-5050	80	4	dose	dose	NOUN
dpc-5050	80	5	categories	category	NOUN
dpc-5050	80	6	,	,	PUNCT
dpc-5050	80	7	a	a	DET
dpc-5050	80	8	significant	significant	ADJ
dpc-5050	80	9	decrease	decrease	NOUN
dpc-5050	80	10	in	in	ADP
dpc-5050	80	11	femur	femur	ADJ
dpc-5050	80	12	t	t	PROPN
dpc-5050	80	13	-	-	PUNCT
dpc-5050	80	14	scores	score	NOUN
dpc-5050	80	15	was	be	AUX
dpc-5050	80	16	observed	observe	VERB
dpc-5050	80	17	in	in	ADP
dpc-5050	80	18	patients	patient	NOUN
dpc-5050	80	19	receiving	receive	VERB
dpc-5050	80	20	moderate	moderate	ADJ
dpc-5050	80	21	doses	dose	NOUN
dpc-5050	80	22	,	,	PUNCT
dpc-5050	80	23	while	while	SCONJ
dpc-5050	80	24	a	a	DET
dpc-5050	80	25	significant	significant	ADJ
dpc-5050	80	26	decrease	decrease	NOUN
dpc-5050	80	27	in	in	ADP
dpc-5050	80	28	lumbar	lumbar	PROPN
dpc-5050	80	29	t	t	PROPN
dpc-5050	80	30	-	-	PUNCT
dpc-5050	80	31	scores	score	NOUN
dpc-5050	80	32	was	be	AUX
dpc-5050	80	33	found	find	VERB
dpc-5050	80	34	in	in	ADP
dpc-5050	80	35	the	the	DET
dpc-5050	80	36	high	high	ADJ
dpc-5050	80	37	-	-	PUNCT
dpc-5050	80	38	dose	dose	NOUN
dpc-5050	80	39	group	group	NOUN
dpc-5050	80	40	(	(	PUNCT
dpc-5050	80	41	p=0.000	p=0.000	NOUN
dpc-5050	80	42	and	and	CCONJ
dpc-5050	80	43	p=0.018	p=0.018	NOUN
dpc-5050	80	44	,	,	PUNCT
dpc-5050	80	45	respectively	respectively	ADV
dpc-5050	80	46	)	)	PUNCT
dpc-5050	80	47	.	.	PUNCT
dpc-5050	81	1	no	no	DET
dpc-5050	81	2	significant	significant	ADJ
dpc-5050	81	3	decrease	decrease	NOUN
dpc-5050	81	4	in	in	ADP
dpc-5050	81	5	t	t	PROPN
dpc-5050	81	6	-	-	PUNCT
dpc-5050	81	7	scores	score	NOUN
dpc-5050	81	8	was	be	AUX
dpc-5050	81	9	observed	observe	VERB
dpc-5050	81	10	in	in	ADP
dpc-5050	81	11	the	the	DET
dpc-5050	81	12	low	low	ADJ
dpc-5050	81	13	-	-	PUNCT
dpc-5050	81	14	dose	dose	NOUN
dpc-5050	81	15	group	group	NOUN
dpc-5050	81	16	(	(	PUNCT
dpc-5050	81	17	table	table	NOUN
dpc-5050	81	18	5	5	NUM
dpc-5050	81	19	)	)	PUNCT
dpc-5050	81	20	.	.	PUNCT
dpc-5050	82	1	conclusions	conclusion	NOUN
dpc-5050	82	2	this	this	DET
dpc-5050	82	3	study	study	NOUN
dpc-5050	82	4	describes	describe	VERB
dpc-5050	82	5	the	the	DET
dpc-5050	82	6	change	change	NOUN
dpc-5050	82	7	in	in	ADP
dpc-5050	82	8	bone	bone	NOUN
dpc-5050	82	9	mineral	mineral	NOUN
dpc-5050	82	10	density	density	NOUN
dpc-5050	82	11	status	status	NOUN
dpc-5050	82	12	in	in	ADP
dpc-5050	82	13	a	a	DET
dpc-5050	82	14	population	population	NOUN
dpc-5050	82	15	of	of	ADP
dpc-5050	82	16	66	66	NUM
dpc-5050	82	17	pv	pv	NOUN
dpc-5050	82	18	patients	patient	NOUN
dpc-5050	82	19	treated	treat	VERB
dpc-5050	82	20	with	with	ADP
dpc-5050	82	21	glucocorticoids	glucocorticoid	NOUN
dpc-5050	82	22	.	.	PUNCT
dpc-5050	83	1	although	although	SCONJ
dpc-5050	83	2	corticosteroids	corticosteroid	NOUN
dpc-5050	83	3	have	have	AUX
dpc-5050	83	4	been	be	AUX
dpc-5050	83	5	prioritized	prioritize	VERB
dpc-5050	83	6	with	with	ADP
dpc-5050	83	7	rituximab	rituximab	NOUN
dpc-5050	83	8	in	in	ADP
dpc-5050	83	9	the	the	DET
dpc-5050	83	10	treatment	treatment	NOUN
dpc-5050	83	11	of	of	ADP
dpc-5050	83	12	moderate	moderate	ADJ
dpc-5050	83	13	-	-	PUNCT
dpc-5050	83	14	to	to	ADP
dpc-5050	83	15	-	-	PUNCT
dpc-5050	83	16	severe	severe	ADJ
dpc-5050	83	17	pemphigus	pemphigus	NOUN
dpc-5050	83	18	vulgaris	vulgaris	NOUN
dpc-5050	83	19	in	in	ADP
dpc-5050	83	20	recent	recent	ADJ
dpc-5050	83	21	years	year	NOUN
dpc-5050	83	22	,	,	PUNCT
dpc-5050	83	23	they	they	PRON
dpc-5050	83	24	are	be	AUX
dpc-5050	83	25	still	still	ADV
dpc-5050	83	26	among	among	ADP
dpc-5050	83	27	the	the	DET
dpc-5050	83	28	chronically	chronically	ADV
dpc-5050	83	29	used	use	VERB
dpc-5050	83	30	medications	medication	NOUN
dpc-5050	83	31	[	[	X
dpc-5050	83	32	5	5	NUM
dpc-5050	83	33	]	]	PUNCT
dpc-5050	83	34	.	.	PUNCT
dpc-5050	84	1	previous	previous	ADJ
dpc-5050	84	2	studies	study	NOUN
dpc-5050	84	3	have	have	AUX
dpc-5050	84	4	shown	show	VERB
dpc-5050	84	5	that	that	SCONJ
dpc-5050	84	6	osteoporosis	osteoporosis	NOUN
dpc-5050	84	7	,	,	PUNCT
dpc-5050	84	8	one	one	NUM
dpc-5050	84	9	of	of	ADP
dpc-5050	84	10	the	the	DET
dpc-5050	84	11	well	well	ADV
dpc-5050	84	12	-	-	PUNCT
dpc-5050	84	13	known	know	VERB
dpc-5050	84	14	side	side	NOUN
dpc-5050	84	15	effects	effect	NOUN
dpc-5050	84	16	of	of	ADP
dpc-5050	84	17	systemic	systemic	ADJ
dpc-5050	84	18	glucocorticoids	glucocorticoid	NOUN
dpc-5050	84	19	,	,	PUNCT
dpc-5050	84	20	is	be	AUX
dpc-5050	84	21	increased	increase	VERB
dpc-5050	84	22	in	in	ADP
dpc-5050	84	23	pv	pv	NOUN
dpc-5050	84	24	patients	patient	NOUN
dpc-5050	84	25	compared	compare	VERB
dpc-5050	84	26	to	to	ADP
dpc-5050	84	27	healthy	healthy	ADJ
dpc-5050	84	28	volunteers	volunteer	NOUN
dpc-5050	84	29	even	even	ADV
dpc-5050	84	30	before	before	ADP
dpc-5050	84	31	treatment	treatment	NOUN
dpc-5050	84	32	[	[	X
dpc-5050	84	33	11	11	NUM
dpc-5050	84	34	]	]	PUNCT
dpc-5050	84	35	.	.	PUNCT
dpc-5050	85	1	this	this	DET
dpc-5050	85	2	difference	difference	NOUN
dpc-5050	85	3	could	could	AUX
dpc-5050	85	4	not	not	PART
dpc-5050	85	5	be	be	AUX
dpc-5050	85	6	confirmed	confirm	VERB
dpc-5050	85	7	in	in	ADP
dpc-5050	85	8	our	our	PRON
dpc-5050	85	9	case	case	NOUN
dpc-5050	85	10	series	series	NOUN
dpc-5050	85	11	since	since	SCONJ
dpc-5050	85	12	our	our	PRON
dpc-5050	85	13	study	study	NOUN
dpc-5050	85	14	lacked	lack	VERB
dpc-5050	85	15	a	a	DET
dpc-5050	85	16	control	control	NOUN
dpc-5050	85	17	group	group	NOUN
dpc-5050	85	18	.	.	PUNCT
dpc-5050	86	1	similar	similar	ADJ
dpc-5050	86	2	to	to	ADP
dpc-5050	86	3	our	our	PRON
dpc-5050	86	4	study	study	NOUN
dpc-5050	86	5	,	,	PUNCT
dpc-5050	86	6	marzano	marzano	PROPN
dpc-5050	86	7	et	et	PROPN
dpc-5050	86	8	al	al	PROPN
dpc-5050	86	9	.	.	PROPN
dpc-5050	86	10	found	find	VERB
dpc-5050	86	11	that	that	SCONJ
dpc-5050	86	12	pv	pv	NOUN
dpc-5050	86	13	patients	patient	NOUN
dpc-5050	86	14	have	have	VERB
dpc-5050	86	15	lower	low	ADJ
dpc-5050	86	16	serum	serum	NOUN
dpc-5050	86	17	calcium	calcium	NOUN
dpc-5050	86	18	and	and	CCONJ
dpc-5050	86	19	vitamin	vitamin	NOUN
dpc-5050	86	20	d	d	PROPN
dpc-5050	86	21	levels	level	NOUN
dpc-5050	86	22	compared	compare	VERB
dpc-5050	86	23	to	to	ADP
dpc-5050	86	24	controls	control	NOUN
dpc-5050	86	25	before	before	ADP
dpc-5050	86	26	treatment	treatment	NOUN
dpc-5050	86	27	.	.	PUNCT
dpc-5050	87	1	along	along	ADP
dpc-5050	87	2	with	with	ADP
dpc-5050	87	3	this	this	DET
dpc-5050	87	4	result	result	NOUN
dpc-5050	87	5	,	,	PUNCT
dpc-5050	87	6	they	they	PRON
dpc-5050	87	7	suggested	suggest	VERB
dpc-5050	87	8	that	that	SCONJ
dpc-5050	87	9	low	low	ADJ
dpc-5050	87	10	vitamin	vitamin	NOUN
dpc-5050	87	11	d	d	NOUN
dpc-5050	87	12	might	might	AUX
dpc-5050	87	13	play	play	VERB
dpc-5050	87	14	a	a	DET
dpc-5050	87	15	role	role	NOUN
dpc-5050	87	16	in	in	ADP
dpc-5050	87	17	the	the	DET
dpc-5050	87	18	pathogenesis	pathogenesis	NOUN
dpc-5050	87	19	of	of	ADP
dpc-5050	87	20	pemphigus	pemphigus	ADJ
dpc-5050	87	21	vulgaris	vulgaris	NOUN
dpc-5050	87	22	[	[	X
dpc-5050	87	23	12,13	12,13	NUM
dpc-5050	87	24	]	]	PUNCT
dpc-5050	87	25	.	.	PUNCT
dpc-5050	88	1	although	although	SCONJ
dpc-5050	88	2	the	the	DET
dpc-5050	88	3	absence	absence	NOUN
dpc-5050	88	4	of	of	ADP
dpc-5050	88	5	a	a	DET
dpc-5050	88	6	significant	significant	ADJ
dpc-5050	88	7	decrease	decrease	NOUN
dpc-5050	88	8	in	in	ADP
dpc-5050	88	9	calcium	calcium	NOUN
dpc-5050	88	10	and	and	CCONJ
dpc-5050	88	11	vitamin	vitamin	NOUN
dpc-5050	88	12	d	d	PROPN
dpc-5050	88	13	levels	level	NOUN
dpc-5050	88	14	post	post	ADJ
dpc-5050	88	15	-	-	ADJ
dpc-5050	88	16	treatment	treatment	NOUN
dpc-5050	88	17	suggests	suggest	VERB
dpc-5050	88	18	that	that	SCONJ
dpc-5050	88	19	prophylaxis	prophylaxis	PRON
dpc-5050	88	20	may	may	AUX
dpc-5050	88	21	be	be	AUX
dpc-5050	88	22	adequate	adequate	ADJ
dpc-5050	88	23	,	,	PUNCT
dpc-5050	88	24	low	low	ADJ
dpc-5050	88	25	vitamin	vitamin	NOUN
dpc-5050	88	26	d	d	NOUN
dpc-5050	88	27	levels	level	NOUN
dpc-5050	88	28	before	before	ADP
dpc-5050	88	29	treatment	treatment	NOUN
dpc-5050	88	30	,	,	PUNCT
dpc-5050	88	31	malnutrition	malnutrition	NOUN
dpc-5050	88	32	,	,	PUNCT
dpc-5050	88	33	table	table	NOUN
dpc-5050	88	34	1	1	NUM
dpc-5050	88	35	.	.	PUNCT
dpc-5050	89	1	characteristics	characteristic	NOUN
dpc-5050	89	2	of	of	ADP
dpc-5050	89	3	the	the	DET
dpc-5050	89	4	study	study	NOUN
dpc-5050	89	5	population	population	NOUN
dpc-5050	89	6	.	.	PUNCT
dpc-5050	90	1	variable	variable	ADJ
dpc-5050	90	2	total	total	NOUN
dpc-5050	90	3	(	(	PUNCT
dpc-5050	90	4	n=66	n=66	NOUN
dpc-5050	90	5	)	)	PUNCT
dpc-5050	90	6	mean	mean	NOUN
dpc-5050	90	7	(	(	PUNCT
dpc-5050	90	8	sd	sd	NOUN
dpc-5050	90	9	)	)	PUNCT
dpc-5050	90	10	male	male	NOUN
dpc-5050	90	11	(	(	PUNCT
dpc-5050	90	12	n=27	n=27	PROPN
dpc-5050	90	13	)	)	PUNCT
dpc-5050	90	14	mean	mean	NOUN
dpc-5050	90	15	(	(	PUNCT
dpc-5050	90	16	sd	sd	NOUN
dpc-5050	90	17	)	)	PUNCT
dpc-5050	90	18	female	female	NOUN
dpc-5050	90	19	(	(	PUNCT
dpc-5050	90	20	n=39	n=39	PROPN
dpc-5050	90	21	)	)	PUNCT
dpc-5050	90	22	mean	mean	NOUN
dpc-5050	90	23	(	(	PUNCT
dpc-5050	90	24	sd	sd	NOUN
dpc-5050	90	25	)	)	PUNCT
dpc-5050	90	26	p	p	NOUN
dpc-5050	90	27	-	-	PUNCT
dpc-5050	90	28	value	value	NOUN
dpc-5050	90	29	age	age	NOUN
dpc-5050	90	30	(	(	PUNCT
dpc-5050	90	31	years	year	NOUN
dpc-5050	90	32	)	)	PUNCT
dpc-5050	90	33	53.83	53.83	NUM
dpc-5050	90	34	(	(	PUNCT
dpc-5050	90	35	16.15	16.15	NUM
dpc-5050	90	36	)	)	PUNCT
dpc-5050	90	37	54.8	54.8	NUM
dpc-5050	90	38	(	(	PUNCT
dpc-5050	90	39	14.9	14.9	NUM
dpc-5050	90	40	)	)	PUNCT
dpc-5050	90	41	53.15	53.15	NUM
dpc-5050	90	42	(	(	PUNCT
dpc-5050	90	43	17.06	17.06	NUM
dpc-5050	90	44	)	)	PUNCT
dpc-5050	90	45	0.685	0.685	NUM
dpc-5050	90	46	bmi	bmi	X
dpc-5050	90	47	(	(	PUNCT
dpc-5050	90	48	mg	mg	PROPN
dpc-5050	90	49	/	/	SYM
dpc-5050	90	50	m2	m2	PROPN
dpc-5050	90	51	)	)	PUNCT
dpc-5050	90	52	27.61	27.61	NUM
dpc-5050	90	53	(	(	PUNCT
dpc-5050	90	54	5.06	5.06	NUM
dpc-5050	90	55	)	)	PUNCT
dpc-5050	90	56	26.7	26.7	NUM
dpc-5050	90	57	(	(	PUNCT
dpc-5050	90	58	3.72	3.72	NUM
dpc-5050	90	59	)	)	PUNCT
dpc-5050	90	60	28.2	28.2	NUM
dpc-5050	90	61	(	(	PUNCT
dpc-5050	90	62	5.79	5.79	NUM
dpc-5050	90	63	)	)	PUNCT
dpc-5050	90	64	0.228	0.228	NUM
dpc-5050	90	65	time	time	NOUN
dpc-5050	90	66	before	before	ADP
dpc-5050	90	67	diagnosis	diagnosis	NOUN
dpc-5050	90	68	(	(	PUNCT
dpc-5050	90	69	months	month	NOUN
dpc-5050	90	70	)	)	PUNCT
dpc-5050	90	71	10.14	10.14	NUM
dpc-5050	90	72	(	(	PUNCT
dpc-5050	90	73	13.89	13.89	NUM
dpc-5050	90	74	)	)	PUNCT
dpc-5050	90	75	10.78	10.78	NUM
dpc-5050	90	76	(	(	PUNCT
dpc-5050	90	77	12.7	12.7	NUM
dpc-5050	90	78	)	)	PUNCT
dpc-5050	90	79	9.69	9.69	NUM
dpc-5050	90	80	(	(	PUNCT
dpc-5050	90	81	14.7	14.7	NUM
dpc-5050	90	82	)	)	PUNCT
dpc-5050	90	83	0.758	0.758	NUM
dpc-5050	90	84	cumulative	cumulative	ADJ
dpc-5050	90	85	prednisone	prednisone	PROPN
dpc-5050	90	86	dose	dose	PROPN
dpc-5050	90	87	(	(	PUNCT
dpc-5050	90	88	mg	mg	PROPN
dpc-5050	90	89	)	)	PUNCT
dpc-5050	90	90	6190.08	6190.08	NUM
dpc-5050	90	91	(	(	PUNCT
dpc-5050	90	92	3598.4	3598.4	NUM
dpc-5050	90	93	)	)	PUNCT
dpc-5050	90	94	6828.8	6828.8	NUM
dpc-5050	90	95	(	(	PUNCT
dpc-5050	90	96	4030.1	4030.1	NUM
dpc-5050	90	97	)	)	PUNCT
dpc-5050	90	98	5747.88	5747.88	NUM
dpc-5050	90	99	(	(	PUNCT
dpc-5050	90	100	3247.4	3247.4	NUM
dpc-5050	90	101	)	)	PUNCT
dpc-5050	90	102	0.233	0.233	NUM
dpc-5050	90	103	daily	daily	ADJ
dpc-5050	90	104	prednisone	prednisone	PROPN
dpc-5050	90	105	dose	dose	PROPN
dpc-5050	90	106	(	(	PUNCT
dpc-5050	90	107	mg	mg	PROPN
dpc-5050	90	108	)	)	PUNCT
dpc-5050	90	109	16.95	16.95	NUM
dpc-5050	90	110	(	(	PUNCT
dpc-5050	90	111	16.10	16.10	NUM
dpc-5050	90	112	)	)	PUNCT
dpc-5050	90	113	20.78	20.78	NUM
dpc-5050	90	114	(	(	PUNCT
dpc-5050	90	115	10.84	10.84	NUM
dpc-5050	90	116	)	)	PUNCT
dpc-5050	90	117	17.76	17.76	NUM
dpc-5050	90	118	(	(	PUNCT
dpc-5050	90	119	9.53	9.53	NUM
dpc-5050	90	120	)	)	PUNCT
dpc-5050	90	121	0.236	0.236	NUM
dpc-5050	90	122	abbreviations	abbreviation	NOUN
dpc-5050	90	123	:	:	PUNCT
dpc-5050	90	124	bmi	bmi	PROPN
dpc-5050	90	125	=	=	SYM
dpc-5050	90	126	body	body	PROPN
dpc-5050	90	127	mass	mass	PROPN
dpc-5050	90	128	index	index	NOUN
dpc-5050	90	129	;	;	PUNCT
dpc-5050	90	130	sd	sd	NOUN
dpc-5050	90	131	=	=	SYM
dpc-5050	90	132	standard	standard	ADJ
dpc-5050	90	133	deviation	deviation	NOUN
dpc-5050	90	134	.	.	PUNCT
dpc-5050	90	135	table	table	NOUN
dpc-5050	90	136	2	2	NUM
dpc-5050	90	137	.	.	PUNCT
dpc-5050	90	138	comparison	comparison	NOUN
dpc-5050	90	139	of	of	ADP
dpc-5050	90	140	t	t	PROPN
dpc-5050	90	141	-	-	PUNCT
dpc-5050	90	142	scores	score	NOUN
dpc-5050	90	143	and	and	CCONJ
dpc-5050	90	144	laboratory	laboratory	NOUN
dpc-5050	90	145	values	value	NOUN
dpc-5050	90	146	before	before	ADP
dpc-5050	90	147	and	and	CCONJ
dpc-5050	90	148	after	after	ADP
dpc-5050	90	149	treatment	treatment	NOUN
dpc-5050	90	150	.	.	PUNCT
dpc-5050	91	1	variable	variable	NOUN
dpc-5050	91	2	before	before	ADP
dpc-5050	91	3	treatment	treatment	NOUN
dpc-5050	91	4	mean	mean	NOUN
dpc-5050	91	5	±	±	NUM
dpc-5050	91	6	sd	sd	NOUN
dpc-5050	91	7	after	after	ADP
dpc-5050	91	8	treatment	treatment	NOUN
dpc-5050	91	9	mean	mean	NOUN
dpc-5050	91	10	±	±	NUM
dpc-5050	91	11	sd	sd	ADP
dpc-5050	91	12	p	p	NOUN
dpc-5050	91	13	-	-	PUNCT
dpc-5050	91	14	value	value	NOUN
dpc-5050	91	15	lumbar	lumbar	NOUN
dpc-5050	91	16	t	t	NOUN
dpc-5050	91	17	-	-	PUNCT
dpc-5050	91	18	score	score	NOUN
dpc-5050	91	19	−0.91	−0.91	NOUN
dpc-5050	91	20	±	±	NUM
dpc-5050	91	21	1.56	1.56	NUM
dpc-5050	91	22	−1.06	−1.06	PROPN
dpc-5050	91	23	±	±	NUM
dpc-5050	91	24	1.44	1.44	NUM
dpc-5050	91	25	0.102	0.102	NUM
dpc-5050	91	26	femur	femur	ADJ
dpc-5050	91	27	t	t	NOUN
dpc-5050	91	28	-	-	PUNCT
dpc-5050	91	29	score	score	NOUN
dpc-5050	91	30	−0.64	−0.64	PUNCT
dpc-5050	91	31	±	±	NUM
dpc-5050	91	32	1.10	1.10	NUM
dpc-5050	91	33	−0.87	−0.87	NUM
dpc-5050	91	34	±	±	NUM
dpc-5050	91	35	1.09	1.09	NUM
dpc-5050	91	36	0.001	0.001	NUM
dpc-5050	91	37	alp	alp	PROPN
dpc-5050	91	38	69.90	69.90	NUM
dpc-5050	91	39	±	±	NUM
dpc-5050	91	40	26.22	26.22	NUM
dpc-5050	91	41	68.83	68.83	NUM
dpc-5050	91	42	±	±	NUM
dpc-5050	91	43	22.87	22.87	NUM
dpc-5050	91	44	0.724	0.724	NUM
dpc-5050	91	45	calcium	calcium	NOUN
dpc-5050	91	46	9.43	9.43	NUM
dpc-5050	91	47	±	±	NUM
dpc-5050	91	48	0.48	0.48	NUM
dpc-5050	91	49	9.41	9.41	NUM
dpc-5050	91	50	±	±	NUM
dpc-5050	91	51	0.48	0.48	NUM
dpc-5050	91	52	0.819	0.819	NUM
dpc-5050	91	53	vitamin	vitamin	NOUN
dpc-5050	91	54	d	d	ADP
dpc-5050	91	55	34.64	34.64	NUM
dpc-5050	91	56	±	±	NUM
dpc-5050	91	57	15.62	15.62	NUM
dpc-5050	91	58	39.49	39.49	NUM
dpc-5050	91	59	±	±	NUM
dpc-5050	91	60	19.40	19.40	NUM
dpc-5050	91	61	0.018	0.018	NUM
dpc-5050	91	62	ldh	ldh	PROPN
dpc-5050	91	63	203.03	203.03	NUM
dpc-5050	91	64	±	±	NUM
dpc-5050	91	65	41.79	41.79	NUM
dpc-5050	91	66	232.01	232.01	NUM
dpc-5050	91	67	±	±	NOUN
dpc-5050	91	68	59.54	59.54	NUM
dpc-5050	91	69	<	<	NOUN
dpc-5050	91	70	0.001	0.001	NUM
dpc-5050	91	71	abbreviations	abbreviation	NOUN
dpc-5050	91	72	:	:	PUNCT
dpc-5050	91	73	alp	alp	NOUN
dpc-5050	91	74	=	=	NOUN
dpc-5050	91	75	alkaline	alkaline	NOUN
dpc-5050	91	76	phosphatase	phosphatase	NOUN
dpc-5050	91	77	;	;	PUNCT
dpc-5050	91	78	ldh	ldh	NOUN
dpc-5050	91	79	=	=	SYM
dpc-5050	91	80	lactate	lactate	NOUN
dpc-5050	91	81	dehydrogenase	dehydrogenase	NOUN
dpc-5050	91	82	;	;	PUNCT
dpc-5050	91	83	sd	sd	NOUN
dpc-5050	91	84	=	=	SYM
dpc-5050	91	85	standard	standard	ADJ
dpc-5050	91	86	deviation	deviation	NOUN
dpc-5050	91	87	.	.	PUNCT
dpc-5050	92	1	4	4	NUM
dpc-5050	92	2	original	original	ADJ
dpc-5050	92	3	article	article	NOUN
dpc-5050	92	4	|	|	ADV
dpc-5050	92	5	dermatol	dermatol	ADJ
dpc-5050	92	6	pract	pract	NOUN
dpc-5050	92	7	concept	concept	NOUN
dpc-5050	92	8	.	.	PUNCT
dpc-5050	93	1	2025;15(2):5050	2025;15(2):5050	NUM
dpc-5050	93	2	t	t	NOUN
dpc-5050	93	3	ab	ab	X
dpc-5050	93	4	le	le	X
dpc-5050	93	5	3	3	NUM
dpc-5050	93	6	.	.	PUNCT
dpc-5050	94	1	c	c	NOUN
dpc-5050	94	2	om	om	PROPN
dpc-5050	94	3	pa	pa	PROPN
dpc-5050	94	4	ri	ri	PROPN
dpc-5050	95	1	so	so	ADV
dpc-5050	95	2	n	n	PROPN
dpc-5050	95	3	of	of	ADP
dpc-5050	95	4	b	b	NOUN
dpc-5050	95	5	on	on	ADP
dpc-5050	95	6	e	e	X
dpc-5050	95	7	m	m	NOUN
dpc-5050	95	8	in	in	ADP
dpc-5050	95	9	er	er	INTJ
dpc-5050	95	10	al	al	PROPN
dpc-5050	95	11	d	d	PROPN
dpc-5050	95	12	en	en	ADP
dpc-5050	95	13	si	si	PROPN
dpc-5050	96	1	ty	ty	X
dpc-5050	96	2	v	v	PROPN
dpc-5050	96	3	al	al	PROPN
dpc-5050	96	4	ue	ue	PROPN
dpc-5050	97	1	s	s	PROPN
dpc-5050	97	2	b	b	X
dpc-5050	97	3	ef	ef	PROPN
dpc-5050	97	4	or	or	CCONJ
dpc-5050	97	5	e	e	X
dpc-5050	97	6	an	an	PROPN
dpc-5050	97	7	d	d	X
dpc-5050	97	8	a	a	DET
dpc-5050	97	9	ft	ft	NOUN
dpc-5050	97	10	er	er	INTJ
dpc-5050	97	11	t	t	PROPN
dpc-5050	97	12	re	re	NOUN
dpc-5050	97	13	at	at	ADP
dpc-5050	97	14	m	m	PROPN
dpc-5050	97	15	en	en	ADP
dpc-5050	97	16	t	t	PROPN
dpc-5050	97	17	a	a	DET
dpc-5050	97	18	cc	cc	NOUN
dpc-5050	97	19	or	or	CCONJ
dpc-5050	97	20	di	di	INTJ
dpc-5050	97	21	ng	ng	PROPN
dpc-5050	97	22	t	t	PROPN
dpc-5050	98	1	o	o	X
dpc-5050	98	2	se	se	PROPN
dpc-5050	98	3	x	x	X
dpc-5050	98	4	an	an	DET
dpc-5050	98	5	d	d	PROPN
dpc-5050	98	6	b	b	PROPN
dpc-5050	98	7	od	od	PROPN
dpc-5050	98	8	y	y	PROPN
dpc-5050	98	9	m	m	ADV
dpc-5050	98	10	as	as	ADP
dpc-5050	98	11	s	s	PRON
dpc-5050	98	12	in	in	ADP
dpc-5050	98	13	de	de	PROPN
dpc-5050	98	14	x.	x.	PROPN
dpc-5050	98	15	v	v	PROPN
dpc-5050	98	16	ar	ar	PROPN
dpc-5050	98	17	ia	ia	PROPN
dpc-5050	98	18	bl	bl	PROPN
dpc-5050	98	19	e	e	PROPN
dpc-5050	98	20	se	se	X
dpc-5050	98	21	x	x	PROPN
dpc-5050	99	1	m	m	VERB
dpc-5050	99	2	ea	ea	NOUN
dpc-5050	99	3	n	n	ADP
dpc-5050	99	4	±	±	NUM
dpc-5050	99	5	sd	sd	ADP
dpc-5050	99	6	b	b	PROPN
dpc-5050	99	7	od	od	PROPN
dpc-5050	99	8	y	y	PROPN
dpc-5050	99	9	m	m	ADV
dpc-5050	99	10	as	as	ADP
dpc-5050	99	11	s	s	PRON
dpc-5050	99	12	in	in	ADP
dpc-5050	99	13	de	de	X
dpc-5050	99	14	x	x	X
dpc-5050	99	15	m	m	PROPN
dpc-5050	99	16	ea	ea	PROPN
dpc-5050	99	17	n	n	ADP
dpc-5050	99	18	±	±	NUM
dpc-5050	99	19	sd	sd	ADP
dpc-5050	99	20	m	m	PROPN
dpc-5050	99	21	al	al	PROPN
dpc-5050	99	22	e	e	PROPN
dpc-5050	99	23	fe	fe	X
dpc-5050	99	24	m	m	PROPN
dpc-5050	99	25	al	al	PROPN
dpc-5050	99	26	e	e	PROPN
dpc-5050	99	27	pva	pva	NOUN
dpc-5050	99	28	lu	lu	NOUN
dpc-5050	99	29	e	e	PROPN
dpc-5050	99	30	≥3	≥3	PROPN
dpc-5050	99	31	0	0	NUM
dpc-5050	99	32	m	m	NOUN
dpc-5050	99	33	g/	g/	NOUN
dpc-5050	99	34	m	m	VERB
dpc-5050	99	35	2	2	NUM
dpc-5050	99	36	<3	<3	NOUN
dpc-5050	99	37	0	0	NUM
dpc-5050	100	1	m	m	VERB
dpc-5050	100	2	g/	g/	NOUN
dpc-5050	100	3	m	m	PROPN
dpc-5050	100	4	2	2	NUM
dpc-5050	100	5	pva	pva	NOUN
dpc-5050	100	6	lu	lu	PROPN
dpc-5050	100	7	e	e	X
dpc-5050	100	8	fe	fe	X
dpc-5050	100	9	m	m	VERB
dpc-5050	100	10	ur	ur	INTJ
dpc-5050	100	11	t	t	X
dpc-5050	100	12	-s	-s	PROPN
dpc-5050	100	13	co	co	X
dpc-5050	100	14	re	re	PROPN
dpc-5050	100	15	b	b	PROPN
dpc-5050	100	16	ef	ef	PROPN
dpc-5050	100	17	or	or	CCONJ
dpc-5050	100	18	e	e	X
dpc-5050	100	19	-0	-0	NOUN
dpc-5050	100	20	.6	.6	NUM
dpc-5050	101	1	7±	7±	NUM
dpc-5050	101	2	0	0	NUM
dpc-5050	101	3	.	.	PUNCT
dpc-5050	102	1	93	93	NUM
dpc-5050	102	2	-0	-0	SYM
dpc-5050	102	3	.6	.6	NUM
dpc-5050	102	4	1±	1±	NUM
dpc-5050	102	5	1	1	NUM
dpc-5050	102	6	.	.	PUNCT
dpc-5050	102	7	22	22	NUM
dpc-5050	102	8	0	0	NUM
dpc-5050	102	9	.	.	PUNCT
dpc-5050	102	10	82	82	NUM
dpc-5050	102	11	4	4	NUM
dpc-5050	102	12	-0	-0	SYM
dpc-5050	102	13	.4	.4	NUM
dpc-5050	102	14	3±	3±	NUM
dpc-5050	102	15	1	1	NUM
dpc-5050	102	16	.	.	NUM
dpc-5050	102	17	06	06	NUM
dpc-5050	102	18	-0	-0	X
dpc-5050	102	19	.7	.7	PROPN
dpc-5050	102	20	4±	4±	PROPN
dpc-5050	102	21	1	1	NUM
dpc-5050	102	22	.	.	PROPN
dpc-5050	102	23	12	12	NUM
dpc-5050	102	24	0	0	NUM
dpc-5050	102	25	.	.	NOUN
dpc-5050	102	26	29	29	NUM
dpc-5050	102	27	3	3	NUM
dpc-5050	102	28	a	a	DET
dpc-5050	102	29	ft	ft	NOUN
dpc-5050	102	30	er	er	INTJ
dpc-5050	102	31	-0	-0	INTJ
dpc-5050	102	32	.7	.7	NOUN
dpc-5050	102	33	0±	0±	NOUN
dpc-5050	102	34	1	1	NUM
dpc-5050	102	35	.	.	NUM
dpc-5050	102	36	06	06	NUM
dpc-5050	102	37	-0	-0	INTJ
dpc-5050	102	38	.9	.9	NUM
dpc-5050	102	39	8±	8±	NUM
dpc-5050	102	40	1	1	NUM
dpc-5050	102	41	.	.	PUNCT
dpc-5050	102	42	12	12	NUM
dpc-5050	102	43	0	0	NUM
dpc-5050	102	44	.	.	PUNCT
dpc-5050	102	45	31	31	NUM
dpc-5050	102	46	8	8	NUM
dpc-5050	102	47	-0	-0	SYM
dpc-5050	102	48	.8	.8	NUM
dpc-5050	102	49	1±	1±	NUM
dpc-5050	102	50	0	0	NUM
dpc-5050	102	51	.	.	PROPN
dpc-5050	102	52	89	89	NUM
dpc-5050	102	53	-0	-0	SYM
dpc-5050	102	54	.8	.8	NUM
dpc-5050	102	55	9±	9±	NUM
dpc-5050	102	56	1	1	NUM
dpc-5050	102	57	.	.	NOUN
dpc-5050	102	58	19	19	NUM
dpc-5050	102	59	0	0	NUM
dpc-5050	102	60	.	.	PUNCT
dpc-5050	102	61	78	78	NUM
dpc-5050	102	62	5	5	NUM
dpc-5050	102	63	l	l	NOUN
dpc-5050	102	64	um	um	INTJ
dpc-5050	102	65	ba	ba	PROPN
dpc-5050	102	66	r	r	NOUN
dpc-5050	102	67	tsc	tsc	PROPN
dpc-5050	102	68	or	or	CCONJ
dpc-5050	102	69	e	e	PROPN
dpc-5050	102	70	b	b	PROPN
dpc-5050	102	71	ef	ef	PROPN
dpc-5050	102	72	or	or	CCONJ
dpc-5050	102	73	e	e	PROPN
dpc-5050	102	74	-0	-0	PROPN
dpc-5050	102	75	.7	.7	NUM
dpc-5050	102	76	9±	9±	NUM
dpc-5050	102	77	1	1	NUM
dpc-5050	102	78	.	.	X
dpc-5050	102	79	41	41	NUM
dpc-5050	102	80	-1	-1	SYM
dpc-5050	102	81	.0	.0	NUM
dpc-5050	102	82	0±	0±	NOUN
dpc-5050	102	83	1	1	NUM
dpc-5050	102	84	.	.	PUNCT
dpc-5050	102	85	67	67	NUM
dpc-5050	102	86	0	0	NUM
dpc-5050	102	87	.	.	PUNCT
dpc-5050	102	88	60	60	NUM
dpc-5050	102	89	3	3	NUM
dpc-5050	102	90	-0	-0	NOUN
dpc-5050	102	91	.7	.7	NUM
dpc-5050	102	92	7±	7±	NUM
dpc-5050	102	93	1	1	NUM
dpc-5050	102	94	.	.	X
dpc-5050	102	95	53	53	NUM
dpc-5050	102	96	-0	-0	SYM
dpc-5050	102	97	.9	.9	NUM
dpc-5050	102	98	9±	9±	NUM
dpc-5050	102	99	1	1	NUM
dpc-5050	102	100	.	.	X
dpc-5050	102	101	59	59	NUM
dpc-5050	102	102	0	0	NUM
dpc-5050	102	103	.	.	PUNCT
dpc-5050	102	104	59	59	NUM
dpc-5050	102	105	8	8	NUM
dpc-5050	102	106	a	a	DET
dpc-5050	102	107	ft	ft	NOUN
dpc-5050	102	108	er	er	INTJ
dpc-5050	102	109	-0	-0	INTJ
dpc-5050	102	110	.8	.8	NUM
dpc-5050	102	111	2±	2±	NUM
dpc-5050	102	112	1	1	NUM
dpc-5050	102	113	.	.	NUM
dpc-5050	102	114	21	21	NUM
dpc-5050	102	115	-1	-1	NOUN
dpc-5050	102	116	.2	.2	NUM
dpc-5050	102	117	3±	3±	NUM
dpc-5050	102	118	1	1	NUM
dpc-5050	102	119	.	.	PUNCT
dpc-5050	102	120	57	57	NUM
dpc-5050	102	121	0	0	NUM
dpc-5050	102	122	.	.	PUNCT
dpc-5050	102	123	25	25	NUM
dpc-5050	102	124	6	6	NUM
dpc-5050	102	125	-1	-1	SYM
dpc-5050	102	126	.1	.1	NUM
dpc-5050	102	127	±1	±1	VERB
dpc-5050	102	128	.3	.3	NUM
dpc-5050	102	129	9	9	NUM
dpc-5050	102	130	-1	-1	SYM
dpc-5050	102	131	.0	.0	NUM
dpc-5050	102	132	5±	5±	NUM
dpc-5050	102	133	1	1	NUM
dpc-5050	102	134	.	.	PUNCT
dpc-5050	102	135	48	48	NUM
dpc-5050	102	136	0	0	NUM
dpc-5050	102	137	.	.	NUM
dpc-5050	103	1	89	89	NUM
dpc-5050	103	2	6	6	NUM
dpc-5050	103	3	a	a	DET
dpc-5050	103	4	l	l	NOUN
dpc-5050	103	5	p	p	X
dpc-5050	103	6	b	b	PROPN
dpc-5050	103	7	ef	ef	PROPN
dpc-5050	103	8	or	or	CCONJ
dpc-5050	103	9	e	e	X
dpc-5050	103	10	69	69	NUM
dpc-5050	103	11	.0	.0	NUM
dpc-5050	104	1	7±	7±	NUM
dpc-5050	104	2	25	25	NUM
dpc-5050	104	3	.5	.5	NUM
dpc-5050	104	4	6	6	NUM
dpc-5050	104	5	70	70	NUM
dpc-5050	104	6	.4	.4	NUM
dpc-5050	104	7	8±	8±	NUM
dpc-5050	104	8	26	26	NUM
dpc-5050	104	9	.9	.9	NUM
dpc-5050	104	10	9	9	NUM
dpc-5050	104	11	0	0	NUM
dpc-5050	104	12	.	.	NOUN
dpc-5050	104	13	83	83	NUM
dpc-5050	104	14	2	2	NUM
dpc-5050	104	15	77	77	NUM
dpc-5050	104	16	.8	.8	NUM
dpc-5050	104	17	1±	1±	NUM
dpc-5050	104	18	35	35	NUM
dpc-5050	104	19	.2	.2	NUM
dpc-5050	104	20	5	5	NUM
dpc-5050	104	21	65	65	NUM
dpc-5050	104	22	.9	.9	NUM
dpc-5050	104	23	±1	±1	VERB
dpc-5050	104	24	9	9	NUM
dpc-5050	104	25	.	.	NOUN
dpc-5050	104	26	61	61	NUM
dpc-5050	104	27	0	0	NUM
dpc-5050	104	28	.	.	NOUN
dpc-5050	104	29	15	15	NUM
dpc-5050	104	30	3	3	NUM
dpc-5050	104	31	a	a	DET
dpc-5050	104	32	ft	ft	NOUN
dpc-5050	104	33	er	er	INTJ
dpc-5050	104	34	69	69	NUM
dpc-5050	104	35	.8	.8	NUM
dpc-5050	104	36	5±	5±	NUM
dpc-5050	104	37	22	22	NUM
dpc-5050	104	38	.6	.6	NUM
dpc-5050	104	39	6	6	NUM
dpc-5050	104	40	68	68	NUM
dpc-5050	104	41	.1	.1	NUM
dpc-5050	105	1	2±	2±	NUM
dpc-5050	105	2	23	23	NUM
dpc-5050	106	1	.2	.2	NUM
dpc-5050	106	2	9	9	NUM
dpc-5050	106	3	0	0	NUM
dpc-5050	106	4	.	.	PUNCT
dpc-5050	107	1	76	76	NUM
dpc-5050	107	2	5	5	NUM
dpc-5050	107	3	70	70	NUM
dpc-5050	107	4	.6	.6	NUM
dpc-5050	107	5	3±	3±	NUM
dpc-5050	107	6	24	24	NUM
dpc-5050	107	7	.3	.3	NUM
dpc-5050	107	8	1	1	NUM
dpc-5050	107	9	67	67	NUM
dpc-5050	107	10	.9	.9	NUM
dpc-5050	107	11	3±	3±	NUM
dpc-5050	107	12	22	22	NUM
dpc-5050	107	13	.3	.3	NUM
dpc-5050	107	14	5	5	NUM
dpc-5050	107	15	0	0	NUM
dpc-5050	107	16	.	.	PUNCT
dpc-5050	107	17	65	65	NUM
dpc-5050	107	18	4	4	NUM
dpc-5050	107	19	c	c	NOUN
dpc-5050	107	20	al	al	PROPN
dpc-5050	107	21	ci	ci	PROPN
dpc-5050	107	22	um	um	INTJ
dpc-5050	107	23	b	b	PROPN
dpc-5050	107	24	ef	ef	PROPN
dpc-5050	107	25	or	or	CCONJ
dpc-5050	107	26	e	e	PROPN
dpc-5050	107	27	9	9	NUM
dpc-5050	107	28	.	.	NOUN
dpc-5050	107	29	45	45	NUM
dpc-5050	107	30	±0	±0	ADJ
dpc-5050	107	31	.3	.3	NUM
dpc-5050	107	32	8	8	NUM
dpc-5050	107	33	9	9	NUM
dpc-5050	107	34	.	.	PUNCT
dpc-5050	107	35	41	41	NUM
dpc-5050	107	36	±0	±0	NOUN
dpc-5050	107	37	.5	.5	NUM
dpc-5050	107	38	5	5	NUM
dpc-5050	107	39	0	0	NUM
dpc-5050	107	40	.	.	PUNCT
dpc-5050	107	41	79	79	NUM
dpc-5050	107	42	2	2	NUM
dpc-5050	107	43	9	9	NUM
dpc-5050	107	44	.	.	PUNCT
dpc-5050	108	1	4±	4±	PROPN
dpc-5050	108	2	0	0	NUM
dpc-5050	108	3	.	.	PROPN
dpc-5050	108	4	31	31	NUM
dpc-5050	108	5	9	9	NUM
dpc-5050	108	6	.	.	X
dpc-5050	108	7	44	44	NUM
dpc-5050	108	8	±0	±0	NOUN
dpc-5050	108	9	.5	.5	NUM
dpc-5050	108	10	6	6	NUM
dpc-5050	108	11	0	0	NUM
dpc-5050	108	12	.	.	PUNCT
dpc-5050	108	13	79	79	NUM
dpc-5050	108	14	2	2	NUM
dpc-5050	108	15	a	a	DET
dpc-5050	108	16	ft	ft	NOUN
dpc-5050	108	17	er	er	INTJ
dpc-5050	108	18	9	9	NUM
dpc-5050	108	19	.	.	X
dpc-5050	108	20	41	41	NUM
dpc-5050	108	21	±0	±0	ADJ
dpc-5050	108	22	.3	.3	NUM
dpc-5050	108	23	9	9	NUM
dpc-5050	108	24	9	9	NUM
dpc-5050	108	25	.	.	X
dpc-5050	108	26	41	41	NUM
dpc-5050	108	27	±0	±0	NOUN
dpc-5050	108	28	.5	.5	NUM
dpc-5050	108	29	5	5	NUM
dpc-5050	108	30	0	0	NUM
dpc-5050	108	31	.	.	PUNCT
dpc-5050	109	1	97	97	NUM
dpc-5050	109	2	5	5	NUM
dpc-5050	109	3	9	9	NUM
dpc-5050	109	4	.	.	PUNCT
dpc-5050	109	5	38	38	NUM
dpc-5050	109	6	±0	±0	NOUN
dpc-5050	109	7	.5	.5	NUM
dpc-5050	109	8	1	1	NUM
dpc-5050	109	9	9	9	NUM
dpc-5050	109	10	.	.	PUNCT
dpc-5050	109	11	43	43	NUM
dpc-5050	109	12	±0	±0	VERB
dpc-5050	109	13	.4	.4	NUM
dpc-5050	109	14	7	7	NUM
dpc-5050	109	15	0	0	NUM
dpc-5050	109	16	.	.	PUNCT
dpc-5050	110	1	73	73	NUM
dpc-5050	110	2	5	5	NUM
dpc-5050	110	3	v	v	NOUN
dpc-5050	110	4	it	it	PRON
dpc-5050	110	5	am	be	AUX
dpc-5050	110	6	in	in	ADP
dpc-5050	110	7	d	d	PROPN
dpc-5050	110	8	b	b	SYM
dpc-5050	110	9	ef	ef	PROPN
dpc-5050	110	10	or	or	CCONJ
dpc-5050	110	11	e	e	ADJ
dpc-5050	110	12	41	41	NUM
dpc-5050	110	13	.7	.7	NUM
dpc-5050	110	14	4±	4±	NUM
dpc-5050	110	15	15	15	NUM
dpc-5050	110	16	.1	.1	NUM
dpc-5050	110	17	2	2	NUM
dpc-5050	110	18	29	29	NUM
dpc-5050	111	1	.7	.7	NUM
dpc-5050	112	1	2±	2±	NUM
dpc-5050	112	2	14	14	NUM
dpc-5050	112	3	.1	.1	NUM
dpc-5050	112	4	6	6	NUM
dpc-5050	112	5	0	0	NUM
dpc-5050	112	6	.	.	PUNCT
dpc-5050	112	7	00	00	NUM
dpc-5050	113	1	2	2	NUM
dpc-5050	113	2	35	35	NUM
dpc-5050	113	3	.1	.1	NUM
dpc-5050	113	4	3±	3±	NUM
dpc-5050	113	5	14	14	NUM
dpc-5050	113	6	.3	.3	NUM
dpc-5050	113	7	3	3	NUM
dpc-5050	113	8	34	34	NUM
dpc-5050	113	9	.3	.3	NUM
dpc-5050	113	10	9±	9±	NUM
dpc-5050	113	11	16	16	NUM
dpc-5050	113	12	.3	.3	NUM
dpc-5050	113	13	8	8	NUM
dpc-5050	113	14	0	0	NUM
dpc-5050	113	15	.	.	NOUN
dpc-5050	113	16	85	85	NUM
dpc-5050	113	17	8	8	NUM
dpc-5050	113	18	a	a	DET
dpc-5050	113	19	ft	ft	NOUN
dpc-5050	113	20	er	er	INTJ
dpc-5050	113	21	46	46	NUM
dpc-5050	113	22	.8	.8	NUM
dpc-5050	113	23	9±	9±	NUM
dpc-5050	113	24	21	21	NUM
dpc-5050	113	25	.4	.4	NUM
dpc-5050	113	26	8	8	NUM
dpc-5050	113	27	34	34	NUM
dpc-5050	113	28	.3	.3	NUM
dpc-5050	113	29	6±	6±	NUM
dpc-5050	113	30	16	16	NUM
dpc-5050	113	31	.2	.2	NUM
dpc-5050	113	32	0	0	NUM
dpc-5050	113	33	0	0	NUM
dpc-5050	113	34	.	.	NOUN
dpc-5050	113	35	01	01	NUM
dpc-5050	113	36	4	4	NUM
dpc-5050	113	37	38	38	NUM
dpc-5050	113	38	.6	.6	NUM
dpc-5050	113	39	5±	5±	NOUN
dpc-5050	113	40	18	18	NUM
dpc-5050	113	41	.4	.4	NUM
dpc-5050	113	42	1	1	NUM
dpc-5050	113	43	39	39	NUM
dpc-5050	113	44	.9	.9	NUM
dpc-5050	113	45	1±	1±	NUM
dpc-5050	113	46	20	20	NUM
dpc-5050	113	47	.0	.0	NUM
dpc-5050	113	48	8	8	NUM
dpc-5050	113	49	0	0	NUM
dpc-5050	113	50	.	.	NOUN
dpc-5050	113	51	80	80	NUM
dpc-5050	113	52	7	7	NUM
dpc-5050	113	53	l	l	NOUN
dpc-5050	114	1	d	d	NOUN
dpc-5050	114	2	h	h	NOUN
dpc-5050	114	3	b	b	X
dpc-5050	114	4	ef	ef	PROPN
dpc-5050	114	5	or	or	CCONJ
dpc-5050	114	6	e	e	X
dpc-5050	114	7	20	20	NUM
dpc-5050	114	8	2	2	NUM
dpc-5050	114	9	.	.	PUNCT
dpc-5050	115	1	51	51	NUM
dpc-5050	115	2	±3	±3	ADJ
dpc-5050	115	3	8	8	NUM
dpc-5050	115	4	.	.	NOUN
dpc-5050	115	5	86	86	NUM
dpc-5050	115	6	20	20	NUM
dpc-5050	115	7	3	3	NUM
dpc-5050	115	8	.	.	X
dpc-5050	115	9	38	38	NUM
dpc-5050	115	10	±4	±4	NUM
dpc-5050	115	11	4	4	NUM
dpc-5050	115	12	.	.	NOUN
dpc-5050	115	13	20	20	NUM
dpc-5050	115	14	0	0	NUM
dpc-5050	115	15	.	.	PUNCT
dpc-5050	116	1	93	93	NUM
dpc-5050	116	2	5	5	NUM
dpc-5050	116	3	20	20	NUM
dpc-5050	116	4	6	6	NUM
dpc-5050	116	5	.	.	X
dpc-5050	116	6	86	86	NUM
dpc-5050	116	7	±4	±4	NUM
dpc-5050	116	8	1	1	NUM
dpc-5050	116	9	.	.	NOUN
dpc-5050	116	10	29	29	NUM
dpc-5050	116	11	20	20	NUM
dpc-5050	116	12	1	1	NUM
dpc-5050	116	13	.	.	X
dpc-5050	116	14	11	11	NUM
dpc-5050	116	15	±4	±4	NUM
dpc-5050	116	16	2	2	NUM
dpc-5050	116	17	.	.	PUNCT
dpc-5050	116	18	38	38	NUM
dpc-5050	116	19	0	0	NUM
dpc-5050	116	20	.	.	PUNCT
dpc-5050	117	1	60	60	NUM
dpc-5050	117	2	2	2	NUM
dpc-5050	117	3	a	a	DET
dpc-5050	117	4	ft	ft	NOUN
dpc-5050	117	5	er	er	INTJ
dpc-5050	117	6	21	21	NUM
dpc-5050	117	7	8	8	NUM
dpc-5050	117	8	.	.	PUNCT
dpc-5050	118	1	96	96	NUM
dpc-5050	118	2	±4	±4	NUM
dpc-5050	118	3	1	1	NUM
dpc-5050	118	4	.	.	PUNCT
dpc-5050	118	5	83	83	NUM
dpc-5050	118	6	24	24	NUM
dpc-5050	118	7	1	1	NUM
dpc-5050	118	8	.	.	PUNCT
dpc-5050	119	1	05	05	NUM
dpc-5050	119	2	±6	±6	NOUN
dpc-5050	119	3	8	8	NUM
dpc-5050	119	4	.	.	PUNCT
dpc-5050	119	5	28	28	NUM
dpc-5050	119	6	0	0	NUM
dpc-5050	119	7	.	.	PUNCT
dpc-5050	120	1	10	10	NUM
dpc-5050	120	2	9	9	NUM
dpc-5050	120	3	23	23	NUM
dpc-5050	120	4	5	5	NUM
dpc-5050	120	5	.	.	SYM
dpc-5050	120	6	31	31	NUM
dpc-5050	120	7	±5	±5	VERB
dpc-5050	120	8	6	6	NUM
dpc-5050	120	9	.	.	NOUN
dpc-5050	120	10	67	67	NUM
dpc-5050	120	11	23	23	NUM
dpc-5050	120	12	0	0	NUM
dpc-5050	120	13	.	.	X
dpc-5050	121	1	36	36	NUM
dpc-5050	121	2	±6	±6	NOUN
dpc-5050	121	3	1	1	NUM
dpc-5050	121	4	.	.	NOUN
dpc-5050	121	5	50	50	NUM
dpc-5050	121	6	0	0	NUM
dpc-5050	121	7	.	.	PUNCT
dpc-5050	121	8	75	75	NUM
dpc-5050	121	9	3	3	NUM
dpc-5050	121	10	a	a	DET
dpc-5050	121	11	bb	bb	INTJ
dpc-5050	121	12	re	re	ADJ
dpc-5050	121	13	vi	vi	PROPN
dpc-5050	121	14	at	at	ADP
dpc-5050	121	15	io	io	X
dpc-5050	121	16	ns	ns	NUM
dpc-5050	121	17	:	:	PUNCT
dpc-5050	121	18	a	a	DET
dpc-5050	121	19	l	l	NOUN
dpc-5050	121	20	p	p	X
dpc-5050	121	21	=	=	PROPN
dpc-5050	121	22	al	al	PROPN
dpc-5050	121	23	ka	ka	PROPN
dpc-5050	121	24	lin	lin	PROPN
dpc-5050	121	25	e	e	PROPN
dpc-5050	121	26	ph	ph	PROPN
dpc-5050	121	27	os	os	NOUN
dpc-5050	121	28	ph	ph	NOUN
dpc-5050	121	29	at	at	ADP
dpc-5050	121	30	as	as	ADP
dpc-5050	121	31	e	e	NOUN
dpc-5050	121	32	;	;	PUNCT
dpc-5050	121	33	l	l	NOUN
dpc-5050	122	1	d	d	PUNCT
dpc-5050	122	2	h	h	NOUN
dpc-5050	122	3	=	=	PUNCT
dpc-5050	122	4	la	la	INTJ
dpc-5050	122	5	ct	ct	PROPN
dpc-5050	122	6	at	at	ADP
dpc-5050	122	7	e	e	PROPN
dpc-5050	122	8	de	de	PROPN
dpc-5050	122	9	hy	hy	PROPN
dpc-5050	122	10	dr	dr	PROPN
dpc-5050	122	11	og	og	PROPN
dpc-5050	122	12	en	en	ADV
dpc-5050	122	13	as	as	ADP
dpc-5050	122	14	e	e	NOUN
dpc-5050	122	15	;	;	PUNCT
dpc-5050	122	16	s	s	PART
dpc-5050	122	17	d	d	NOUN
dpc-5050	122	18	=	=	SYM
dpc-5050	122	19	s	s	PROPN
dpc-5050	122	20	ta	ta	PROPN
dpc-5050	122	21	nd	nd	INTJ
dpc-5050	122	22	ar	ar	PROPN
dpc-5050	122	23	d	d	PROPN
dpc-5050	122	24	de	de	X
dpc-5050	122	25	vi	vi	PROPN
dpc-5050	122	26	at	at	ADP
dpc-5050	122	27	io	io	X
dpc-5050	122	28	n.	n.	PROPN
dpc-5050	122	29	original	original	ADJ
dpc-5050	122	30	article	article	NOUN
dpc-5050	122	31	|	|	ADV
dpc-5050	122	32	dermatol	dermatol	ADJ
dpc-5050	122	33	pract	pract	NOUN
dpc-5050	122	34	concept	concept	NOUN
dpc-5050	122	35	.	.	PUNCT
dpc-5050	123	1	2025;15(2):5050	2025;15(2):5050	NUM
dpc-5050	123	2	5	5	NUM
dpc-5050	123	3	table	table	NOUN
dpc-5050	123	4	4	4	NUM
dpc-5050	123	5	.	.	PUNCT
dpc-5050	123	6	comparison	comparison	NOUN
dpc-5050	123	7	of	of	ADP
dpc-5050	123	8	bone	bone	NOUN
dpc-5050	123	9	mineral	mineral	NOUN
dpc-5050	123	10	density	density	NOUN
dpc-5050	123	11	values	value	NOUN
dpc-5050	123	12	before	before	ADP
dpc-5050	123	13	and	and	CCONJ
dpc-5050	123	14	after	after	ADP
dpc-5050	123	15	treatment	treatment	NOUN
dpc-5050	123	16	according	accord	VERB
dpc-5050	123	17	to	to	ADP
dpc-5050	123	18	menopausal	menopausal	ADJ
dpc-5050	123	19	state	state	NOUN
dpc-5050	123	20	.	.	PUNCT
dpc-5050	124	1	variable	variable	ADJ
dpc-5050	124	2	menopausal	menopausal	ADJ
dpc-5050	124	3	state	state	NOUN
dpc-5050	124	4	mean	mean	VERB
dpc-5050	124	5	±	±	PROPN
dpc-5050	124	6	sd	sd	ADP
dpc-5050	124	7	menopausal	menopausal	ADJ
dpc-5050	124	8	non	non	ADJ
dpc-5050	124	9	-	-	ADJ
dpc-5050	124	10	menopausal	menopausal	ADJ
dpc-5050	124	11	p	p	ADJ
dpc-5050	124	12	-	-	PUNCT
dpc-5050	124	13	value	value	NOUN
dpc-5050	124	14	femur	femur	NOUN
dpc-5050	124	15	t	t	NOUN
dpc-5050	124	16	-	-	PUNCT
dpc-5050	124	17	score	score	NOUN
dpc-5050	124	18	before	before	ADP
dpc-5050	124	19	-0.66±1.30	-0.66±1.30	PRON
dpc-5050	124	20	-0.61±0.93	-0.61±0.93	NUM
dpc-5050	124	21	0.869	0.869	NUM
dpc-5050	124	22	after	after	ADP
dpc-5050	124	23	-0.97±1.25	-0.97±1.25	NOUN
dpc-5050	124	24	-0.78±0.96	-0.78±0.96	PROPN
dpc-5050	124	25	0.493	0.493	NUM
dpc-5050	124	26	lumbar	lumbar	NOUN
dpc-5050	124	27	t	t	NOUN
dpc-5050	124	28	-	-	PUNCT
dpc-5050	124	29	score	score	NOUN
dpc-5050	124	30	before	before	ADP
dpc-5050	124	31	-1.17±1.76	-1.17±1.76	PROPN
dpc-5050	124	32	-0.70±1.36	-0.70±1.36	NOUN
dpc-5050	124	33	0.224	0.224	NUM
dpc-5050	124	34	after	after	ADP
dpc-5050	124	35	-1.25±1.74	-1.25±1.74	PROPN
dpc-5050	124	36	0.91±1.13	0.91±1.13	NOUN
dpc-5050	124	37	0.370	0.370	NUM
dpc-5050	124	38	alp	alp	NOUN
dpc-5050	124	39	before	before	ADP
dpc-5050	124	40	71.76±24.88	71.76±24.88	NUM
dpc-5050	124	41	68.36±27.55	68.36±27.55	NUM
dpc-5050	124	42	0.603	0.603	NUM
dpc-5050	124	43	after	after	ADP
dpc-5050	124	44	70.23±25.24	70.23±25.24	NOUN
dpc-5050	124	45	67.66±20.99	67.66±20.99	NUM
dpc-5050	124	46	0.653	0.653	NUM
dpc-5050	124	47	calcium	calcium	NOUN
dpc-5050	124	48	before	before	ADP
dpc-5050	124	49	9.37±0.51	9.37±0.51	PROPN
dpc-5050	124	50	9.48±0.46	9.48±0.46	NOUN
dpc-5050	124	51	0.353	0.353	NUM
dpc-5050	124	52	after	after	ADP
dpc-5050	124	53	9.40±0.51	9.40±0.51	PROPN
dpc-5050	124	54	9.42±0.47	9.42±0.47	PROPN
dpc-5050	124	55	0.823	0.823	NUM
dpc-5050	124	56	vitamin	vitamin	NOUN
dpc-5050	124	57	d	d	NOUN
dpc-5050	124	58	before	before	ADP
dpc-5050	124	59	30.54±14.91	30.54±14.91	NUM
dpc-5050	124	60	38.06±15.58	38.06±15.58	NUM
dpc-5050	124	61	0.051	0.051	NUM
dpc-5050	124	62	after	after	ADP
dpc-5050	124	63	34.25±17.15	34.25±17.15	PROPN
dpc-5050	124	64	43.85±20.31	43.85±20.31	PROPN
dpc-5050	124	65	0.044	0.044	NUM
dpc-5050	124	66	ldh	ldh	NOUN
dpc-5050	124	67	before	before	ADP
dpc-5050	124	68	207.60±41.58	207.60±41.58	NUM
dpc-5050	124	69	199.22±42.17	199.22±42.17	NUM
dpc-5050	124	70	0.422	0.422	NUM
dpc-5050	124	71	after	after	ADP
dpc-5050	124	72	246.86±68.01	246.86±68.01	NUM
dpc-5050	124	73	219.63±49.04	219.63±49.04	NUM
dpc-5050	124	74	0.064	0.064	NUM
dpc-5050	124	75	abbreviations	abbreviation	NOUN
dpc-5050	124	76	:	:	PUNCT
dpc-5050	124	77	alp	alp	NOUN
dpc-5050	124	78	=	=	NOUN
dpc-5050	124	79	alkaline	alkaline	NOUN
dpc-5050	124	80	phosphatase	phosphatase	NOUN
dpc-5050	124	81	;	;	PUNCT
dpc-5050	124	82	ldh	ldh	NOUN
dpc-5050	124	83	=	=	SYM
dpc-5050	124	84	lactate	lactate	NOUN
dpc-5050	124	85	dehydrogenase	dehydrogenase	NOUN
dpc-5050	124	86	;	;	PUNCT
dpc-5050	124	87	sd	sd	NOUN
dpc-5050	124	88	=	=	SYM
dpc-5050	124	89	standard	standard	ADJ
dpc-5050	124	90	deviation	deviation	NOUN
dpc-5050	124	91	.	.	PUNCT
dpc-5050	125	1	table	table	NOUN
dpc-5050	125	2	5	5	NUM
dpc-5050	125	3	.	.	PUNCT
dpc-5050	125	4	comparison	comparison	NOUN
dpc-5050	125	5	of	of	ADP
dpc-5050	125	6	t	t	PROPN
dpc-5050	125	7	-	-	PUNCT
dpc-5050	125	8	scores	score	NOUN
dpc-5050	125	9	before	before	ADV
dpc-5050	125	10	and	and	CCONJ
dpc-5050	125	11	after	after	ADP
dpc-5050	125	12	treatment	treatment	NOUN
dpc-5050	125	13	according	accord	VERB
dpc-5050	125	14	to	to	ADP
dpc-5050	125	15	dose	dose	NOUN
dpc-5050	125	16	categories	category	NOUN
dpc-5050	125	17	.	.	PUNCT
dpc-5050	126	1	before	before	ADP
dpc-5050	126	2	treatment	treatment	NOUN
dpc-5050	126	3	mean	mean	NOUN
dpc-5050	126	4	(	(	PUNCT
dpc-5050	126	5	sd	sd	NOUN
dpc-5050	126	6	)	)	PUNCT
dpc-5050	126	7	after	after	ADP
dpc-5050	126	8	treatment	treatment	NOUN
dpc-5050	126	9	mean	mean	NOUN
dpc-5050	126	10	(	(	PUNCT
dpc-5050	126	11	sd	sd	NOUN
dpc-5050	126	12	)	)	PUNCT
dpc-5050	126	13	p	p	NOUN
dpc-5050	126	14	-	-	PUNCT
dpc-5050	126	15	value	value	NOUN
dpc-5050	126	16	low	low	ADJ
dpc-5050	126	17	dose	dose	NOUN
dpc-5050	126	18	femur	femur	NOUN
dpc-5050	126	19	t	t	NOUN
dpc-5050	126	20	-	-	PUNCT
dpc-5050	126	21	score	score	NOUN
dpc-5050	126	22	-0.49	-0.49	NOUN
dpc-5050	126	23	(	(	PUNCT
dpc-5050	126	24	0.89	0.89	NUM
dpc-5050	126	25	)	)	PUNCT
dpc-5050	126	26	-0.4	-0.4	NOUN
dpc-5050	126	27	(	(	PUNCT
dpc-5050	126	28	1.11	1.11	NUM
dpc-5050	126	29	)	)	PUNCT
dpc-5050	126	30	0.571	0.571	NUM
dpc-5050	126	31	lumbar	lumbar	PROPN
dpc-5050	126	32	t	t	PROPN
dpc-5050	126	33	-	-	PUNCT
dpc-5050	126	34	score	score	NOUN
dpc-5050	126	35	-0.63	-0.63	NOUN
dpc-5050	126	36	(	(	PUNCT
dpc-5050	126	37	1.25	1.25	NUM
dpc-5050	126	38	)	)	PUNCT
dpc-5050	126	39	-0.6	-0.6	NOUN
dpc-5050	126	40	(	(	PUNCT
dpc-5050	126	41	1.47	1.47	NUM
dpc-5050	126	42	)	)	PUNCT
dpc-5050	126	43	0.908	0.908	NUM
dpc-5050	126	44	medium	medium	NOUN
dpc-5050	126	45	dose	dose	NOUN
dpc-5050	126	46	femur	femur	NOUN
dpc-5050	126	47	t	t	NOUN
dpc-5050	126	48	-	-	PUNCT
dpc-5050	126	49	score	score	NOUN
dpc-5050	126	50	-0.8	-0.8	PROPN
dpc-5050	126	51	(	(	PUNCT
dpc-5050	126	52	1.13	1.13	NUM
dpc-5050	126	53	)	)	PUNCT
dpc-5050	126	54	-1.02	-1.02	NUM
dpc-5050	126	55	(	(	PUNCT
dpc-5050	126	56	1.09	1.09	NUM
dpc-5050	126	57	)	)	PUNCT
dpc-5050	126	58	0.000	0.000	NUM
dpc-5050	126	59	lumbar	lumbar	NOUN
dpc-5050	126	60	t	t	PROPN
dpc-5050	126	61	-	-	PUNCT
dpc-5050	126	62	score	score	NOUN
dpc-5050	126	63	-1.26	-1.26	NUM
dpc-5050	126	64	(	(	PUNCT
dpc-5050	126	65	1.5	1.5	NUM
dpc-5050	126	66	)	)	PUNCT
dpc-5050	126	67	-1.24	-1.24	NOUN
dpc-5050	126	68	(	(	PUNCT
dpc-5050	126	69	1.47	1.47	NUM
dpc-5050	126	70	)	)	PUNCT
dpc-5050	126	71	0.785	0.785	NUM
dpc-5050	126	72	high	high	ADJ
dpc-5050	126	73	dose	dose	NOUN
dpc-5050	126	74	femur	femur	NOUN
dpc-5050	126	75	t	t	NOUN
dpc-5050	126	76	-	-	PUNCT
dpc-5050	126	77	score	score	NOUN
dpc-5050	126	78	-0.2	-0.2	PROPN
dpc-5050	126	79	(	(	PUNCT
dpc-5050	126	80	1.15	1.15	NUM
dpc-5050	126	81	)	)	PUNCT
dpc-5050	126	82	-0.79	-0.79	NOUN
dpc-5050	126	83	(	(	PUNCT
dpc-5050	126	84	1.02	1.02	NUM
dpc-5050	126	85	)	)	PUNCT
dpc-5050	126	86	0.018	0.018	NUM
dpc-5050	126	87	lumbar	lumbar	PROPN
dpc-5050	126	88	t	t	PROPN
dpc-5050	126	89	-	-	PUNCT
dpc-5050	126	90	score	score	NOUN
dpc-5050	126	91	-0.01	-0.01	NUM
dpc-5050	126	92	(	(	PUNCT
dpc-5050	126	93	1.73	1.73	NUM
dpc-5050	126	94	)	)	PUNCT
dpc-5050	126	95	-0.89	-0.89	NUM
dpc-5050	126	96	(	(	PUNCT
dpc-5050	126	97	1.29	1.29	NUM
dpc-5050	126	98	)	)	PUNCT
dpc-5050	126	99	0.059	0.059	NUM
dpc-5050	126	100	abbreviation	abbreviation	NOUN
dpc-5050	126	101	:	:	PUNCT
dpc-5050	126	102	sd	sd	NOUN
dpc-5050	126	103	=	=	SYM
dpc-5050	126	104	standard	standard	ADJ
dpc-5050	126	105	deviation	deviation	NOUN
dpc-5050	126	106	.	.	PUNCT
dpc-5050	127	1	and	and	CCONJ
dpc-5050	127	2	pre	pre	ADJ
dpc-5050	127	3	-	-	ADJ
dpc-5050	127	4	existing	existing	ADJ
dpc-5050	127	5	inflammation	inflammation	NOUN
dpc-5050	127	6	may	may	AUX
dpc-5050	127	7	contribute	contribute	VERB
dpc-5050	127	8	to	to	ADP
dpc-5050	127	9	the	the	DET
dpc-5050	127	10	significant	significant	ADJ
dpc-5050	127	11	decrease	decrease	NOUN
dpc-5050	127	12	in	in	ADP
dpc-5050	127	13	femur	femur	ADJ
dpc-5050	127	14	t	t	PROPN
dpc-5050	127	15	-	-	PUNCT
dpc-5050	127	16	scores	score	NOUN
dpc-5050	127	17	in	in	ADP
dpc-5050	127	18	pv	pv	NOUN
dpc-5050	127	19	patients	patient	NOUN
dpc-5050	127	20	and	and	CCONJ
dpc-5050	127	21	that	that	SCONJ
dpc-5050	127	22	there	there	PRON
dpc-5050	127	23	may	may	AUX
dpc-5050	127	24	be	be	AUX
dpc-5050	127	25	a	a	DET
dpc-5050	127	26	need	need	NOUN
dpc-5050	127	27	to	to	PART
dpc-5050	127	28	initiate	initiate	VERB
dpc-5050	127	29	additional	additional	ADJ
dpc-5050	127	30	anti	anti	ADJ
dpc-5050	127	31	-	-	ADJ
dpc-5050	127	32	resorptive	resorptive	ADJ
dpc-5050	127	33	treatments	treatment	NOUN
dpc-5050	128	1	earlier	early	ADV
dpc-5050	128	2	[	[	X
dpc-5050	128	3	12,14,15	12,14,15	NUM
dpc-5050	128	4	]	]	PUNCT
dpc-5050	128	5	.	.	PUNCT
dpc-5050	129	1	additionally	additionally	ADV
dpc-5050	129	2	,	,	PUNCT
dpc-5050	129	3	glucocorticoids	glucocorticoid	NOUN
dpc-5050	129	4	directly	directly	ADV
dpc-5050	129	5	affect	affect	VERB
dpc-5050	129	6	osteoclasts	osteoclast	NOUN
dpc-5050	129	7	and	and	CCONJ
dpc-5050	129	8	osteoblasts	osteoblast	NOUN
dpc-5050	129	9	,	,	PUNCT
dpc-5050	129	10	reducing	reduce	VERB
dpc-5050	129	11	bone	bone	NOUN
dpc-5050	129	12	mineral	mineral	NOUN
dpc-5050	129	13	density	density	NOUN
dpc-5050	129	14	,	,	PUNCT
dpc-5050	129	15	which	which	PRON
dpc-5050	129	16	negatively	negatively	ADV
dpc-5050	129	17	contributes	contribute	VERB
dpc-5050	129	18	to	to	ADP
dpc-5050	129	19	the	the	DET
dpc-5050	129	20	current	current	ADJ
dpc-5050	129	21	condition	condition	NOUN
dpc-5050	129	22	of	of	ADP
dpc-5050	129	23	bone	bone	NOUN
dpc-5050	129	24	mineral	mineral	NOUN
dpc-5050	129	25	density	density	NOUN
dpc-5050	129	26	[	[	X
dpc-5050	129	27	16	16	NUM
dpc-5050	129	28	-	-	SYM
dpc-5050	129	29	18	18	NUM
dpc-5050	129	30	]	]	PUNCT
dpc-5050	129	31	.	.	PUNCT
dpc-5050	130	1	this	this	DET
dpc-5050	130	2	study	study	NOUN
dpc-5050	130	3	has	have	VERB
dpc-5050	130	4	potential	potential	ADJ
dpc-5050	130	5	limitations	limitation	NOUN
dpc-5050	130	6	.	.	PUNCT
dpc-5050	131	1	first	first	ADV
dpc-5050	131	2	,	,	PUNCT
dpc-5050	131	3	the	the	DET
dpc-5050	131	4	retrospective	retrospective	ADJ
dpc-5050	131	5	design	design	NOUN
dpc-5050	131	6	of	of	ADP
dpc-5050	131	7	our	our	PRON
dpc-5050	131	8	study	study	NOUN
dpc-5050	131	9	limited	limit	VERB
dpc-5050	131	10	our	our	PRON
dpc-5050	131	11	ability	ability	NOUN
dpc-5050	131	12	to	to	PART
dpc-5050	131	13	clearly	clearly	ADV
dpc-5050	131	14	evaluate	evaluate	VERB
dpc-5050	131	15	the	the	DET
dpc-5050	131	16	presence	presence	NOUN
dpc-5050	131	17	of	of	ADP
dpc-5050	131	18	malnutrition	malnutrition	NOUN
dpc-5050	131	19	in	in	ADP
dpc-5050	131	20	the	the	DET
dpc-5050	131	21	patients	patient	NOUN
dpc-5050	131	22	.	.	PUNCT
dpc-5050	132	1	the	the	DET
dpc-5050	132	2	compliance	compliance	NOUN
dpc-5050	132	3	with	with	ADP
dpc-5050	132	4	physical	physical	ADJ
dpc-5050	132	5	activity	activity	NOUN
dpc-5050	132	6	and	and	CCONJ
dpc-5050	132	7	dietary	dietary	ADJ
dpc-5050	132	8	follow	follow	NOUN
dpc-5050	132	9	-	-	PUNCT
dpc-5050	132	10	up	up	NOUN
dpc-5050	132	11	could	could	AUX
dpc-5050	132	12	not	not	PART
dpc-5050	132	13	be	be	AUX
dpc-5050	132	14	monitored	monitor	VERB
dpc-5050	132	15	.	.	PUNCT
dpc-5050	133	1	second	second	ADJ
dpc-5050	133	2	,	,	PUNCT
dpc-5050	133	3	the	the	DET
dpc-5050	133	4	lack	lack	NOUN
dpc-5050	133	5	of	of	ADP
dpc-5050	133	6	control	control	NOUN
dpc-5050	133	7	group	group	NOUN
dpc-5050	133	8	limits	limit	VERB
dpc-5050	133	9	establishing	establish	VERB
dpc-5050	133	10	causal	causal	ADJ
dpc-5050	133	11	relationships	relationship	NOUN
dpc-5050	133	12	and	and	CCONJ
dpc-5050	133	13	comparing	compare	VERB
dpc-5050	133	14	outcomes	outcome	NOUN
dpc-5050	133	15	with	with	ADP
dpc-5050	133	16	alternative	alternative	ADJ
dpc-5050	133	17	treatment	treatment	NOUN
dpc-5050	133	18	strategies	strategy	NOUN
dpc-5050	133	19	.	.	PUNCT
dpc-5050	134	1	third	third	ADJ
dpc-5050	134	2	,	,	PUNCT
dpc-5050	134	3	since	since	SCONJ
dpc-5050	134	4	disease	disease	NOUN
dpc-5050	134	5	severity	severity	NOUN
dpc-5050	134	6	was	be	AUX
dpc-5050	134	7	not	not	PART
dpc-5050	134	8	included	include	VERB
dpc-5050	134	9	in	in	ADP
dpc-5050	134	10	the	the	DET
dpc-5050	134	11	study	study	NOUN
dpc-5050	134	12	,	,	PUNCT
dpc-5050	134	13	its	its	PRON
dpc-5050	134	14	relationship	relationship	NOUN
dpc-5050	134	15	with	with	ADP
dpc-5050	134	16	bone	bone	NOUN
dpc-5050	134	17	mineral	mineral	NOUN
dpc-5050	134	18	density	density	NOUN
dpc-5050	134	19	could	could	AUX
dpc-5050	134	20	not	not	PART
dpc-5050	134	21	be	be	AUX
dpc-5050	134	22	determined	determine	VERB
dpc-5050	134	23	.	.	PUNCT
dpc-5050	135	1	van	van	PROPN
dpc-5050	135	2	staa	staa	PROPN
dpc-5050	135	3	et	et	PROPN
dpc-5050	135	4	al	al	PROPN
dpc-5050	135	5	.	.	PROPN
dpc-5050	135	6	demonstrated	demonstrate	VERB
dpc-5050	135	7	that	that	SCONJ
dpc-5050	135	8	the	the	DET
dpc-5050	135	9	risk	risk	NOUN
dpc-5050	135	10	of	of	ADP
dpc-5050	135	11	6	6	NUM
dpc-5050	135	12	original	original	ADJ
dpc-5050	135	13	article	article	NOUN
dpc-5050	135	14	|	|	ADV
dpc-5050	135	15	dermatol	dermatol	ADJ
dpc-5050	135	16	pract	pract	NOUN
dpc-5050	135	17	concept	concept	NOUN
dpc-5050	135	18	.	.	PUNCT
dpc-5050	136	1	2025;15(2):5050	2025;15(2):5050	NUM
dpc-5050	136	2	venereol	venereol	ADJ
dpc-5050	136	3	.	.	PUNCT
dpc-5050	137	1	2015;29(3):405	2015;29(3):405	NUM
dpc-5050	137	2	-	-	PUNCT
dpc-5050	137	3	414	414	NUM
dpc-5050	137	4	.	.	PUNCT
dpc-5050	138	1	doi	doi	NOUN
dpc-5050	138	2	:	:	PUNCT
dpc-5050	138	3	10.1111	10.1111	NUM
dpc-5050	138	4	/	/	SYM
dpc-5050	138	5	jdv.12772	jdv.12772	PROPN
dpc-5050	138	6	.	.	PUNCT
dpc-5050	139	1	pmid	pmid	NOUN
dpc-5050	139	2	:	:	PUNCT
dpc-5050	139	3	25338479	25338479	NUM
dpc-5050	139	4	.	.	PUNCT
dpc-5050	140	1	7	7	X
dpc-5050	140	2	.	.	X
dpc-5050	140	3	armas	armas	PROPN
dpc-5050	140	4	la	la	PROPN
dpc-5050	140	5	,	,	PUNCT
dpc-5050	140	6	recker	recker	PROPN
dpc-5050	140	7	rr	rr	PROPN
dpc-5050	140	8	.	.	PROPN
dpc-5050	140	9	pathophysiology	pathophysiology	NOUN
dpc-5050	140	10	of	of	ADP
dpc-5050	140	11	osteoporosis	osteoporosis	NOUN
dpc-5050	140	12	:	:	PUNCT
dpc-5050	140	13	new	new	ADJ
dpc-5050	140	14	mechanistic	mechanistic	ADJ
dpc-5050	140	15	insights	insight	NOUN
dpc-5050	140	16	.	.	PUNCT
dpc-5050	141	1	endocrinol	endocrinol	NOUN
dpc-5050	141	2	metab	metab	PROPN
dpc-5050	141	3	clin	clin	PROPN
dpc-5050	141	4	north	north	PROPN
dpc-5050	141	5	am	be	AUX
dpc-5050	141	6	.	.	PUNCT
dpc-5050	142	1	2012;41(3):475	2012;41(3):475	NUM
dpc-5050	142	2	-	-	SYM
dpc-5050	142	3	486	486	NUM
dpc-5050	142	4	.	.	PUNCT
dpc-5050	143	1	doi	doi	NOUN
dpc-5050	143	2	:	:	PUNCT
dpc-5050	143	3	10.1016	10.1016	NUM
dpc-5050	143	4	/	/	SYM
dpc-5050	143	5	j.ecl.2012.04.006	j.ecl.2012.04.006	PROPN
dpc-5050	143	6	.	.	PUNCT
dpc-5050	144	1	pmid	pmid	NOUN
dpc-5050	144	2	:	:	PUNCT
dpc-5050	144	3	22877425	22877425	NUM
dpc-5050	144	4	.	.	PUNCT
dpc-5050	145	1	8	8	X
dpc-5050	145	2	.	.	X
dpc-5050	146	1	humphrey	humphrey	PROPN
dpc-5050	146	2	mb	mb	PROPN
dpc-5050	146	3	,	,	PUNCT
dpc-5050	146	4	russell	russell	PROPN
dpc-5050	146	5	l	l	PROPN
dpc-5050	146	6	,	,	PUNCT
dpc-5050	146	7	danila	danila	PROPN
dpc-5050	146	8	mi	mi	PROPN
dpc-5050	146	9	,	,	PUNCT
dpc-5050	146	10	et	et	PROPN
dpc-5050	146	11	al	al	PROPN
dpc-5050	146	12	.	.	PROPN
dpc-5050	146	13	2022	2022	NUM
dpc-5050	146	14	american	american	PROPN
dpc-5050	146	15	college	college	PROPN
dpc-5050	146	16	of	of	ADP
dpc-5050	146	17	rheumatology	rheumatology	NOUN
dpc-5050	146	18	guideline	guideline	NOUN
dpc-5050	146	19	for	for	ADP
dpc-5050	146	20	the	the	DET
dpc-5050	146	21	prevention	prevention	NOUN
dpc-5050	146	22	and	and	CCONJ
dpc-5050	146	23	treatment	treatment	NOUN
dpc-5050	146	24	of	of	ADP
dpc-5050	146	25	glucocorticoid	glucocorticoid	NOUN
dpc-5050	146	26	-	-	PUNCT
dpc-5050	146	27	induced	induce	VERB
dpc-5050	146	28	osteoporosis	osteoporosis	NOUN
dpc-5050	146	29	.	.	PUNCT
dpc-5050	147	1	arthritis	arthritis	NOUN
dpc-5050	147	2	rheumatol	rheumatol	NOUN
dpc-5050	147	3	.	.	PUNCT
dpc-5050	148	1	2023;75(12):2088	2023;75(12):2088	NUM
dpc-5050	148	2	-	-	PUNCT
dpc-5050	148	3	2102	2102	NUM
dpc-5050	148	4	.	.	PUNCT
dpc-5050	149	1	doi	doi	NOUN
dpc-5050	149	2	:	:	PUNCT
dpc-5050	149	3	10.1002	10.1002	NUM
dpc-5050	149	4	/	/	SYM
dpc-5050	149	5	art.42646	art.42646	NOUN
dpc-5050	149	6	.	.	PUNCT
dpc-5050	150	1	pmid	pmid	NOUN
dpc-5050	150	2	:	:	PUNCT
dpc-5050	150	3	37845798	37845798	NUM
dpc-5050	150	4	.	.	PUNCT
dpc-5050	151	1	9	9	X
dpc-5050	151	2	.	.	X
dpc-5050	151	3	park	park	PROPN
dpc-5050	151	4	sy	sy	PROPN
dpc-5050	151	5	,	,	PUNCT
dpc-5050	151	6	gong	gong	PROPN
dpc-5050	151	7	hs	hs	PROPN
dpc-5050	151	8	,	,	PUNCT
dpc-5050	151	9	kim	kim	PROPN
dpc-5050	151	10	km	km	PROPN
dpc-5050	151	11	,	,	PUNCT
dpc-5050	151	12	et	et	PROPN
dpc-5050	151	13	al	al	PROPN
dpc-5050	151	14	.	.	PUNCT
dpc-5050	152	1	korean	korean	ADJ
dpc-5050	152	2	guideline	guideline	NOUN
dpc-5050	152	3	for	for	ADP
dpc-5050	152	4	the	the	DET
dpc-5050	152	5	prevention	prevention	NOUN
dpc-5050	152	6	and	and	CCONJ
dpc-5050	152	7	treatment	treatment	NOUN
dpc-5050	152	8	of	of	ADP
dpc-5050	152	9	glucocorticoid	glucocorticoid	NOUN
dpc-5050	152	10	-	-	PUNCT
dpc-5050	152	11	induced	induce	VERB
dpc-5050	152	12	osteoporosis	osteoporosis	NOUN
dpc-5050	152	13	.	.	PUNCT
dpc-5050	153	1	j	j	PROPN
dpc-5050	153	2	bone	bone	NOUN
dpc-5050	153	3	metab	metab	NOUN
dpc-5050	153	4	.	.	PUNCT
dpc-5050	154	1	2018;25(4):195	2018;25(4):195	NUM
dpc-5050	154	2	-	-	PUNCT
dpc-5050	154	3	211	211	NUM
dpc-5050	154	4	.	.	PUNCT
dpc-5050	155	1	doi	doi	NOUN
dpc-5050	155	2	:	:	PUNCT
dpc-5050	155	3	10.11005	10.11005	NUM
dpc-5050	155	4	/jbm.2018.25.4.195	/jbm.2018.25.4.195	NOUN
dpc-5050	155	5	.	.	PUNCT
dpc-5050	156	1	pmid	pmid	NOUN
dpc-5050	156	2	:	:	PUNCT
dpc-5050	156	3	30574464	30574464	NUM
dpc-5050	156	4	.	.	PUNCT
dpc-5050	157	1	10	10	NUM
dpc-5050	157	2	.	.	PUNCT
dpc-5050	158	1	buttgereit	buttgereit	PROPN
dpc-5050	158	2	f	f	PROPN
dpc-5050	158	3	,	,	PUNCT
dpc-5050	158	4	da	da	PROPN
dpc-5050	158	5	silva	silva	PROPN
dpc-5050	158	6	ja	ja	PROPN
dpc-5050	158	7	,	,	PUNCT
dpc-5050	158	8	boers	boers	PROPN
dpc-5050	158	9	m	m	PRON
dpc-5050	158	10	,	,	PUNCT
dpc-5050	158	11	et	et	PROPN
dpc-5050	158	12	al	al	PROPN
dpc-5050	158	13	.	.	PROPN
dpc-5050	158	14	standardised	standardise	VERB
dpc-5050	158	15	nomenclature	nomenclature	NOUN
dpc-5050	158	16	for	for	ADP
dpc-5050	158	17	glucocorticoid	glucocorticoid	ADJ
dpc-5050	158	18	dosages	dosage	NOUN
dpc-5050	158	19	and	and	CCONJ
dpc-5050	158	20	glucocorticoid	glucocorticoid	ADJ
dpc-5050	158	21	treatment	treatment	NOUN
dpc-5050	158	22	regimens	regimen	NOUN
dpc-5050	158	23	:	:	PUNCT
dpc-5050	158	24	current	current	ADJ
dpc-5050	158	25	questions	question	NOUN
dpc-5050	158	26	and	and	CCONJ
dpc-5050	158	27	tentative	tentative	ADJ
dpc-5050	158	28	answers	answer	NOUN
dpc-5050	158	29	in	in	ADP
dpc-5050	158	30	rheumatology	rheumatology	NOUN
dpc-5050	158	31	.	.	PUNCT
dpc-5050	159	1	ann	ann	PROPN
dpc-5050	159	2	rheum	rheum	PROPN
dpc-5050	159	3	dis	dis	PROPN
dpc-5050	159	4	.	.	PUNCT
dpc-5050	160	1	2002;61(8):718	2002;61(8):718	NUM
dpc-5050	160	2	-	-	PUNCT
dpc-5050	160	3	722	722	NUM
dpc-5050	160	4	.	.	PUNCT
dpc-5050	160	5	doi	doi	NOUN
dpc-5050	160	6	:	:	PUNCT
dpc-5050	160	7	10.1136	10.1136	NUM
dpc-5050	160	8	/	/	SYM
dpc-5050	160	9	ard	ard	PROPN
dpc-5050	160	10	.61.8.718	.61.8.718	PROPN
dpc-5050	160	11	.	.	PUNCT
dpc-5050	161	1	pmid	pmid	NOUN
dpc-5050	161	2	:	:	PUNCT
dpc-5050	161	3	12117678	12117678	NUM
dpc-5050	161	4	.	.	PUNCT
dpc-5050	162	1	11	11	NUM
dpc-5050	162	2	.	.	PUNCT
dpc-5050	163	1	wohl	wohl	PROPN
dpc-5050	163	2	y	y	PROPN
dpc-5050	163	3	,	,	PUNCT
dpc-5050	163	4	dreiher	dreiher	PROPN
dpc-5050	163	5	j	j	PROPN
dpc-5050	163	6	,	,	PUNCT
dpc-5050	163	7	cohen	cohen	PROPN
dpc-5050	163	8	ad	ad	NOUN
dpc-5050	163	9	.	.	PUNCT
dpc-5050	164	1	pemphigus	pemphigus	PROPN
dpc-5050	164	2	and	and	CCONJ
dpc-5050	164	3	osteoporosis	osteoporosis	NOUN
dpc-5050	164	4	:	:	PUNCT
dpc-5050	164	5	a	a	DET
dpc-5050	164	6	case	case	NOUN
dpc-5050	164	7	-	-	PUNCT
dpc-5050	164	8	control	control	NOUN
dpc-5050	164	9	study	study	NOUN
dpc-5050	164	10	.	.	PUNCT
dpc-5050	165	1	arch	arch	ADJ
dpc-5050	165	2	dermatol	dermatol	NOUN
dpc-5050	165	3	.	.	PUNCT
dpc-5050	166	1	2010;146(10):1126	2010;146(10):1126	NUM
dpc-5050	166	2	-	-	SYM
dpc-5050	166	3	1131	1131	NUM
dpc-5050	166	4	.	.	PUNCT
dpc-5050	167	1	doi	doi	NOUN
dpc-5050	167	2	:	:	PUNCT
dpc-5050	167	3	10.1001	10.1001	NUM
dpc-5050	167	4	/	/	SYM
dpc-5050	167	5	archdermatol.2010.257	archdermatol.2010.257	PROPN
dpc-5050	167	6	.	.	PUNCT
dpc-5050	168	1	pmid	pmid	NOUN
dpc-5050	168	2	:	:	PUNCT
dpc-5050	168	3	20956645	20956645	NUM
dpc-5050	168	4	.	.	PUNCT
dpc-5050	169	1	12	12	NUM
dpc-5050	169	2	.	.	PUNCT
dpc-5050	170	1	marzano	marzano	PROPN
dpc-5050	170	2	av	av	PROPN
dpc-5050	170	3	,	,	PUNCT
dpc-5050	170	4	trevisan	trevisan	PROPN
dpc-5050	170	5	v	v	NOUN
dpc-5050	170	6	,	,	PUNCT
dpc-5050	170	7	eller	eller	NOUN
dpc-5050	170	8	-	-	PUNCT
dpc-5050	170	9	vainicher	vainicher	NOUN
dpc-5050	170	10	c	c	NOUN
dpc-5050	170	11	,	,	PUNCT
dpc-5050	170	12	et	et	PROPN
dpc-5050	170	13	al	al	PROPN
dpc-5050	170	14	.	.	PROPN
dpc-5050	170	15	evidence	evidence	NOUN
dpc-5050	170	16	for	for	ADP
dpc-5050	170	17	vitamin	vitamin	NOUN
dpc-5050	170	18	d	d	NOUN
dpc-5050	170	19	deficiency	deficiency	NOUN
dpc-5050	170	20	and	and	CCONJ
dpc-5050	170	21	increased	increase	VERB
dpc-5050	170	22	prevalence	prevalence	NOUN
dpc-5050	170	23	of	of	ADP
dpc-5050	170	24	fractures	fracture	NOUN
dpc-5050	170	25	in	in	ADP
dpc-5050	170	26	autoimmune	autoimmune	ADJ
dpc-5050	170	27	bullous	bullous	ADJ
dpc-5050	170	28	skin	skin	NOUN
dpc-5050	170	29	diseases	disease	NOUN
dpc-5050	170	30	.	.	PUNCT
dpc-5050	171	1	br	br	PROPN
dpc-5050	171	2	j	j	PROPN
dpc-5050	171	3	dermatol	dermatol	NOUN
dpc-5050	171	4	.	.	PUNCT
dpc-5050	172	1	2012;167(3):688	2012;167(3):688	NUM
dpc-5050	172	2	-	-	SYM
dpc-5050	172	3	691	691	NUM
dpc-5050	172	4	.	.	PUNCT
dpc-5050	173	1	doi	doi	NOUN
dpc-5050	173	2	:	:	PUNCT
dpc-5050	173	3	10.1111	10.1111	NUM
dpc-5050	173	4	/	/	SYM
dpc-5050	173	5	j.1365	j.1365	NOUN
dpc-5050	173	6	-	-	PUNCT
dpc-5050	173	7	2133.2012.10982.x	2133.2012.10982.x	NUM
dpc-5050	173	8	.	.	PUNCT
dpc-5050	174	1	pmid	pmid	NOUN
dpc-5050	174	2	:	:	PUNCT
dpc-5050	174	3	22486251	22486251	NUM
dpc-5050	174	4	.	.	PUNCT
dpc-5050	175	1	13	13	NUM
dpc-5050	175	2	.	.	PUNCT
dpc-5050	175	3	marzano	marzano	PROPN
dpc-5050	175	4	av	av	PROPN
dpc-5050	175	5	,	,	PUNCT
dpc-5050	175	6	trevisan	trevisan	PROPN
dpc-5050	175	7	v	v	NOUN
dpc-5050	175	8	,	,	PUNCT
dpc-5050	175	9	cairoli	cairoli	PROPN
dpc-5050	175	10	e	e	NOUN
dpc-5050	175	11	,	,	PUNCT
dpc-5050	175	12	et	et	PROPN
dpc-5050	175	13	al	al	PROPN
dpc-5050	175	14	.	.	PUNCT
dpc-5050	175	15	vitamin	vitamin	PROPN
dpc-5050	175	16	d	d	NOUN
dpc-5050	175	17	and	and	CCONJ
dpc-5050	175	18	skeletal	skeletal	ADJ
dpc-5050	175	19	health	health	NOUN
dpc-5050	175	20	in	in	ADP
dpc-5050	175	21	autoimmune	autoimmune	ADJ
dpc-5050	175	22	bullous	bullous	ADJ
dpc-5050	175	23	skin	skin	NOUN
dpc-5050	175	24	diseases	disease	NOUN
dpc-5050	175	25	:	:	PUNCT
dpc-5050	175	26	a	a	DET
dpc-5050	175	27	case	case	NOUN
dpc-5050	175	28	control	control	NOUN
dpc-5050	175	29	study	study	NOUN
dpc-5050	175	30	.	.	PUNCT
dpc-5050	176	1	orphanet	orphanet	PROPN
dpc-5050	176	2	j	j	PROPN
dpc-5050	176	3	rare	rare	ADJ
dpc-5050	176	4	dis	dis	PROPN
dpc-5050	176	5	.	.	PUNCT
dpc-5050	177	1	2015;10:8	2015;10:8	X
dpc-5050	177	2	.	.	PUNCT
dpc-5050	177	3	published	publish	VERB
dpc-5050	177	4	2015	2015	NUM
dpc-5050	177	5	feb	feb	NOUN
dpc-5050	177	6	3	3	NUM
dpc-5050	177	7	.	.	PUNCT
dpc-5050	177	8	doi	doi	NOUN
dpc-5050	177	9	:	:	PUNCT
dpc-5050	177	10	10.1186	10.1186	NUM
dpc-5050	177	11	/	/	SYM
dpc-5050	177	12	s13023	s13023	PROPN
dpc-5050	177	13	-	-	PUNCT
dpc-5050	177	14	015	015	NUM
dpc-5050	177	15	-	-	PUNCT
dpc-5050	177	16	0230	0230	NUM
dpc-5050	177	17	-	-	PUNCT
dpc-5050	177	18	0	0	NUM
dpc-5050	177	19	.	.	PUNCT
dpc-5050	178	1	pmid	pmid	NOUN
dpc-5050	178	2	:	:	PUNCT
dpc-5050	178	3	25644263	25644263	NUM
dpc-5050	178	4	.	.	PUNCT
dpc-5050	179	1	14	14	NUM
dpc-5050	179	2	.	.	X
dpc-5050	179	3	echigo	echigo	PROPN
dpc-5050	179	4	t	t	PROPN
dpc-5050	179	5	,	,	PUNCT
dpc-5050	179	6	hasegawa	hasegawa	PROPN
dpc-5050	179	7	m	m	PROPN
dpc-5050	179	8	,	,	PUNCT
dpc-5050	179	9	shimada	shimada	PROPN
dpc-5050	179	10	y	y	PROPN
dpc-5050	179	11	,	,	PUNCT
dpc-5050	179	12	inaoki	inaoki	PROPN
dpc-5050	179	13	m	m	PROPN
dpc-5050	179	14	,	,	PUNCT
dpc-5050	179	15	takehara	takehara	PROPN
dpc-5050	179	16	k	k	PROPN
dpc-5050	179	17	,	,	PUNCT
dpc-5050	179	18	sato	sato	PROPN
dpc-5050	179	19	s.	s.	PROPN
dpc-5050	179	20	both	both	PRON
dpc-5050	179	21	th1	th1	PROPN
dpc-5050	179	22	and	and	CCONJ
dpc-5050	179	23	th2	th2	PROPN
dpc-5050	179	24	chemokines	chemokine	NOUN
dpc-5050	179	25	are	be	AUX
dpc-5050	179	26	elevated	elevate	VERB
dpc-5050	179	27	in	in	ADP
dpc-5050	179	28	sera	sera	NOUN
dpc-5050	179	29	of	of	ADP
dpc-5050	179	30	patients	patient	NOUN
dpc-5050	179	31	with	with	ADP
dpc-5050	179	32	autoimmune	autoimmune	ADJ
dpc-5050	179	33	blistering	blister	VERB
dpc-5050	179	34	diseases	disease	NOUN
dpc-5050	179	35	.	.	PUNCT
dpc-5050	180	1	arch	arch	ADJ
dpc-5050	180	2	dermatol	dermatol	NOUN
dpc-5050	180	3	res	re	NOUN
dpc-5050	180	4	.	.	PUNCT
dpc-5050	181	1	2006;298(1):38	2006;298(1):38	NUM
dpc-5050	181	2	-	-	SYM
dpc-5050	181	3	45	45	NUM
dpc-5050	181	4	.	.	PUNCT
dpc-5050	182	1	doi	doi	NOUN
dpc-5050	182	2	:	:	PUNCT
dpc-5050	182	3	10.1007	10.1007	NUM
dpc-5050	182	4	/	/	SYM
dpc-5050	182	5	s00403	s00403	NOUN
dpc-5050	182	6	-	-	PUNCT
dpc-5050	182	7	006	006	NUM
dpc-5050	182	8	-	-	PUNCT
dpc-5050	182	9	0661	0661	NUM
dpc-5050	182	10	-	-	SYM
dpc-5050	182	11	5	5	NUM
dpc-5050	182	12	.	.	PUNCT
dpc-5050	183	1	pmid	pmid	NOUN
dpc-5050	183	2	:	:	PUNCT
dpc-5050	183	3	16583210	16583210	NUM
dpc-5050	183	4	.	.	PUNCT
dpc-5050	184	1	15	15	NUM
dpc-5050	184	2	.	.	PUNCT
dpc-5050	185	1	pacifici	pacifici	PROPN
dpc-5050	185	2	r.	r.	PROPN
dpc-5050	185	3	the	the	DET
dpc-5050	185	4	immune	immune	ADJ
dpc-5050	185	5	system	system	NOUN
dpc-5050	185	6	and	and	CCONJ
dpc-5050	185	7	bone	bone	NOUN
dpc-5050	185	8	.	.	PUNCT
dpc-5050	186	1	arch	arch	PROPN
dpc-5050	186	2	biochem	biochem	PROPN
dpc-5050	186	3	biophys	biophy	NOUN
dpc-5050	186	4	.	.	PUNCT
dpc-5050	187	1	2010;503(1):41	2010;503(1):41	NUM
dpc-5050	187	2	-	-	SYM
dpc-5050	187	3	53	53	NUM
dpc-5050	187	4	.	.	PUNCT
dpc-5050	188	1	doi	doi	NOUN
dpc-5050	188	2	:	:	PUNCT
dpc-5050	188	3	10.1016	10.1016	NUM
dpc-5050	188	4	/	/	SYM
dpc-5050	188	5	j.abb.2010.05.027	j.abb.2010.05.027	PROPN
dpc-5050	188	6	.	.	PUNCT
dpc-5050	189	1	pmid	pmid	NOUN
dpc-5050	189	2	:	:	PUNCT
dpc-5050	189	3	20599675	20599675	NUM
dpc-5050	189	4	.	.	PUNCT
dpc-5050	190	1	16	16	NUM
dpc-5050	190	2	.	.	PUNCT
dpc-5050	191	1	o’brien	o’brien	PROPN
dpc-5050	191	2	ca	ca	PROPN
dpc-5050	191	3	,	,	PUNCT
dpc-5050	191	4	jia	jia	PROPN
dpc-5050	191	5	d	d	PROPN
dpc-5050	191	6	,	,	PUNCT
dpc-5050	191	7	plotkin	plotkin	PROPN
dpc-5050	191	8	li	li	PROPN
dpc-5050	191	9	,	,	PUNCT
dpc-5050	191	10	et	et	PROPN
dpc-5050	191	11	al	al	PROPN
dpc-5050	191	12	.	.	PUNCT
dpc-5050	192	1	glucocorticoids	glucocorticoid	NOUN
dpc-5050	192	2	act	act	VERB
dpc-5050	192	3	directly	directly	ADV
dpc-5050	192	4	on	on	ADP
dpc-5050	192	5	osteoblasts	osteoblast	NOUN
dpc-5050	192	6	and	and	CCONJ
dpc-5050	192	7	osteocytes	osteocyte	VERB
dpc-5050	192	8	to	to	PART
dpc-5050	192	9	induce	induce	VERB
dpc-5050	192	10	their	their	PRON
dpc-5050	192	11	apoptosis	apoptosis	NOUN
dpc-5050	192	12	and	and	CCONJ
dpc-5050	192	13	reduce	reduce	VERB
dpc-5050	192	14	bone	bone	NOUN
dpc-5050	192	15	formation	formation	NOUN
dpc-5050	192	16	and	and	CCONJ
dpc-5050	192	17	strength	strength	NOUN
dpc-5050	192	18	.	.	PUNCT
dpc-5050	192	19	 	 	SPACE
dpc-5050	192	20	endocrinology	endocrinology	NOUN
dpc-5050	192	21	.	.	PUNCT
dpc-5050	193	1	2004;145(4):1835	2004;145(4):1835	NUM
dpc-5050	193	2	-	-	SYM
dpc-5050	193	3	1841	1841	NUM
dpc-5050	193	4	.	.	PUNCT
dpc-5050	194	1	doi	doi	NOUN
dpc-5050	194	2	:	:	PUNCT
dpc-5050	194	3	10.1210	10.1210	NUM
dpc-5050	194	4	/	/	SYM
dpc-5050	194	5	en.2003	en.2003	PROPN
dpc-5050	194	6	-	-	PUNCT
dpc-5050	194	7	0990	0990	NUM
dpc-5050	194	8	.	.	PUNCT
dpc-5050	195	1	pmid	pmid	NOUN
dpc-5050	195	2	:	:	PUNCT
dpc-5050	195	3	14691012	14691012	NUM
dpc-5050	195	4	.	.	PUNCT
dpc-5050	196	1	17	17	NUM
dpc-5050	196	2	.	.	PUNCT
dpc-5050	197	1	jia	jia	PROPN
dpc-5050	197	2	d	d	PROPN
dpc-5050	197	3	,	,	PUNCT
dpc-5050	197	4	o’brien	o’brien	PROPN
dpc-5050	197	5	ca	ca	PROPN
dpc-5050	197	6	,	,	PUNCT
dpc-5050	197	7	stewart	stewart	PROPN
dpc-5050	197	8	sa	sa	PROPN
dpc-5050	197	9	,	,	PUNCT
dpc-5050	197	10	manolagas	manolagas	PROPN
dpc-5050	197	11	sc	sc	PROPN
dpc-5050	197	12	,	,	PUNCT
dpc-5050	197	13	weinstein	weinstein	PROPN
dpc-5050	197	14	rs	rs	PROPN
dpc-5050	197	15	.	.	PUNCT
dpc-5050	198	1	glucocorticoids	glucocorticoid	NOUN
dpc-5050	198	2	act	act	VERB
dpc-5050	198	3	directly	directly	ADV
dpc-5050	198	4	on	on	ADP
dpc-5050	198	5	osteoclasts	osteoclast	NOUN
dpc-5050	198	6	to	to	PART
dpc-5050	198	7	increase	increase	VERB
dpc-5050	198	8	their	their	PRON
dpc-5050	198	9	life	life	NOUN
dpc-5050	198	10	span	span	NOUN
dpc-5050	198	11	and	and	CCONJ
dpc-5050	198	12	reduce	reduce	VERB
dpc-5050	198	13	bone	bone	NOUN
dpc-5050	198	14	density	density	NOUN
dpc-5050	198	15	.	.	PUNCT
dpc-5050	198	16	  	  	SPACE
dpc-5050	199	1	endocrinology	endocrinology	NOUN
dpc-5050	199	2	.	.	PUNCT
dpc-5050	200	1	2006;147(12):55925599	2006;147(12):55925599	X
dpc-5050	200	2	.	.	PUNCT
dpc-5050	200	3	doi	doi	PROPN
dpc-5050	200	4	:	:	PUNCT
dpc-5050	200	5	10.1210	10.1210	NUM
dpc-5050	200	6	/	/	SYM
dpc-5050	200	7	en.2006	en.2006	PROPN
dpc-5050	200	8	-	-	PUNCT
dpc-5050	200	9	0459	0459	NUM
dpc-5050	200	10	.	.	PUNCT
dpc-5050	201	1	pmid	pmid	NOUN
dpc-5050	201	2	:	:	PUNCT
dpc-5050	201	3	16935844	16935844	NUM
dpc-5050	201	4	.	.	PUNCT
dpc-5050	202	1	18	18	NUM
dpc-5050	202	2	.	.	PUNCT
dpc-5050	202	3	richards	richards	PROPN
dpc-5050	202	4	jb	jb	PROPN
dpc-5050	202	5	,	,	PUNCT
dpc-5050	202	6	rivadeneira	rivadeneira	PROPN
dpc-5050	202	7	f	f	PROPN
dpc-5050	202	8	,	,	PUNCT
dpc-5050	202	9	inouye	inouye	PROPN
dpc-5050	202	10	m	m	PROPN
dpc-5050	202	11	,	,	PUNCT
dpc-5050	202	12	et	et	PROPN
dpc-5050	202	13	al	al	PROPN
dpc-5050	202	14	.	.	PUNCT
dpc-5050	202	15	bone	bone	NOUN
dpc-5050	202	16	mineral	mineral	NOUN
dpc-5050	202	17	density	density	NOUN
dpc-5050	202	18	,	,	PUNCT
dpc-5050	202	19	osteoporosis	osteoporosis	NOUN
dpc-5050	202	20	,	,	PUNCT
dpc-5050	202	21	and	and	CCONJ
dpc-5050	202	22	osteoporotic	osteoporotic	ADJ
dpc-5050	202	23	fractures	fracture	NOUN
dpc-5050	202	24	:	:	PUNCT
dpc-5050	202	25	a	a	DET
dpc-5050	202	26	genome	genome	NOUN
dpc-5050	202	27	-	-	PUNCT
dpc-5050	202	28	wide	wide	ADJ
dpc-5050	202	29	association	association	NOUN
dpc-5050	202	30	study	study	NOUN
dpc-5050	202	31	.	.	PUNCT
dpc-5050	203	1	lancet	lancet	PROPN
dpc-5050	203	2	.	.	PUNCT
dpc-5050	204	1	2008;371(9623):1505	2008;371(9623):1505	NUM
dpc-5050	204	2	-	-	SYM
dpc-5050	204	3	1512	1512	NUM
dpc-5050	204	4	.	.	PUNCT
dpc-5050	205	1	doi	doi	NOUN
dpc-5050	205	2	:	:	PUNCT
dpc-5050	205	3	10.1016	10.1016	NUM
dpc-5050	205	4	/s0140	/s0140	PROPN
dpc-5050	205	5	-	-	PUNCT
dpc-5050	205	6	6736(08)60599	6736(08)60599	NUM
dpc-5050	205	7	-	-	PUNCT
dpc-5050	205	8	1	1	NUM
dpc-5050	205	9	.	.	PUNCT
dpc-5050	206	1	pmid	pmid	NOUN
dpc-5050	206	2	:	:	PUNCT
dpc-5050	206	3	18455228	18455228	NUM
dpc-5050	206	4	.	.	PUNCT
dpc-5050	207	1	19	19	NUM
dpc-5050	207	2	.	.	PUNCT
dpc-5050	208	1	van	van	PROPN
dpc-5050	208	2	staa	staa	PROPN
dpc-5050	208	3	tp	tp	PROPN
dpc-5050	208	4	,	,	PUNCT
dpc-5050	208	5	leufkens	leufken	VERB
dpc-5050	208	6	hg	hg	NOUN
dpc-5050	208	7	,	,	PUNCT
dpc-5050	208	8	abenhaim	abenhaim	PROPN
dpc-5050	208	9	l	l	NOUN
dpc-5050	208	10	,	,	PUNCT
dpc-5050	208	11	zhang	zhang	PROPN
dpc-5050	208	12	b	b	PROPN
dpc-5050	208	13	,	,	PUNCT
dpc-5050	208	14	cooper	cooper	PROPN
dpc-5050	208	15	c.	c.	PROPN
dpc-5050	208	16	oral	oral	ADJ
dpc-5050	208	17	corticosteroids	corticosteroid	NOUN
dpc-5050	208	18	and	and	CCONJ
dpc-5050	208	19	fracture	fracture	NOUN
dpc-5050	208	20	risk	risk	NOUN
dpc-5050	208	21	:	:	PUNCT
dpc-5050	208	22	relationship	relationship	NOUN
dpc-5050	208	23	to	to	ADP
dpc-5050	208	24	daily	daily	ADJ
dpc-5050	208	25	and	and	CCONJ
dpc-5050	208	26	cumulative	cumulative	ADJ
dpc-5050	208	27	doses	dose	NOUN
dpc-5050	208	28	.	.	PUNCT
dpc-5050	208	29	  	  	SPACE
dpc-5050	209	1	rheumatology	rheumatology	NOUN
dpc-5050	209	2	(	(	PUNCT
dpc-5050	209	3	oxford	oxford	PROPN
dpc-5050	209	4	)	)	PUNCT
dpc-5050	209	5	.	.	PUNCT
dpc-5050	210	1	2000;39(12	2000;39(12	NUM
dpc-5050	210	2	):	):	PUNCT
dpc-5050	210	3	1383	1383	NUM
dpc-5050	210	4	-	-	SYM
dpc-5050	210	5	1389	1389	NUM
dpc-5050	210	6	.	.	PUNCT
dpc-5050	211	1	doi	doi	NOUN
dpc-5050	211	2	:	:	PUNCT
dpc-5050	211	3	10.1093	10.1093	NUM
dpc-5050	211	4	/	/	SYM
dpc-5050	211	5	rheumatology/39.12.1383	rheumatology/39.12.1383	NOUN
dpc-5050	211	6	.	.	PUNCT
dpc-5050	212	1	pmid	pmid	NOUN
dpc-5050	212	2	:	:	PUNCT
dpc-5050	212	3	11136882	11136882	NUM
dpc-5050	212	4	.	.	PUNCT
dpc-5050	213	1	20	20	NUM
dpc-5050	213	2	.	.	PUNCT
dpc-5050	214	1	cummings	cummings	PROPN
dpc-5050	214	2	sr	sr	PROPN
dpc-5050	214	3	,	,	PUNCT
dpc-5050	214	4	black	black	ADJ
dpc-5050	214	5	dm	dm	PROPN
dpc-5050	214	6	,	,	PUNCT
dpc-5050	214	7	nevitt	nevitt	PROPN
dpc-5050	214	8	mc	mc	PROPN
dpc-5050	214	9	,	,	PUNCT
dpc-5050	214	10	et	et	PROPN
dpc-5050	214	11	al	al	PROPN
dpc-5050	214	12	.	.	PUNCT
dpc-5050	214	13	bone	bone	NOUN
dpc-5050	214	14	density	density	NOUN
dpc-5050	214	15	at	at	ADP
dpc-5050	214	16	various	various	ADJ
dpc-5050	214	17	sites	site	NOUN
dpc-5050	214	18	for	for	ADP
dpc-5050	214	19	prediction	prediction	NOUN
dpc-5050	214	20	of	of	ADP
dpc-5050	214	21	hip	hip	NOUN
dpc-5050	214	22	fractures	fracture	NOUN
dpc-5050	214	23	.	.	PUNCT
dpc-5050	215	1	the	the	DET
dpc-5050	215	2	study	study	NOUN
dpc-5050	215	3	of	of	ADP
dpc-5050	215	4	osteoporotic	osteoporotic	ADJ
dpc-5050	215	5	both	both	CCONJ
dpc-5050	215	6	hip	hip	NOUN
dpc-5050	215	7	and	and	CCONJ
dpc-5050	215	8	vertebral	vertebral	ADJ
dpc-5050	215	9	fractures	fracture	NOUN
dpc-5050	215	10	was	be	AUX
dpc-5050	215	11	significantly	significantly	ADV
dpc-5050	215	12	higher	high	ADJ
dpc-5050	215	13	in	in	ADP
dpc-5050	215	14	patients	patient	NOUN
dpc-5050	215	15	receiving	receive	VERB
dpc-5050	215	16	moderate	moderate	ADJ
dpc-5050	215	17	-	-	PUNCT
dpc-5050	215	18	to	to	ADP
dpc-5050	215	19	-	-	PUNCT
dpc-5050	215	20	high	high	ADJ
dpc-5050	215	21	daily	daily	ADJ
dpc-5050	215	22	doses	dose	NOUN
dpc-5050	215	23	of	of	ADP
dpc-5050	215	24	glucocorticoids	glucocorticoid	NOUN
dpc-5050	215	25	(	(	PUNCT
dpc-5050	215	26	7.5	7.5	NUM
dpc-5050	215	27	mg	mg	ADJ
dpc-5050	215	28	and	and	CCONJ
dpc-5050	215	29	above	above	ADV
dpc-5050	215	30	)	)	PUNCT
dpc-5050	215	31	compared	compare	VERB
dpc-5050	215	32	to	to	ADP
dpc-5050	215	33	those	those	PRON
dpc-5050	215	34	on	on	ADP
dpc-5050	215	35	low	low	ADJ
dpc-5050	215	36	doses	dose	NOUN
dpc-5050	215	37	(	(	PUNCT
dpc-5050	215	38	below	below	ADP
dpc-5050	215	39	2.5	2.5	NUM
dpc-5050	215	40	mg	mg	NOUN
dpc-5050	215	41	)	)	PUNCT
dpc-5050	216	1	[	[	X
dpc-5050	216	2	19	19	NUM
dpc-5050	216	3	]	]	PUNCT
dpc-5050	216	4	.	.	PUNCT
dpc-5050	217	1	although	although	SCONJ
dpc-5050	217	2	fracture	fracture	ADJ
dpc-5050	217	3	incidence	incidence	NOUN
dpc-5050	217	4	was	be	AUX
dpc-5050	217	5	not	not	PART
dpc-5050	217	6	included	include	VERB
dpc-5050	217	7	in	in	ADP
dpc-5050	217	8	our	our	PRON
dpc-5050	217	9	study	study	NOUN
dpc-5050	217	10	,	,	PUNCT
dpc-5050	217	11	previous	previous	ADJ
dpc-5050	217	12	studies	study	NOUN
dpc-5050	217	13	have	have	AUX
dpc-5050	217	14	shown	show	VERB
dpc-5050	217	15	that	that	SCONJ
dpc-5050	217	16	low	low	ADJ
dpc-5050	217	17	bmd	bmd	PROPN
dpc-5050	217	18	is	be	AUX
dpc-5050	217	19	a	a	DET
dpc-5050	217	20	crucial	crucial	ADJ
dpc-5050	217	21	determinant	determinant	NOUN
dpc-5050	217	22	of	of	ADP
dpc-5050	217	23	fragility	fragility	NOUN
dpc-5050	217	24	fractures	fracture	NOUN
dpc-5050	217	25	,	,	PUNCT
dpc-5050	217	26	and	and	CCONJ
dpc-5050	217	27	dxa	dxa	VERB
dpc-5050	217	28	measurements	measurement	NOUN
dpc-5050	217	29	of	of	ADP
dpc-5050	217	30	bmd	bmd	PROPN
dpc-5050	217	31	are	be	AUX
dpc-5050	217	32	strong	strong	ADJ
dpc-5050	217	33	predictors	predictor	NOUN
dpc-5050	217	34	of	of	ADP
dpc-5050	217	35	fracture	fracture	ADJ
dpc-5050	217	36	risk	risk	NOUN
dpc-5050	217	37	in	in	ADP
dpc-5050	217	38	individuals	individual	NOUN
dpc-5050	217	39	[	[	X
dpc-5050	217	40	20	20	NUM
dpc-5050	217	41	-	-	SYM
dpc-5050	217	42	22	22	NUM
dpc-5050	217	43	]	]	PUNCT
dpc-5050	217	44	.	.	PUNCT
dpc-5050	218	1	patients	patient	NOUN
dpc-5050	218	2	with	with	ADP
dpc-5050	218	3	a	a	DET
dpc-5050	218	4	bmi	bmi	NOUN
dpc-5050	218	5	<	<	X
dpc-5050	218	6	30	30	NUM
dpc-5050	218	7	kg	kg	NOUN
dpc-5050	218	8	/	/	SYM
dpc-5050	218	9	m²	m²	PROPN
dpc-5050	218	10	had	have	VERB
dpc-5050	218	11	lower	low	ADJ
dpc-5050	218	12	femur	femur	ADJ
dpc-5050	218	13	and	and	CCONJ
dpc-5050	218	14	lumbar	lumbar	NOUN
dpc-5050	218	15	t	t	PROPN
dpc-5050	218	16	-	-	PUNCT
dpc-5050	218	17	scores	score	NOUN
dpc-5050	218	18	before	before	ADP
dpc-5050	218	19	treatment	treatment	NOUN
dpc-5050	218	20	compared	compare	VERB
dpc-5050	218	21	to	to	ADP
dpc-5050	218	22	those	those	PRON
dpc-5050	218	23	with	with	ADP
dpc-5050	218	24	a	a	DET
dpc-5050	218	25	bmi	bmi	NOUN
dpc-5050	218	26	>	>	X
dpc-5050	218	27	30	30	NUM
dpc-5050	218	28	kg	kg	NOUN
dpc-5050	218	29	/	/	SYM
dpc-5050	218	30	m²	m²	PROPN
dpc-5050	218	31	.	.	PUNCT
dpc-5050	219	1	after	after	ADP
dpc-5050	219	2	treatment	treatment	NOUN
dpc-5050	219	3	,	,	PUNCT
dpc-5050	219	4	the	the	DET
dpc-5050	219	5	bmd	bmd	PROPN
dpc-5050	219	6	scores	score	NOUN
dpc-5050	219	7	decreased	decrease	VERB
dpc-5050	219	8	in	in	ADP
dpc-5050	219	9	both	both	DET
dpc-5050	219	10	groups	group	NOUN
dpc-5050	219	11	,	,	PUNCT
dpc-5050	219	12	with	with	ADP
dpc-5050	219	13	no	no	DET
dpc-5050	219	14	significant	significant	ADJ
dpc-5050	219	15	difference	difference	NOUN
dpc-5050	219	16	between	between	ADP
dpc-5050	219	17	them	they	PRON
dpc-5050	219	18	.	.	PUNCT
dpc-5050	220	1	previous	previous	ADJ
dpc-5050	220	2	studies	study	NOUN
dpc-5050	220	3	have	have	AUX
dpc-5050	220	4	shown	show	VERB
dpc-5050	220	5	that	that	SCONJ
dpc-5050	220	6	a	a	DET
dpc-5050	220	7	low	low	ADJ
dpc-5050	220	8	body	body	NOUN
dpc-5050	220	9	mass	mass	NOUN
dpc-5050	220	10	index	index	NOUN
dpc-5050	220	11	causes	cause	VERB
dpc-5050	220	12	osteoporosis	osteoporosis	NOUN
dpc-5050	220	13	and	and	CCONJ
dpc-5050	220	14	a	a	DET
dpc-5050	220	15	decrease	decrease	NOUN
dpc-5050	220	16	in	in	ADP
dpc-5050	220	17	bmd	bmd	PROPN
dpc-5050	221	1	[	[	X
dpc-5050	221	2	23	23	NUM
dpc-5050	221	3	]	]	PUNCT
dpc-5050	221	4	.	.	PUNCT
dpc-5050	222	1	excess	excess	ADJ
dpc-5050	222	2	estrogen	estrogen	NOUN
dpc-5050	222	3	production	production	NOUN
dpc-5050	222	4	in	in	ADP
dpc-5050	222	5	the	the	DET
dpc-5050	222	6	adipose	adipose	ADJ
dpc-5050	222	7	tissue	tissue	NOUN
dpc-5050	222	8	and	and	CCONJ
dpc-5050	222	9	additional	additional	ADJ
dpc-5050	222	10	load	load	NOUN
dpc-5050	222	11	carried	carry	VERB
dpc-5050	222	12	by	by	ADP
dpc-5050	222	13	the	the	DET
dpc-5050	222	14	bone	bone	NOUN
dpc-5050	222	15	,	,	PUNCT
dpc-5050	222	16	which	which	PRON
dpc-5050	222	17	contributes	contribute	VERB
dpc-5050	222	18	to	to	ADP
dpc-5050	222	19	microtrauma	microtrauma	NOUN
dpc-5050	222	20	,	,	PUNCT
dpc-5050	222	21	and	and	CCONJ
dpc-5050	222	22	genetic	genetic	ADJ
dpc-5050	222	23	variations	variation	NOUN
dpc-5050	222	24	may	may	AUX
dpc-5050	222	25	contribute	contribute	VERB
dpc-5050	222	26	to	to	ADP
dpc-5050	222	27	the	the	DET
dpc-5050	222	28	positive	positive	ADJ
dpc-5050	222	29	impact	impact	NOUN
dpc-5050	222	30	of	of	ADP
dpc-5050	222	31	obesity	obesity	NOUN
dpc-5050	222	32	on	on	ADP
dpc-5050	222	33	bmd	bmd	PROPN
dpc-5050	223	1	[	[	X
dpc-5050	223	2	18	18	NUM
dpc-5050	223	3	,	,	PUNCT
dpc-5050	223	4	24	24	NUM
dpc-5050	223	5	]	]	PUNCT
dpc-5050	223	6	.	.	PUNCT
dpc-5050	224	1	for	for	ADP
dpc-5050	224	2	years	year	NOUN
dpc-5050	224	3	,	,	PUNCT
dpc-5050	224	4	various	various	ADJ
dpc-5050	224	5	guidelines	guideline	NOUN
dpc-5050	224	6	have	have	AUX
dpc-5050	224	7	been	be	AUX
dpc-5050	224	8	published	publish	VERB
dpc-5050	224	9	to	to	PART
dpc-5050	224	10	reduce	reduce	VERB
dpc-5050	224	11	and	and	CCONJ
dpc-5050	224	12	prevent	prevent	VERB
dpc-5050	224	13	the	the	DET
dpc-5050	224	14	risk	risk	NOUN
dpc-5050	224	15	of	of	ADP
dpc-5050	224	16	osteoporosis	osteoporosis	NOUN
dpc-5050	224	17	in	in	ADP
dpc-5050	224	18	patients	patient	NOUN
dpc-5050	224	19	with	with	ADP
dpc-5050	224	20	long	long	ADJ
dpc-5050	224	21	-	-	PUNCT
dpc-5050	224	22	term	term	NOUN
dpc-5050	224	23	corticosteroid	corticosteroid	ADJ
dpc-5050	224	24	use	use	NOUN
dpc-5050	224	25	.	.	PUNCT
dpc-5050	225	1	these	these	DET
dpc-5050	225	2	guidelines	guideline	NOUN
dpc-5050	225	3	are	be	AUX
dpc-5050	225	4	generally	generally	ADV
dpc-5050	225	5	not	not	PART
dpc-5050	225	6	disease	disease	NOUN
dpc-5050	225	7	-	-	PUNCT
dpc-5050	225	8	specific	specific	ADJ
dpc-5050	225	9	and	and	CCONJ
dpc-5050	225	10	cover	cover	VERB
dpc-5050	225	11	most	most	ADJ
dpc-5050	225	12	conditions	condition	NOUN
dpc-5050	225	13	.	.	PUNCT
dpc-5050	226	1	considering	consider	VERB
dpc-5050	226	2	the	the	DET
dpc-5050	226	3	variety	variety	NOUN
dpc-5050	226	4	of	of	ADP
dpc-5050	226	5	factors	factor	NOUN
dpc-5050	226	6	that	that	PRON
dpc-5050	226	7	reduce	reduce	VERB
dpc-5050	226	8	bone	bone	NOUN
dpc-5050	226	9	mineral	mineral	NOUN
dpc-5050	226	10	density	density	NOUN
dpc-5050	226	11	in	in	ADP
dpc-5050	226	12	pv	pv	ADV
dpc-5050	226	13	,	,	PUNCT
dpc-5050	226	14	the	the	DET
dpc-5050	226	15	prophylaxis	prophylaxis	NOUN
dpc-5050	226	16	provided	provide	VERB
dpc-5050	226	17	to	to	ADP
dpc-5050	226	18	this	this	DET
dpc-5050	226	19	patient	patient	ADJ
dpc-5050	226	20	group	group	NOUN
dpc-5050	226	21	may	may	AUX
dpc-5050	226	22	need	need	VERB
dpc-5050	226	23	to	to	PART
dpc-5050	226	24	be	be	AUX
dpc-5050	226	25	re	re	VERB
dpc-5050	226	26	-	-	VERB
dpc-5050	226	27	evaluated	evaluated	ADJ
dpc-5050	226	28	,	,	PUNCT
dpc-5050	226	29	and	and	CCONJ
dpc-5050	226	30	additional	additional	ADJ
dpc-5050	226	31	recommendations	recommendation	NOUN
dpc-5050	226	32	may	may	AUX
dpc-5050	226	33	need	need	VERB
dpc-5050	226	34	to	to	PART
dpc-5050	226	35	be	be	AUX
dpc-5050	226	36	included	include	VERB
dpc-5050	226	37	in	in	ADP
dpc-5050	226	38	pemphigus	pemphigus	NOUN
dpc-5050	226	39	guidelines	guideline	NOUN
dpc-5050	226	40	.	.	PUNCT
dpc-5050	227	1	references	reference	NOUN
dpc-5050	227	2	1	1	NUM
dpc-5050	227	3	.	.	PUNCT
dpc-5050	227	4	amagai	amagai	PROPN
dpc-5050	227	5	m	m	PROPN
dpc-5050	227	6	,	,	PUNCT
dpc-5050	227	7	klaus	klaus	PROPN
dpc-5050	227	8	-	-	PUNCT
dpc-5050	227	9	kovtun	kovtun	PROPN
dpc-5050	227	10	v	v	PROPN
dpc-5050	227	11	,	,	PUNCT
dpc-5050	227	12	stanley	stanley	PROPN
dpc-5050	227	13	jr	jr	PROPN
dpc-5050	227	14	.	.	PROPN
dpc-5050	227	15	autoantibodies	autoantibody	NOUN
dpc-5050	227	16	against	against	ADP
dpc-5050	227	17	a	a	DET
dpc-5050	227	18	novel	novel	ADJ
dpc-5050	227	19	epithelial	epithelial	ADJ
dpc-5050	227	20	cadherin	cadherin	NOUN
dpc-5050	227	21	in	in	ADP
dpc-5050	227	22	pemphigus	pemphigus	PROPN
dpc-5050	227	23	vulgaris	vulgaris	NOUN
dpc-5050	227	24	,	,	PUNCT
dpc-5050	227	25	a	a	DET
dpc-5050	227	26	disease	disease	NOUN
dpc-5050	227	27	of	of	ADP
dpc-5050	227	28	cell	cell	NOUN
dpc-5050	227	29	adhesion	adhesion	NOUN
dpc-5050	227	30	.	.	PUNCT
dpc-5050	227	31	  	  	SPACE
dpc-5050	228	1	cell	cell	NOUN
dpc-5050	228	2	.	.	PUNCT
dpc-5050	229	1	1991;67(5):869	1991;67(5):869	NUM
dpc-5050	229	2	-	-	PUNCT
dpc-5050	229	3	877	877	NUM
dpc-5050	229	4	.	.	PUNCT
dpc-5050	230	1	doi	doi	NOUN
dpc-5050	230	2	:	:	PUNCT
dpc-5050	230	3	10.1016/0092	10.1016/0092	NUM
dpc-5050	230	4	-8674(91)90360	-8674(91)90360	X
dpc-5050	230	5	-	-	PUNCT
dpc-5050	230	6	b.	b.	NOUN
dpc-5050	230	7	pmid	pmid	PROPN
dpc-5050	230	8	:	:	PUNCT
dpc-5050	230	9	1720352	1720352	NUM
dpc-5050	230	10	.	.	PUNCT
dpc-5050	231	1	2	2	X
dpc-5050	231	2	.	.	X
dpc-5050	231	3	lin	lin	PROPN
dpc-5050	231	4	ms	ms	PROPN
dpc-5050	231	5	,	,	PUNCT
dpc-5050	231	6	swartz	swartz	PROPN
dpc-5050	231	7	sj	sj	PROPN
dpc-5050	231	8	,	,	PUNCT
dpc-5050	231	9	lopez	lopez	PROPN
dpc-5050	231	10	a	a	X
dpc-5050	231	11	,	,	PUNCT
dpc-5050	231	12	ding	ding	NOUN
dpc-5050	231	13	x	x	SYM
dpc-5050	231	14	,	,	PUNCT
dpc-5050	231	15	fairley	fairley	PROPN
dpc-5050	231	16	ja	ja	PROPN
dpc-5050	231	17	,	,	PUNCT
dpc-5050	231	18	diaz	diaz	PROPN
dpc-5050	231	19	la	la	PROPN
dpc-5050	231	20	.	.	PROPN
dpc-5050	231	21	t	t	PROPN
dpc-5050	231	22	lymphocytes	lymphocyte	VERB
dpc-5050	231	23	from	from	ADP
dpc-5050	231	24	a	a	DET
dpc-5050	231	25	subset	subset	NOUN
dpc-5050	231	26	of	of	ADP
dpc-5050	231	27	patients	patient	NOUN
dpc-5050	231	28	with	with	ADP
dpc-5050	231	29	pemphigus	pemphigus	NOUN
dpc-5050	231	30	vulgaris	vulgaris	NOUN
dpc-5050	231	31	respond	respond	VERB
dpc-5050	231	32	to	to	ADP
dpc-5050	231	33	both	both	DET
dpc-5050	231	34	desmoglein-3	desmoglein-3	PROPN
dpc-5050	231	35	and	and	CCONJ
dpc-5050	231	36	desmoglein-1	desmoglein-1	PROPN
dpc-5050	231	37	.	.	PUNCT
dpc-5050	232	1	j	j	PROPN
dpc-5050	232	2	invest	invest	VERB
dpc-5050	232	3	dermatol	dermatol	NOUN
dpc-5050	232	4	.	.	PUNCT
dpc-5050	233	1	1997;109(6):734	1997;109(6):734	NUM
dpc-5050	233	2	-	-	SYM
dpc-5050	233	3	737	737	NUM
dpc-5050	233	4	.	.	PUNCT
dpc-5050	233	5	doi	doi	NOUN
dpc-5050	233	6	:	:	PUNCT
dpc-5050	233	7	10.1111/1523	10.1111/1523	NUM
dpc-5050	233	8	-	-	SYM
dpc-5050	233	9	1747	1747	NUM
dpc-5050	233	10	.	.	PUNCT
dpc-5050	234	1	ep12340738	ep12340738	NOUN
dpc-5050	234	2	.	.	PUNCT
dpc-5050	235	1	pmid	pmid	NOUN
dpc-5050	235	2	:	:	PUNCT
dpc-5050	235	3	9406813	9406813	NUM
dpc-5050	235	4	.	.	PUNCT
dpc-5050	236	1	3	3	X
dpc-5050	236	2	.	.	X
dpc-5050	236	3	di	di	PROPN
dpc-5050	236	4	lernia	lernia	PROPN
dpc-5050	236	5	v	v	PROPN
dpc-5050	236	6	,	,	PUNCT
dpc-5050	236	7	casanova	casanova	X
dpc-5050	236	8	dm	dm	PROPN
dpc-5050	236	9	,	,	PUNCT
dpc-5050	236	10	goldust	goldust	PROPN
dpc-5050	236	11	m	m	PROPN
dpc-5050	236	12	,	,	PUNCT
dpc-5050	236	13	ricci	ricci	PROPN
dpc-5050	236	14	c.	c.	PROPN
dpc-5050	236	15	pemphigus	pemphigus	PROPN
dpc-5050	236	16	vulgaris	vulgaris	PROPN
dpc-5050	236	17	and	and	CCONJ
dpc-5050	236	18	bullous	bullous	ADJ
dpc-5050	236	19	pemphigoid	pemphigoid	NOUN
dpc-5050	236	20	:	:	PUNCT
dpc-5050	236	21	update	update	NOUN
dpc-5050	236	22	on	on	ADP
dpc-5050	236	23	diagnosis	diagnosis	NOUN
dpc-5050	236	24	and	and	CCONJ
dpc-5050	236	25	treatment	treatment	NOUN
dpc-5050	236	26	.	.	PUNCT
dpc-5050	237	1	dermatol	dermatol	NOUN
dpc-5050	237	2	pract	pract	PROPN
dpc-5050	237	3	concept	concept	NOUN
dpc-5050	237	4	.	.	PUNCT
dpc-5050	238	1	2020	2020	NUM
dpc-5050	238	2	jun	jun	PROPN
dpc-5050	238	3	29;10(3):e2020050	29;10(3):e2020050	NUM
dpc-5050	238	4	.	.	PUNCT
dpc-5050	239	1	doi	doi	NOUN
dpc-5050	239	2	:	:	PUNCT
dpc-5050	239	3	10.5826	10.5826	NUM
dpc-5050	239	4	/	/	SYM
dpc-5050	239	5	dpc.1003a50	dpc.1003a50	PROPN
dpc-5050	239	6	.	.	PUNCT
dpc-5050	240	1	pmid	pmid	NOUN
dpc-5050	240	2	:	:	PUNCT
dpc-5050	240	3	32642305	32642305	NUM
dpc-5050	240	4	.	.	PUNCT
dpc-5050	241	1	4	4	X
dpc-5050	241	2	.	.	X
dpc-5050	241	3	zhao	zhao	PROPN
dpc-5050	241	4	l	l	PROPN
dpc-5050	241	5	,	,	PUNCT
dpc-5050	241	6	chen	chen	PROPN
dpc-5050	241	7	y	y	PROPN
dpc-5050	241	8	,	,	PUNCT
dpc-5050	241	9	wang	wang	PROPN
dpc-5050	241	10	m.	m.	VERB
dpc-5050	241	11	the	the	DET
dpc-5050	241	12	global	global	ADJ
dpc-5050	241	13	incidence	incidence	NOUN
dpc-5050	241	14	rate	rate	NOUN
dpc-5050	241	15	of	of	ADP
dpc-5050	241	16	pemphigus	pemphigus	NOUN
dpc-5050	241	17	vulgaris	vulgaris	NOUN
dpc-5050	241	18	:	:	PUNCT
dpc-5050	241	19	a	a	DET
dpc-5050	241	20	systematic	systematic	ADJ
dpc-5050	241	21	review	review	NOUN
dpc-5050	241	22	and	and	CCONJ
dpc-5050	241	23	meta	meta	ADJ
dpc-5050	241	24	-	-	PUNCT
dpc-5050	241	25	analysis	analysis	NOUN
dpc-5050	241	26	.	.	PUNCT
dpc-5050	242	1	dermatology	dermatology	NOUN
dpc-5050	242	2	.	.	PUNCT
dpc-5050	243	1	2023;239(4):514	2023;239(4):514	NUM
dpc-5050	243	2	-	-	SYM
dpc-5050	243	3	522	522	NUM
dpc-5050	243	4	.	.	PUNCT
dpc-5050	244	1	doi	doi	NOUN
dpc-5050	244	2	:	:	PUNCT
dpc-5050	244	3	10.1159/000530121	10.1159/000530121	NUM
dpc-5050	244	4	.	.	PUNCT
dpc-5050	245	1	pmid	pmid	NOUN
dpc-5050	245	2	:	:	PUNCT
dpc-5050	245	3	36944327	36944327	NUM
dpc-5050	245	4	.	.	PUNCT
dpc-5050	246	1	5	5	X
dpc-5050	246	2	.	.	X
dpc-5050	246	3	joly	joly	PROPN
dpc-5050	246	4	p	p	PROPN
dpc-5050	246	5	,	,	PUNCT
dpc-5050	246	6	horvath	horvath	PROPN
dpc-5050	246	7	b	b	PROPN
dpc-5050	246	8	,	,	PUNCT
dpc-5050	246	9	patsatsi	patsatsi	PROPN
dpc-5050	246	10	α	α	PROPN
dpc-5050	246	11	,	,	PUNCT
dpc-5050	246	12	et	et	PROPN
dpc-5050	246	13	al	al	PROPN
dpc-5050	246	14	.	.	PROPN
dpc-5050	246	15	updated	update	VERB
dpc-5050	246	16	s2k	s2k	PROPN
dpc-5050	246	17	guidelines	guideline	NOUN
dpc-5050	246	18	on	on	ADP
dpc-5050	246	19	the	the	DET
dpc-5050	246	20	management	management	NOUN
dpc-5050	246	21	of	of	ADP
dpc-5050	246	22	pemphigus	pemphigus	NOUN
dpc-5050	246	23	vulgaris	vulgaris	NOUN
dpc-5050	246	24	and	and	CCONJ
dpc-5050	247	1	foliaceus	foliaceus	PROPN
dpc-5050	247	2	initiated	initiate	VERB
dpc-5050	247	3	by	by	ADP
dpc-5050	247	4	the	the	DET
dpc-5050	247	5	european	european	PROPN
dpc-5050	247	6	academy	academy	PROPN
dpc-5050	247	7	of	of	ADP
dpc-5050	247	8	dermatology	dermatology	NOUN
dpc-5050	247	9	and	and	CCONJ
dpc-5050	247	10	venereology	venereology	NOUN
dpc-5050	247	11	(	(	PUNCT
dpc-5050	247	12	eadv	eadv	ADJ
dpc-5050	247	13	)	)	PUNCT
dpc-5050	247	14	.	.	PUNCT
dpc-5050	247	15	 	 	SPACE
dpc-5050	248	1	j	j	PROPN
dpc-5050	248	2	eur	eur	PROPN
dpc-5050	248	3	acad	acad	PROPN
dpc-5050	248	4	dermatol	dermatol	NOUN
dpc-5050	248	5	venereol	venereol	NOUN
dpc-5050	248	6	.	.	PUNCT
dpc-5050	249	1	2020;34(9):1900	2020;34(9):1900	NUM
dpc-5050	249	2	-	-	SYM
dpc-5050	249	3	1913	1913	NUM
dpc-5050	249	4	.	.	PUNCT
dpc-5050	250	1	doi	doi	NOUN
dpc-5050	250	2	:	:	PUNCT
dpc-5050	250	3	10.1111	10.1111	NUM
dpc-5050	250	4	/	/	SYM
dpc-5050	250	5	jdv.16752	jdv.16752	NUM
dpc-5050	250	6	.	.	PUNCT
dpc-5050	251	1	pmid	pmid	NOUN
dpc-5050	251	2	:	:	PUNCT
dpc-5050	251	3	32830877	32830877	NUM
dpc-5050	251	4	.	.	PUNCT
dpc-5050	252	1	6	6	NUM
dpc-5050	252	2	.	.	X
dpc-5050	252	3	hertl	hertl	PROPN
dpc-5050	252	4	m	m	PROPN
dpc-5050	252	5	,	,	PUNCT
dpc-5050	252	6	jedlickova	jedlickova	PROPN
dpc-5050	252	7	h	h	PROPN
dpc-5050	252	8	,	,	PUNCT
dpc-5050	252	9	karpati	karpati	PROPN
dpc-5050	252	10	s	s	PART
dpc-5050	252	11	,	,	PUNCT
dpc-5050	252	12	et	et	PROPN
dpc-5050	252	13	al	al	PROPN
dpc-5050	252	14	.	.	PROPN
dpc-5050	252	15	pemphigus	pemphigus	PROPN
dpc-5050	252	16	.	.	PUNCT
dpc-5050	253	1	s2	s2	PROPN
dpc-5050	253	2	guideline	guideline	NOUN
dpc-5050	253	3	for	for	ADP
dpc-5050	253	4	diagnosis	diagnosis	NOUN
dpc-5050	253	5	and	and	CCONJ
dpc-5050	253	6	treatment	treatment	NOUN
dpc-5050	253	7	--	--	PUNCT
dpc-5050	253	8	guided	guide	VERB
dpc-5050	253	9	by	by	ADP
dpc-5050	253	10	the	the	DET
dpc-5050	253	11	european	european	PROPN
dpc-5050	253	12	dermatology	dermatology	PROPN
dpc-5050	253	13	forum	forum	PROPN
dpc-5050	253	14	(	(	PUNCT
dpc-5050	253	15	edf	edf	PROPN
dpc-5050	253	16	)	)	PUNCT
dpc-5050	253	17	in	in	ADP
dpc-5050	253	18	cooperation	cooperation	NOUN
dpc-5050	253	19	with	with	ADP
dpc-5050	253	20	the	the	DET
dpc-5050	253	21	european	european	PROPN
dpc-5050	253	22	academy	academy	PROPN
dpc-5050	253	23	of	of	ADP
dpc-5050	253	24	dermatology	dermatology	NOUN
dpc-5050	253	25	and	and	CCONJ
dpc-5050	253	26	venereology	venereology	NOUN
dpc-5050	253	27	(	(	PUNCT
dpc-5050	253	28	eadv	eadv	ADJ
dpc-5050	253	29	)	)	PUNCT
dpc-5050	253	30	.	.	PUNCT
dpc-5050	254	1	j	j	PROPN
dpc-5050	254	2	eur	eur	PROPN
dpc-5050	254	3	acad	acad	PROPN
dpc-5050	254	4	dermatol	dermatol	NOUN
dpc-5050	254	5	original	original	ADJ
dpc-5050	254	6	article	article	NOUN
dpc-5050	254	7	|	|	ADV
dpc-5050	254	8	dermatol	dermatol	ADJ
dpc-5050	254	9	pract	pract	NOUN
dpc-5050	254	10	concept	concept	NOUN
dpc-5050	254	11	.	.	PUNCT
dpc-5050	255	1	2025;15(2):5050	2025;15(2):5050	NUM
dpc-5050	255	2	7	7	NUM
dpc-5050	255	3	intern	intern	NOUN
dpc-5050	255	4	med	me	VERB
dpc-5050	255	5	.	.	PUNCT
dpc-5050	256	1	2007;167(2):155	2007;167(2):155	NUM
dpc-5050	256	2	-	-	SYM
dpc-5050	256	3	160	160	NUM
dpc-5050	256	4	.	.	PUNCT
dpc-5050	257	1	doi	doi	NOUN
dpc-5050	257	2	:	:	PUNCT
dpc-5050	257	3	10.1001	10.1001	NUM
dpc-5050	257	4	/	/	SYM
dpc-5050	257	5	archinte.167.2	archinte.167.2	PROPN
dpc-5050	257	6	.155	.155	NUM
dpc-5050	257	7	.	.	PUNCT
dpc-5050	258	1	pmid	pmid	NOUN
dpc-5050	258	2	:	:	PUNCT
dpc-5050	258	3	17242316	17242316	NUM
dpc-5050	258	4	.	.	PUNCT
dpc-5050	259	1	23	23	NUM
dpc-5050	259	2	.	.	PUNCT
dpc-5050	260	1	morin	morin	PROPN
dpc-5050	260	2	s	s	PROPN
dpc-5050	260	3	,	,	PUNCT
dpc-5050	260	4	leslie	leslie	PROPN
dpc-5050	260	5	wd	wd	PROPN
dpc-5050	260	6	;	;	PUNCT
dpc-5050	260	7	manitoba	manitoba	PROPN
dpc-5050	260	8	bone	bone	PROPN
dpc-5050	260	9	density	density	NOUN
dpc-5050	260	10	program	program	NOUN
dpc-5050	260	11	.	.	PUNCT
dpc-5050	261	1	high	high	ADJ
dpc-5050	261	2	bone	bone	NOUN
dpc-5050	261	3	mineral	mineral	NOUN
dpc-5050	261	4	density	density	NOUN
dpc-5050	261	5	is	be	AUX
dpc-5050	261	6	associated	associate	VERB
dpc-5050	261	7	with	with	ADP
dpc-5050	261	8	high	high	ADJ
dpc-5050	261	9	body	body	NOUN
dpc-5050	261	10	mass	mass	NOUN
dpc-5050	261	11	index	index	NOUN
dpc-5050	261	12	.	.	PUNCT
dpc-5050	262	1	osteoporos	osteoporos	PROPN
dpc-5050	262	2	int	int	PROPN
dpc-5050	262	3	.	.	PUNCT
dpc-5050	263	1	2009;20(7):1267	2009;20(7):1267	PROPN
dpc-5050	263	2	-	-	PUNCT
dpc-5050	263	3	1271	1271	NUM
dpc-5050	263	4	.	.	PUNCT
dpc-5050	264	1	doi	doi	NOUN
dpc-5050	264	2	:	:	PUNCT
dpc-5050	264	3	10.1007	10.1007	NUM
dpc-5050	264	4	/	/	SYM
dpc-5050	264	5	s00198008	s00198008	NOUN
dpc-5050	264	6	-	-	PUNCT
dpc-5050	264	7	0797	0797	NUM
dpc-5050	264	8	-	-	PUNCT
dpc-5050	264	9	6	6	NUM
dpc-5050	264	10	.	.	PUNCT
dpc-5050	265	1	pmid	pmid	NOUN
dpc-5050	265	2	:	:	PUNCT
dpc-5050	265	3	19034375	19034375	NUM
dpc-5050	265	4	.	.	PUNCT
dpc-5050	266	1	24	24	NUM
dpc-5050	266	2	.	.	PUNCT
dpc-5050	266	3	crepaldi	crepaldi	PROPN
dpc-5050	266	4	g	g	PROPN
dpc-5050	266	5	,	,	PUNCT
dpc-5050	266	6	romanato	romanato	PROPN
dpc-5050	266	7	g	g	PROPN
dpc-5050	266	8	,	,	PUNCT
dpc-5050	266	9	tonin	tonin	NOUN
dpc-5050	266	10	p	p	NOUN
dpc-5050	266	11	,	,	PUNCT
dpc-5050	266	12	maggi	maggi	PROPN
dpc-5050	266	13	s.	s.	PROPN
dpc-5050	266	14	osteoporosis	osteoporosis	NOUN
dpc-5050	266	15	and	and	CCONJ
dpc-5050	266	16	body	body	NOUN
dpc-5050	266	17	composition	composition	NOUN
dpc-5050	266	18	.	.	PUNCT
dpc-5050	267	1	j	j	PROPN
dpc-5050	267	2	endocrinol	endocrinol	NOUN
dpc-5050	267	3	invest	inv	ADJ
dpc-5050	267	4	.	.	PUNCT
dpc-5050	268	1	2007;30(6	2007;30(6	NUM
dpc-5050	268	2	suppl):42	suppl):42	PROPN
dpc-5050	268	3	-	-	PUNCT
dpc-5050	268	4	47	47	NUM
dpc-5050	268	5	.	.	PUNCT
dpc-5050	269	1	pmid	pmid	NOUN
dpc-5050	269	2	:	:	PUNCT
dpc-5050	269	3	17721073	17721073	NUM
dpc-5050	269	4	.	.	PUNCT
dpc-5050	270	1	fractures	fracture	VERB
dpc-5050	270	2	research	research	NOUN
dpc-5050	270	3	group	group	NOUN
dpc-5050	270	4	.	.	PUNCT
dpc-5050	270	5	 	 	SPACE
dpc-5050	271	1	lancet	lancet	NOUN
dpc-5050	271	2	.	.	PUNCT
dpc-5050	272	1	1993;341(8837):72	1993;341(8837):72	PROPN
dpc-5050	272	2	-	-	PUNCT
dpc-5050	272	3	75	75	NUM
dpc-5050	272	4	.	.	PUNCT
dpc-5050	273	1	doi	doi	NOUN
dpc-5050	273	2	:	:	PUNCT
dpc-5050	273	3	10.1016/0140	10.1016/0140	NUM
dpc-5050	273	4	-	-	PUNCT
dpc-5050	273	5	6736(93)92555	6736(93)92555	NUM
dpc-5050	273	6	-	-	SYM
dpc-5050	273	7	8	8	NUM
dpc-5050	273	8	.	.	PUNCT
dpc-5050	274	1	pmid	pmid	NOUN
dpc-5050	274	2	:	:	PUNCT
dpc-5050	274	3	8093403	8093403	NUM
dpc-5050	274	4	.	.	PUNCT
dpc-5050	275	1	21	21	NUM
dpc-5050	275	2	.	.	PUNCT
dpc-5050	276	1	cummings	cummings	PROPN
dpc-5050	276	2	sr	sr	PROPN
dpc-5050	276	3	,	,	PUNCT
dpc-5050	276	4	nevitt	nevitt	PROPN
dpc-5050	276	5	mc	mc	PROPN
dpc-5050	276	6	,	,	PUNCT
dpc-5050	276	7	browner	brown	ADJ
dpc-5050	276	8	ws	ws	PROPN
dpc-5050	276	9	,	,	PUNCT
dpc-5050	276	10	et	et	PROPN
dpc-5050	276	11	al	al	PROPN
dpc-5050	276	12	.	.	PUNCT
dpc-5050	277	1	risk	risk	NOUN
dpc-5050	277	2	factors	factor	NOUN
dpc-5050	277	3	for	for	ADP
dpc-5050	277	4	hip	hip	NOUN
dpc-5050	277	5	fracture	fracture	NOUN
dpc-5050	277	6	in	in	ADP
dpc-5050	277	7	white	white	ADJ
dpc-5050	277	8	women	woman	NOUN
dpc-5050	277	9	.	.	PUNCT
dpc-5050	278	1	study	study	NOUN
dpc-5050	278	2	of	of	ADP
dpc-5050	278	3	osteoporotic	osteoporotic	ADJ
dpc-5050	278	4	fractures	fracture	NOUN
dpc-5050	278	5	research	research	NOUN
dpc-5050	278	6	group	group	NOUN
dpc-5050	278	7	.	.	PUNCT
dpc-5050	278	8	  	  	SPACE
dpc-5050	279	1	n	n	CCONJ
dpc-5050	279	2	engl	engl	PROPN
dpc-5050	279	3	j	j	PROPN
dpc-5050	279	4	med	med	PROPN
dpc-5050	279	5	.	.	PUNCT
dpc-5050	280	1	1995;332(12):767	1995;332(12):767	NUM
dpc-5050	280	2	-	-	SYM
dpc-5050	280	3	773	773	NUM
dpc-5050	280	4	.	.	PUNCT
dpc-5050	281	1	doi	doi	NOUN
dpc-5050	281	2	:	:	PUNCT
dpc-5050	281	3	10.1056	10.1056	NUM
dpc-5050	281	4	/	/	SYM
dpc-5050	281	5	nejm199503233321202	nejm199503233321202	PROPN
dpc-5050	281	6	.	.	PUNCT
dpc-5050	282	1	pmid	pmid	NOUN
dpc-5050	282	2	:	:	PUNCT
dpc-5050	282	3	7862179	7862179	NUM
dpc-5050	282	4	.	.	PUNCT
dpc-5050	283	1	22	22	NUM
dpc-5050	283	2	.	.	PUNCT
dpc-5050	284	1	hillier	hilli	ADJ
dpc-5050	284	2	ta	ta	PROPN
dpc-5050	284	3	,	,	PUNCT
dpc-5050	284	4	stone	stone	NOUN
dpc-5050	284	5	kl	kl	PROPN
dpc-5050	284	6	,	,	PUNCT
dpc-5050	284	7	bauer	bauer	PROPN
dpc-5050	284	8	dc	dc	PROPN
dpc-5050	284	9	,	,	PUNCT
dpc-5050	284	10	et	et	PROPN
dpc-5050	284	11	al	al	PROPN
dpc-5050	284	12	.	.	PUNCT
dpc-5050	285	1	evaluating	evaluate	VERB
dpc-5050	285	2	the	the	DET
dpc-5050	285	3	value	value	NOUN
dpc-5050	285	4	of	of	ADP
dpc-5050	285	5	repeat	repeat	NOUN
dpc-5050	285	6	bone	bone	NOUN
dpc-5050	285	7	mineral	mineral	NOUN
dpc-5050	285	8	density	density	NOUN
dpc-5050	285	9	measurement	measurement	NOUN
dpc-5050	285	10	and	and	CCONJ
dpc-5050	285	11	prediction	prediction	NOUN
dpc-5050	285	12	of	of	ADP
dpc-5050	285	13	fractures	fracture	NOUN
dpc-5050	285	14	in	in	ADP
dpc-5050	285	15	older	old	ADJ
dpc-5050	285	16	women	woman	NOUN
dpc-5050	285	17	:	:	PUNCT
dpc-5050	285	18	the	the	DET
dpc-5050	285	19	study	study	NOUN
dpc-5050	285	20	of	of	ADP
dpc-5050	285	21	osteoporotic	osteoporotic	ADJ
dpc-5050	285	22	fractures	fracture	NOUN
dpc-5050	285	23	.	.	PUNCT
dpc-5050	285	24	 	 	SPACE
dpc-5050	285	25	arch	arch	VERB